CINXE.COM

<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Anticoagulant - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy", "wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"4e70cef4-47fe-413c-aa7d-596fd0491d2f","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Anticoagulant","wgTitle":"Anticoagulant","wgCurRevisionId":1253673333,"wgRevisionId":1253673333,"wgArticleId":178212,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with short description","Short description is different from Wikidata","All articles with unsourced statements","Articles with unsourced statements from November 2021","Articles with unsourced statements from August 2022","Articles containing potentially dated statements from November 2021","All articles containing potentially dated statements","Anticoagulants","Blood tests","Medical signs"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel": "wikitext","wgRelevantPageName":"Anticoagulant","wgRelevantArticleId":178212,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":80000,"wgRelatedArticlesCompat":[],"wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q215118","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness", "fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher", "ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.growthExperiments.SuggestedEditSession","wikibase.sidebar.tracking"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&only=styles&skin=vector-2022"> <script async="" src="/w/load.php?lang=en&modules=startup&only=scripts&raw=1&skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&modules=site.styles&only=styles&skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.4"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/1200px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="508"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/800px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="339"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/640px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="271"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="Anticoagulant - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Anticoagulant"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Anticoagulant&action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Anticoagulant"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="//login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Anticoagulant rootpage-Anticoagulant skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Main menu </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events">Current events</a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x">Random article</a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works">About Wikipedia</a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact us</a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia">Learn to edit</a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors">Community portal</a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r">Recent changes</a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia">Upload file</a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"> Search </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page's font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Appearance </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en" class="">Donate</a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&returnto=Anticoagulant" title="You are encouraged to create an account and log in; however, it is not mandatory" class="">Create account</a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&returnto=Anticoagulant" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o" class="">Log in</a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Personal tools </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en">Donate</a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&returnto=Anticoagulant" title="You are encouraged to create an account and log in; however, it is not mandatory"> Create account</a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&returnto=Anticoagulant" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o"> Log in</a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing">learn more</a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-Medical_uses" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Medical_uses"> <div class="vector-toc-text"> 1 Medical uses </div> </a> <ul id="toc-Medical_uses-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Adverse_effects" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Adverse_effects"> <div class="vector-toc-text"> 2 Adverse effects </div> </a> <ul id="toc-Adverse_effects-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Interactions" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Interactions"> <div class="vector-toc-text"> 3 Interactions </div> </a> <ul id="toc-Interactions-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Types" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Types"> <div class="vector-toc-text"> 4 Types </div> </a> <button aria-controls="toc-Types-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> Toggle Types subsection </button> <ul id="toc-Types-sublist" class="vector-toc-list"> <li id="toc-Coumarins_(vitamin_K_antagonists)" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Coumarins_(vitamin_K_antagonists)"> <div class="vector-toc-text"> 4.1 Coumarins (vitamin K antagonists) </div> </a> <ul id="toc-Coumarins_(vitamin_K_antagonists)-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Heparin_and_derivative_substances" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Heparin_and_derivative_substances"> <div class="vector-toc-text"> 4.2 Heparin and derivative substances </div> </a> <ul id="toc-Heparin_and_derivative_substances-sublist" class="vector-toc-list"> <li id="toc-Low_molecular_weight_heparin_(LMWH)" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Low_molecular_weight_heparin_(LMWH)"> <div class="vector-toc-text"> 4.2.1 Low molecular weight heparin (LMWH) </div> </a> <ul id="toc-Low_molecular_weight_heparin_(LMWH)-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Synthetic_pentasaccharide_inhibitors_of_factor_Xa" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Synthetic_pentasaccharide_inhibitors_of_factor_Xa"> <div class="vector-toc-text"> 4.3 Synthetic pentasaccharide inhibitors of factor Xa </div> </a> <ul id="toc-Synthetic_pentasaccharide_inhibitors_of_factor_Xa-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Direct_oral" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Direct_oral"> <div class="vector-toc-text"> 4.4 Direct oral </div> </a> <ul id="toc-Direct_oral-sublist" class="vector-toc-list"> <li id="toc-Direct_factor_Xa_inhibitors" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Direct_factor_Xa_inhibitors"> <div class="vector-toc-text"> 4.4.1 Direct factor Xa inhibitors </div> </a> <ul id="toc-Direct_factor_Xa_inhibitors-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Direct_thrombin_inhibitors" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Direct_thrombin_inhibitors"> <div class="vector-toc-text"> 4.4.2 Direct thrombin inhibitors </div> </a> <ul id="toc-Direct_thrombin_inhibitors-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Relevance_to_dental_treatments" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Relevance_to_dental_treatments"> <div class="vector-toc-text"> 4.4.3 Relevance to dental treatments </div> </a> <ul id="toc-Relevance_to_dental_treatments-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Antithrombin_protein_therapeutics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Antithrombin_protein_therapeutics"> <div class="vector-toc-text"> 4.5 Antithrombin protein therapeutics </div> </a> <ul id="toc-Antithrombin_protein_therapeutics-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Other" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Other"> <div class="vector-toc-text"> 4.6 Other </div> </a> <ul id="toc-Other-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Reversal_agents" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Reversal_agents"> <div class="vector-toc-text"> 5 Reversal agents </div> </a> <ul id="toc-Reversal_agents-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Coagulation_inhibitor_measurement" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Coagulation_inhibitor_measurement"> <div class="vector-toc-text"> 6 Coagulation inhibitor measurement </div> </a> <ul id="toc-Coagulation_inhibitor_measurement-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Laboratory_use" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Laboratory_use"> <div class="vector-toc-text"> 7 Laboratory use </div> </a> <ul id="toc-Laboratory_use-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Dental_considerations_for_long-term_users" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Dental_considerations_for_long-term_users"> <div class="vector-toc-text"> 8 Dental considerations for long-term users </div> </a> <ul id="toc-Dental_considerations_for_long-term_users-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Research" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Research"> <div class="vector-toc-text"> 9 Research </div> </a> <ul id="toc-Research-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-See_also" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#See_also"> <div class="vector-toc-text"> 10 See also </div> </a> <ul id="toc-See_also-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> 11 References </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-External_links" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#External_links"> <div class="vector-toc-text"> 12 External links </div> </a> <ul id="toc-External_links-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Toggle the table of contents </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading">Anticoagulant</h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 47 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-47" aria-hidden="true" > 47 languages </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D9%85%D8%B6%D8%A7%D8%AF_%D8%AA%D8%AE%D8%AB%D8%B1" title="مضاد تخثر – Arabic" lang="ar" hreflang="ar" data-title="مضاد تخثر" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target">العربية</a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D0%B0%D0%BD%D1%82" title="Антикоагулант – Bulgarian" lang="bg" hreflang="bg" data-title="Антикоагулант" data-language-autonym="Български" data-language-local-name="Bulgarian" class="interlanguage-link-target">Български</a></li><li class="interlanguage-link interwiki-bs mw-list-item"><a href="https://bs.wikipedia.org/wiki/Antikoagulans" title="Antikoagulans – Bosnian" lang="bs" hreflang="bs" data-title="Antikoagulans" data-language-autonym="Bosanski" data-language-local-name="Bosnian" class="interlanguage-link-target">Bosanski</a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Anticoagulant" title="Anticoagulant – Catalan" lang="ca" hreflang="ca" data-title="Anticoagulant" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target">Català</a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Antikoagulans" title="Antikoagulans – Czech" lang="cs" hreflang="cs" data-title="Antikoagulans" data-language-autonym="Čeština" data-language-local-name="Czech" class="interlanguage-link-target">Čeština</a></li><li class="interlanguage-link interwiki-de badge-Q70894304 mw-list-item" title=""><a href="https://de.wikipedia.org/wiki/Antikoagulans" title="Antikoagulans – German" lang="de" hreflang="de" data-title="Antikoagulans" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target">Deutsch</a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/Antikoagulant" title="Antikoagulant – Estonian" lang="et" hreflang="et" data-title="Antikoagulant" data-language-autonym="Eesti" data-language-local-name="Estonian" class="interlanguage-link-target">Eesti</a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%91%CE%BD%CF%84%CE%B9%CF%80%CE%B7%CE%BA%CF%84%CE%B9%CE%BA%CF%8C_%CF%86%CE%AC%CF%81%CE%BC%CE%B1%CE%BA%CE%BF" title="Αντιπηκτικό φάρμακο – Greek" lang="el" hreflang="el" data-title="Αντιπηκτικό φάρμακο" data-language-autonym="Ελληνικά" data-language-local-name="Greek" class="interlanguage-link-target">Ελληνικά</a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Anticoagulante" title="Anticoagulante – Spanish" lang="es" hreflang="es" data-title="Anticoagulante" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target">Español</a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Antikoagulanto" title="Antikoagulanto – Esperanto" lang="eo" hreflang="eo" data-title="Antikoagulanto" data-language-autonym="Esperanto" data-language-local-name="Esperanto" class="interlanguage-link-target">Esperanto</a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Antikoagulatzaile" title="Antikoagulatzaile – Basque" lang="eu" hreflang="eu" data-title="Antikoagulatzaile" data-language-autonym="Euskara" data-language-local-name="Basque" class="interlanguage-link-target">Euskara</a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%B6%D8%AF%D8%A7%D9%86%D8%B9%D9%82%D8%A7%D8%AF" title="ضدانعقاد – Persian" lang="fa" hreflang="fa" data-title="ضدانعقاد" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target">فارسی</a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Anticoagulant" title="Anticoagulant – French" lang="fr" hreflang="fr" data-title="Anticoagulant" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target">Français</a></li><li class="interlanguage-link interwiki-ga mw-list-item"><a href="https://ga.wikipedia.org/wiki/Antaith%C3%A9achtach" title="Antaithéachtach – Irish" lang="ga" hreflang="ga" data-title="Antaithéachtach" data-language-autonym="Gaeilge" data-language-local-name="Irish" class="interlanguage-link-target">Gaeilge</a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%ED%95%AD%EC%9D%91%EA%B3%A0%EC%A0%9C" title="항응고제 – Korean" lang="ko" hreflang="ko" data-title="항응고제" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target">한국어</a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D5%80%D5%A1%D5%AF%D5%A1%D5%B4%D5%A1%D5%AF%D5%A1%D6%80%D5%A4%D5%AB%D5%B9%D5%B6%D5%A5%D6%80" title="Հակամակարդիչներ – Armenian" lang="hy" hreflang="hy" data-title="Հակամակարդիչներ" data-language-autonym="Հայերեն" data-language-local-name="Armenian" class="interlanguage-link-target">Հայերեն</a></li><li class="interlanguage-link interwiki-hi mw-list-item"><a href="https://hi.wikipedia.org/wiki/%E0%A4%8F%E0%A4%82%E0%A4%9F%E0%A5%80%E0%A4%95%E0%A5%8C%E0%A4%AF%E0%A4%97%E0%A5%81%E0%A4%B2%E0%A4%BE%E0%A4%82%E0%A4%9F" title="एंटीकौयगुलांट – Hindi" lang="hi" hreflang="hi" data-title="एंटीकौयगुलांट" data-language-autonym="हिन्दी" data-language-local-name="Hindi" class="interlanguage-link-target">हिन्दी</a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Antikoagulansi" title="Antikoagulansi – Croatian" lang="hr" hreflang="hr" data-title="Antikoagulansi" data-language-autonym="Hrvatski" data-language-local-name="Croatian" class="interlanguage-link-target">Hrvatski</a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Antikoagulan" title="Antikoagulan – Indonesian" lang="id" hreflang="id" data-title="Antikoagulan" data-language-autonym="Bahasa Indonesia" data-language-local-name="Indonesian" class="interlanguage-link-target">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Anticoagulante" title="Anticoagulante – Italian" lang="it" hreflang="it" data-title="Anticoagulante" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target">Italiano</a></li><li class="interlanguage-link interwiki-kk mw-list-item"><a href="https://kk.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D1%8F%D0%BD%D1%82%D1%82%D0%B0%D1%80" title="Антикоагулянттар – Kazakh" lang="kk" hreflang="kk" data-title="Антикоагулянттар" data-language-autonym="Қазақша" data-language-local-name="Kazakh" class="interlanguage-link-target">Қазақша</a></li><li class="interlanguage-link interwiki-ky mw-list-item"><a href="https://ky.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D1%8F%D0%BD%D1%82%D1%82%D0%B0%D1%80" title="Антикоагулянттар – Kyrgyz" lang="ky" hreflang="ky" data-title="Антикоагулянттар" data-language-autonym="Кыргызча" data-language-local-name="Kyrgyz" class="interlanguage-link-target">Кыргызча</a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Antikoagulants" title="Antikoagulants – Latvian" lang="lv" hreflang="lv" data-title="Antikoagulants" data-language-autonym="Latviešu" data-language-local-name="Latvian" class="interlanguage-link-target">Latviešu</a></li><li class="interlanguage-link interwiki-lt mw-list-item"><a href="https://lt.wikipedia.org/wiki/Antitrombotikai" title="Antitrombotikai – Lithuanian" lang="lt" hreflang="lt" data-title="Antitrombotikai" data-language-autonym="Lietuvių" data-language-local-name="Lithuanian" class="interlanguage-link-target">Lietuvių</a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D0%B0%D0%BD%D1%81" title="Антикоагуланс – Macedonian" lang="mk" hreflang="mk" data-title="Антикоагуланс" data-language-autonym="Македонски" data-language-local-name="Macedonian" class="interlanguage-link-target">Македонски</a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Anticoagulantia" title="Anticoagulantia – Dutch" lang="nl" hreflang="nl" data-title="Anticoagulantia" data-language-autonym="Nederlands" data-language-local-name="Dutch" class="interlanguage-link-target">Nederlands</a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E6%8A%97%E5%87%9D%E5%9B%BA%E8%96%AC" title="抗凝固薬 – Japanese" lang="ja" hreflang="ja" data-title="抗凝固薬" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target">日本語</a></li><li class="interlanguage-link interwiki-nn mw-list-item"><a href="https://nn.wikipedia.org/wiki/Antikoagulant" title="Antikoagulant – Norwegian Nynorsk" lang="nn" hreflang="nn" data-title="Antikoagulant" data-language-autonym="Norsk nynorsk" data-language-local-name="Norwegian Nynorsk" class="interlanguage-link-target">Norsk nynorsk</a></li><li class="interlanguage-link interwiki-uz mw-list-item"><a href="https://uz.wikipedia.org/wiki/Antikoagulyantlar" title="Antikoagulyantlar – Uzbek" lang="uz" hreflang="uz" data-title="Antikoagulyantlar" data-language-autonym="Oʻzbekcha / ўзбекча" data-language-local-name="Uzbek" class="interlanguage-link-target">Oʻzbekcha / ўзбекча</a></li><li class="interlanguage-link interwiki-nds mw-list-item"><a href="https://nds.wikipedia.org/wiki/Antikoagulatschoon" title="Antikoagulatschoon – Low German" lang="nds" hreflang="nds" data-title="Antikoagulatschoon" data-language-autonym="Plattdüütsch" data-language-local-name="Low German" class="interlanguage-link-target">Plattdüütsch</a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Leki_przeciwzakrzepowe" title="Leki przeciwzakrzepowe – Polish" lang="pl" hreflang="pl" data-title="Leki przeciwzakrzepowe" data-language-autonym="Polski" data-language-local-name="Polish" class="interlanguage-link-target">Polski</a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Anticoagulante" title="Anticoagulante – Portuguese" lang="pt" hreflang="pt" data-title="Anticoagulante" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target">Português</a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Anticoagulant" title="Anticoagulant – Romanian" lang="ro" hreflang="ro" data-title="Anticoagulant" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target">Română</a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D1%8F%D0%BD%D1%82%D1%8B" title="Антикоагулянты – Russian" lang="ru" hreflang="ru" data-title="Антикоагулянты" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target">Русский</a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Anticoagulant" title="Anticoagulant – Simple English" lang="en-simple" hreflang="en-simple" data-title="Anticoagulant" data-language-autonym="Simple English" data-language-local-name="Simple English" class="interlanguage-link-target">Simple English</a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Antikoagulans" title="Antikoagulans – Slovak" lang="sk" hreflang="sk" data-title="Antikoagulans" data-language-autonym="Slovenčina" data-language-local-name="Slovak" class="interlanguage-link-target">Slovenčina</a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Antikoagulant" title="Antikoagulant – Slovenian" lang="sl" hreflang="sl" data-title="Antikoagulant" data-language-autonym="Slovenščina" data-language-local-name="Slovenian" class="interlanguage-link-target">Slovenščina</a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D0%B0%D0%BD%D1%81" title="Антикоагуланс – Serbian" lang="sr" hreflang="sr" data-title="Антикоагуланс" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Antikoagulans" title="Antikoagulans – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Antikoagulans" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Antikoagulantit" title="Antikoagulantit – Finnish" lang="fi" hreflang="fi" data-title="Antikoagulantit" data-language-autonym="Suomi" data-language-local-name="Finnish" class="interlanguage-link-target">Suomi</a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Antikoagulantia" title="Antikoagulantia – Swedish" lang="sv" hreflang="sv" data-title="Antikoagulantia" data-language-autonym="Svenska" data-language-local-name="Swedish" class="interlanguage-link-target">Svenska</a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B8%AA%E0%B8%B2%E0%B8%A3%E0%B8%81%E0%B8%B1%E0%B8%99%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B9%80%E0%B8%9B%E0%B9%87%E0%B8%99%E0%B8%A5%E0%B8%B4%E0%B9%88%E0%B8%A1" title="สารกันเลือดเป็นลิ่ม – Thai" lang="th" hreflang="th" data-title="สารกันเลือดเป็นลิ่ม" data-language-autonym="ไทย" data-language-local-name="Thai" class="interlanguage-link-target">ไทย</a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Antikoag%C3%BClan" title="Antikoagülan – Turkish" lang="tr" hreflang="tr" data-title="Antikoagülan" data-language-autonym="Türkçe" data-language-local-name="Turkish" class="interlanguage-link-target">Türkçe</a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D0%BA%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D1%8F%D0%BD%D1%82%D0%B8" title="Антикоагулянти – Ukrainian" lang="uk" hreflang="uk" data-title="Антикоагулянти" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target">Українська</a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/Thu%E1%BB%91c_ch%E1%BB%91ng_%C4%91%C3%B4ng" title="Thuốc chống đông – Vietnamese" lang="vi" hreflang="vi" data-title="Thuốc chống đông" data-language-autonym="Tiếng Việt" data-language-local-name="Vietnamese" class="interlanguage-link-target">Tiếng Việt</a></li><li class="interlanguage-link interwiki-zh-yue mw-list-item"><a href="https://zh-yue.wikipedia.org/wiki/%E8%96%84%E8%A1%80%E8%97%A5" title="薄血藥 – Cantonese" lang="yue" hreflang="yue" data-title="薄血藥" data-language-autonym="粵語" data-language-local-name="Cantonese" class="interlanguage-link-target">粵語</a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E6%8A%97%E5%87%9D%E5%89%82" title="抗凝剂 – Chinese" lang="zh" hreflang="zh" data-title="抗凝剂" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target">中文</a></li> </ul> <div class="after-portlet after-portlet-lang"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q215118#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Anticoagulant" title="View the content page [c]" accesskey="c">Article</a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Anticoagulant" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t">Talk</a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" >English </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Anticoagulant">Read</a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Anticoagulant&action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Anticoagulant&action=history" title="Past revisions of this page [h]" accesskey="h">View history</a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" >Tools </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Anticoagulant">Read</a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Anticoagulant&action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Anticoagulant&action=history">View history</a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Anticoagulant" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Anticoagulant" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Anticoagulant&oldid=1253673333" title="Permanent link to this revision of this page">Permanent link</a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Anticoagulant&action=info" title="More information about this page">Page information</a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&page=Anticoagulant&id=1253673333&wpFormIdentifier=titleform" title="Information on how to cite this page">Cite this page</a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FAnticoagulant">Get shortened URL</a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FAnticoagulant">Download QR code</a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&page=Anticoagulant&action=show-download-screen" title="Download this page as a PDF file">Download as PDF</a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Anticoagulant&printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Anticoagulants" hreflang="en">Wikimedia Commons</a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q215118" title="Structured data on this page hosted by Wikidata [g]" accesskey="g">Wikidata item</a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Class of drugs</div> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background-color: #ddbbee">Anticoagulant</th></tr><tr><td colspan="2" class="infobox-subheader"><a href="/wiki/Drug_class" title="Drug class">Drug class</a></td></tr><tr><td colspan="2" class="infobox-image"><a href="/wiki/File:Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/280px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png" decoding="async" width="280" height="119" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/420px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png/560px-Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png 2x" data-file-width="1824" data-file-height="772" /></a><div class="infobox-caption">Coagulation cascade and major classes of anticoagulants</div></td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">Class identifiers</th></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><a href="/wiki/ATC_code_B01" title="ATC code B01">B01</a></td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">External links</th></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th><td class="infobox-data"><a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D00534-class">D00534-class</a></td></tr><tr><th colspan="2" class="infobox-header" style="background: #e8e8e8;">Legal status</th></tr><tr><td colspan="2" class="infobox-below" style="background: #e8e8e8; text-align: center"><a href="https://www.wikidata.org/wiki/Q215118" class="extiw" title="d:Q215118">In Wikidata</a></td></tr></tbody></table> An anticoagulant, commonly known as a blood thinner, is a <a href="/wiki/Chemical_substance" title="Chemical substance">chemical substance</a> that prevents or reduces the <a href="/wiki/Coagulation" title="Coagulation">coagulation</a> of <a href="/wiki/Blood" title="Blood">blood</a>, prolonging the <a href="/wiki/Clotting_time" title="Clotting time">clotting time</a>.<a href="#cite_note-1">[1]</a> Some occur naturally in <a href="/wiki/Hematophagy" title="Hematophagy">blood-eating</a> animals, such as <a href="/wiki/Leech" title="Leech">leeches</a> and <a href="/wiki/Mosquito" title="Mosquito">mosquitoes</a>, which help keep the bite area unclotted long enough for the animal to obtain blood.<a href="#cite_note-2">[2]</a><a href="#cite_note-3">[3]</a> As a class of <a href="/wiki/Pharmaceutical_drug" class="mw-redirect" title="Pharmaceutical drug">medications</a>, anticoagulants are used in <a href="/wiki/Therapy" title="Therapy">therapy</a> for <a href="/wiki/Thrombosis" title="Thrombosis">thrombotic disorders</a>.<a href="#cite_note-4">[4]</a> <a href="/wiki/Oral_administration" title="Oral administration">Oral</a> anticoagulants (OACs) are taken by many people in <a href="/wiki/Pill_(pharmacy)" class="mw-redirect" title="Pill (pharmacy)">pill</a> or <a href="/wiki/Tablet_(pharmacy)" title="Tablet (pharmacy)">tablet</a> form, and various <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous</a> anticoagulant <a href="/wiki/Dosage_form" title="Dosage form">dosage forms</a> are used in hospitals.<a href="#cite_note-5">[5]</a><a href="#cite_note-6">[6]</a> Some anticoagulants are used in medical equipment, such as sample tubes, <a href="/wiki/Blood_transfusion" title="Blood transfusion">blood transfusion</a> bags, <a href="/wiki/Cardiopulmonary_bypass" title="Cardiopulmonary bypass">heart–lung machines</a>, and <a href="/wiki/Kidney_dialysis" title="Kidney dialysis">dialysis</a> equipment.<a href="#cite_note-7">[7]</a><a href="#cite_note-8">[8]</a> One of the first anticoagulants, <a href="/wiki/Warfarin" title="Warfarin">warfarin</a>, was initially approved as a <a href="/wiki/Rodenticide" title="Rodenticide">rodenticide</a>.<a href="#cite_note-9">[9]</a> Anticoagulants are closely related to <a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">antiplatelet drugs</a> and <a href="/wiki/Thrombolytic" class="mw-redirect" title="Thrombolytic">thrombolytic</a> drugs by manipulating the various pathways of blood coagulation.<a href="#cite_note-10">[10]</a> Specifically, antiplatelet drugs inhibit platelet aggregation (clumping together), whereas anticoagulants inhibit specific pathways of the coagulation cascade, which happens after the initial platelet aggregation but before the formation of fibrin and stable aggregated platelet products.<a href="#cite_note-11">[11]</a><a href="#cite_note-12">[12]</a> Common anticoagulants include warfarin and <a href="/wiki/Heparin" title="Heparin">heparin</a>.<a href="#cite_note-WSJOct2007-13">[13]</a> <style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div> <div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=1" title="Edit section: Medical uses">edit</a>]</div> The use of anticoagulants is a decision based on the risks and benefits of anticoagulation.<a href="#cite_note-14">[14]</a> The biggest risk of anticoagulation therapy is the increased risk of bleeding.<a href="#cite_note-Parks_514–524-15">[15]</a> In otherwise healthy people, the increased risk of bleeding is minimal, but those who have had recent surgery, <a href="/wiki/Cerebral_aneurysm" class="mw-redirect" title="Cerebral aneurysm">cerebral aneurysms</a>, and other conditions may have too great a risk of bleeding.<a href="#cite_note-16">[16]</a><a href="#cite_note-17">[17]</a> Generally, the benefit of anticoagulation is preventing or reducing the progression of a thromboembolic disease.<a href="#cite_note-18">[18]</a> Some indications for anticoagulant therapy that are known to have benefit from therapy include: <ul><li><a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">Atrial fibrillation</a> — commonly forms an <a href="/wiki/Right_atrium" class="mw-redirect" title="Right atrium">atrial appendage</a> clot<a href="#cite_note-19">[19]</a></li> <li><a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">Coronary artery disease</a><a href="#cite_note-20">[20]</a></li> <li><a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">Deep vein thrombosis</a> — can lead to pulmonary embolism<a href="#cite_note-21">[21]</a></li> <li>Ischemic <a href="/wiki/Stroke" title="Stroke">stroke</a><a href="#cite_note-22">[22]</a></li> <li><a href="/wiki/Hypercoagulable" class="mw-redirect" title="Hypercoagulable">Hypercoagulable</a> states (e.g., <a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">Factor V Leiden</a>) — can lead to deep vein thrombosis<a href="#cite_note-23">[23]</a></li> <li>Mechanical heart valves<a href="#cite_note-24">[24]</a></li> <li><a href="/wiki/Myocardial_infarction" title="Myocardial infarction">Myocardial infarction</a><a href="#cite_note-25">[25]</a></li> <li><a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">Pulmonary embolism</a><a href="#cite_note-26">[26]</a></li> <li><a href="/wiki/Restenosis" title="Restenosis">Restenosis</a> from stents<a href="#cite_note-27">[27]</a></li> <li>Cardiopulmonary bypass (or any other surgeries requiring temporary aortic occlusion)<a href="#cite_note-28">[28]</a></li> <li>Heart failure<a href="#cite_note-29">[29]</a></li></ul> In these cases, anticoagulation therapy <a href="/wiki/Thrombosis_prophylaxis" class="mw-redirect" title="Thrombosis prophylaxis">prevents the formation</a> or growth of dangerous clots.<a href="#cite_note-30">[30]</a> The decision to begin therapeutic anticoagulation often involves the use of multiple bleeding risk predictable outcome tools as non-invasive pre-test stratifications due to the potential for bleeding while on blood thinning agents.<a href="#cite_note-Parks_514–524-15">[15]</a> Among these tools are <a href="/wiki/HAS-BLED" title="HAS-BLED">HAS-BLED</a>,<a href="#cite_note-urlHAS-BLED_Score-31">[31]</a> ATRIA,<a href="#cite_note-urlATRIA_Bleeding_Risk-32">[32]</a> HEMORR2HAGES,<a href="#cite_note-33">[33]</a> and <a href="/wiki/CHA2DS2-VASc" class="mw-redirect" title="CHA2DS2-VASc">CHA2DS2-VASc</a>.<a href="#cite_note-urlCHA2DS2-VASc-34">[34]</a> The risk of bleeding using the risk assessment tools above must then be weighed against thrombotic risk to formally determine the patient's overall benefit in starting anticoagulation therapy.<a href="#cite_note-35">[35]</a> There is no evidence to indicate that adding anticoagulant therapy to standard treatment has a benefit for people with cerebral small vessel disease but not dementia, and there is an increased risk of a person with this disease experiencing a bleed with this approach.<a href="#cite_note-36">[36]</a> <div class="mw-heading mw-heading2"><h2 id="Adverse_effects">Adverse effects</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=2" title="Edit section: Adverse effects">edit</a>]</div> The most serious and common adverse side effects associated with anticoagulants are increased risk of bleeding, both nonmajor and major bleeding events.<a href="#cite_note-37">[37]</a> The bleeding risk depends on the class of anticoagulant agent used, the patient's age, and pre-existing health conditions. Warfarin has an estimated incidence of bleeding of 15-20% per year and a life-threatening bleeding rate of 1-3% per year.<a href="#cite_note-38">[38]</a> Newer non-vitamin K antagonist oral anticoagulants appear to have fewer life-threatening bleeding events than warfarin.<a href="#cite_note-Breadth_of_complications_of_long-te-39">[39]</a><a href="#cite_note-40">[40]</a> Additionally, patients aged 80 years or more may be especially susceptible to bleeding complications, with a rate of 13 bleeds per 100 person-years.<a href="#cite_note-pmid17515465-41">[41]</a> Bleeding risk is especially important to consider in patients with renal impairment and NOAC therapy because all NOACs, to some extent, are excreted by the kidneys.<a href="#cite_note-42">[42]</a> Thus, patients with renal impairment may be at higher risk of increased bleeding.<a href="#cite_note-43">[43]</a> In people with cancer, a systematic review has found warfarin had no effect on death rate or the risk of blood clots.<a href="#cite_note-:2-44">[44]</a> However, it did increase the risk of major bleeding in 107 more people per 1000 population and minor bleeding in 167 more people per 1000 population.<a href="#cite_note-:2-44">[44]</a> Apixaban had no effect on mortality, recurrence of blood clots in blood vessels, or major or minor bleeding. However, this finding comes only from one study.<a href="#cite_note-:2-44">[44]</a> Nonhemorrhagic adverse events are less common than hemorrhagic adverse events but should still be monitored closely.<a href="#cite_note-Breadth_of_complications_of_long-te-39">[39]</a> Nonhemorrhagic adverse events of warfarin include skin <a href="/wiki/Necrosis" title="Necrosis">necrosis</a>, limb gangrene, and purple toe syndrome.<a href="#cite_note-Oral_anticoagulant_therapy:_Antithr-45">[45]</a> Skin necrosis and limb gangrene are most commonly observed on the third to eighth day of therapy.<a href="#cite_note-46">[46]</a><a href="#cite_note-47">[47]</a> The exact pathogenesis of skin necrosis and limb gangrene is not completely understood but it is believed to be associated with warfarin's effect on inhibiting the production of protein C and protein S.<a href="#cite_note-48">[48]</a><a href="#cite_note-49">[49]</a> Purple toe syndrome typically develops three to eight weeks after initiation of warfarin therapy.<a href="#cite_note-50">[50]</a><a href="#cite_note-51">[51]</a> Other adverse effects of warfarin are associated with depletion of vitamin K, which can lead to inhibition of G1a proteins and growth arrest-specific gene 6, which can lead to increased risk of arterial calcification and heart valve, especially if too much Vitamin D is present.<a href="#cite_note-Adams2005-52">[52]</a><a href="#cite_note-53">[53]</a> Warfarin's interference with G1a proteins has also been linked to abnormalities in fetal bone development in mothers who were treated with warfarin during pregnancy.<a href="#cite_note-54">[54]</a><a href="#cite_note-55">[55]</a> Long-term warfarin and heparin usage have also been linked to osteoporosis.<a href="#cite_note-56">[56]</a><a href="#cite_note-Oral_anticoagulant_therapy:_Antithr-45">[45]</a> Another potentially severe complication associated with heparin use is called heparin-induced thrombocytopenia (HIT).<a href="#cite_note-Heparin-induced_thrombocytopenia-57">[57]</a> There are two distinct types: HIT 1) immune-mediated and 2) non-immune-mediated.<a href="#cite_note-Heparin-induced_thrombocytopenia-57">[57]</a> Immune-mediated HIT most commonly arises five to ten days after exposure to heparin.<a href="#cite_note-58">[58]</a> Pathogenesis of immune-mediated HIT is believed to be caused by heparin-dependent immunoglobulin antibodies binding to platelet factor 4/heparin complexes on platelets, leading to widespread platelet activation.<a href="#cite_note-59">[59]</a> <div class="mw-heading mw-heading2"><h2 id="Interactions">Interactions</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=3" title="Edit section: Interactions">edit</a>]</div> Foods and <a href="/wiki/Food_supplement" class="mw-redirect" title="Food supplement">food supplements</a> with blood-thinning effects include <a href="/wiki/Nattokinase" title="Nattokinase">nattokinase</a>, <a href="/wiki/Lumbrokinase" title="Lumbrokinase">lumbrokinase</a>, <a href="/wiki/Beer" title="Beer">beer</a>, <a href="/wiki/Bilberry" title="Bilberry">bilberry</a>, <a href="/wiki/Celery" title="Celery">celery</a>, <a href="/wiki/Cranberry" title="Cranberry">cranberries</a>, <a href="/wiki/Fish_oil" title="Fish oil">fish oil</a>, <a href="/wiki/Garlic" title="Garlic">garlic</a>, <a href="/wiki/Ginger" title="Ginger">ginger</a>, <a href="/wiki/Ginkgo" title="Ginkgo">ginkgo</a>, <a href="/wiki/Ginseng" title="Ginseng">ginseng</a>, <a href="/wiki/Green_tea" title="Green tea">green tea</a>, <a href="/wiki/Horse_chestnut" class="mw-redirect" title="Horse chestnut">horse chestnut</a>, <a href="/wiki/Licorice" class="mw-redirect" title="Licorice">licorice</a>, <a href="/wiki/Niacin_(nutrient)" class="mw-redirect" title="Niacin (nutrient)">niacin</a>, <a href="/wiki/Onion" title="Onion">onion</a>, <a href="/wiki/Papaya" title="Papaya">papaya</a>, <a href="/wiki/Pomegranate" title="Pomegranate">pomegranate</a>, <a href="/wiki/Red_clover" class="mw-redirect" title="Red clover">red clover</a>, <a href="/wiki/Soybean" title="Soybean">soybean</a>, <a href="/wiki/St._John%27s_wort" class="mw-redirect" title="St. John's wort">St. John's wort</a>, <a href="/wiki/Turmeric" title="Turmeric">turmeric</a>, <a href="/wiki/Wheatgrass" title="Wheatgrass">wheatgrass</a>, and <a href="/wiki/Willow" title="Willow">willow</a> bark.<a href="#cite_note-pmid11711691-60">[60]</a><a href="#cite_note-61">[61]</a><a href="#cite_note-62">[62]</a> Many herbal supplements have blood-thinning properties, such as <a href="/wiki/Danshen" class="mw-redirect" title="Danshen">danshen</a> and <a href="/wiki/Feverfew" class="mw-redirect" title="Feverfew">feverfew</a>.<a href="#cite_note-63">[63]</a> Multivitamins that do not interact with clotting are available for patients on anticoagulants.<a href="#cite_note-64">[64]</a> However, some foods and supplements encourage clotting.<a href="#cite_note-65">[65]</a> These include <a href="/wiki/Alfalfa" title="Alfalfa">alfalfa</a>, <a href="/wiki/Avocado" title="Avocado">avocado</a>, <a href="/wiki/Cat%27s_claw" title="Cat's claw">cat's claw</a>, <a href="/wiki/Coenzyme_Q10" title="Coenzyme Q10">coenzyme Q10</a>, and dark leafy greens such as <a href="/wiki/Spinach" title="Spinach">spinach</a>.<a href="#cite_note-66">[66]</a><a href="#cite_note-67">[67]</a> Excessive intake of the food mentioned above should be avoided while taking anticoagulants, or if coagulability is being monitored, their intake should be kept approximately constant so that anticoagulant dosage can be maintained at a level high enough to counteract this effect without fluctuations in coagulability.<a href="#cite_note-68">[68]</a><a href="#cite_note-69">[69]</a> <a href="/wiki/Grapefruit" title="Grapefruit">Grapefruit</a> interferes with some anticoagulant drugs, increasing the time it takes for them to be metabolized out of the body, and should be eaten with caution when on anticoagulant drugs.<a href="#cite_note-70">[70]</a> Anticoagulants are often used to treat acute <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">deep-vein thrombosis</a>.<a href="#cite_note-71">[71]</a><a href="#cite_note-72">[72]</a> People using anticoagulants to treat this condition should avoid using <a href="/wiki/Bed_rest" title="Bed rest">bed rest</a> as a complementary treatment because there are clinical benefits to continuing to walk and remaining mobile while using anticoagulants in this way.<a href="#cite_note-APTAfive-73">[73]</a> Bed rest while using anticoagulants can harm patients in circumstances in which it is not medically necessary.<a href="#cite_note-APTAfive-73">[73]</a> <div class="mw-heading mw-heading2"><h2 id="Types">Types</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=4" title="Edit section: Types">edit</a>]</div> Several anticoagulants are available. Warfarin, other coumarins, and heparins have long been used.<a href="#cite_note-74">[74]</a> Since the 2000s, several agents have been introduced that are collectively referred to as direct oral anticoagulants (DOACs), previously named novel oral anticoagulants (NOACs) or non-vitamin K antagonist oral anticoagulants.<a href="#cite_note-75">[75]</a><a href="#cite_note-76">[76]</a><a href="#cite_note-77">[77]</a><a href="#cite_note-78">[78]</a> These agents include direct thrombin inhibitor (<a href="/wiki/Dabigatran" title="Dabigatran">dabigatran</a>) and factor Xa inhibitor (<a href="/wiki/Rivaroxaban" title="Rivaroxaban">rivaroxaban</a>, <a href="/wiki/Apixaban" title="Apixaban">apixaban</a>, <a href="/wiki/Betrixaban" title="Betrixaban">betrixaban</a> and <a href="/wiki/Edoxaban" title="Edoxaban">edoxaban</a>), and they have been shown to be as good or possibly better than the coumarins with less serious side effects.<a href="#cite_note-79">[79]</a> The newer anticoagulants (NOACs/DOACs) are more expensive than the traditional ones and should be used in caring for patients with kidney problems.<a href="#cite_note-80">[80]</a> <div class="mw-heading mw-heading3"><h3 id="Coumarins_(vitamin_K_antagonists)">Coumarins (vitamin K antagonists)</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=5" title="Edit section: Coumarins (vitamin K antagonists)">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Vitamin_K_antagonist" title="Vitamin K antagonist">Vitamin K antagonist</a></div> These oral anticoagulants are derived from <a href="/wiki/Coumarin" title="Coumarin">coumarin</a> found in many plants. A prominent member of this class, <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> (Coumadin), was found to be the anticoagulant most prescribed in a large multispecialty practice.<a href="#cite_note-81">[81]</a> The anticoagulant effect takes at least 48 to 72 hours to develop. Where an immediate effect is required, <a href="/wiki/Heparin" title="Heparin">heparin</a> is given concomitantly. These anticoagulants are used to treat patients with <a href="/wiki/Deep-vein_thrombosis" class="mw-redirect" title="Deep-vein thrombosis">deep-vein thrombosis</a> (DVT) and <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a> (PE) and to prevent emboli in patients with <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">atrial fibrillation</a> (AF), and mechanical <a href="/wiki/Prosthetic_heart_valve" class="mw-redirect" title="Prosthetic heart valve">prosthetic heart valves</a>. Other examples are <a href="/wiki/Acenocoumarol" title="Acenocoumarol">acenocoumarol</a>, <a href="/wiki/Phenprocoumon" title="Phenprocoumon">phenprocoumon</a>, <a href="/wiki/Atromentin" title="Atromentin">atromentin</a>, and <a href="/wiki/Phenindione" title="Phenindione">phenindione</a>.[<a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a>] The coumarins <a href="/wiki/Brodifacoum" title="Brodifacoum">brodifacoum</a> and <a href="/wiki/Difenacoum" title="Difenacoum">difenacoum</a> are used as mammalicides (particularly as <a href="/wiki/Rodenticide" title="Rodenticide">rodenticides</a>) but are not used medically.[<a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a>] <div class="mw-heading mw-heading3"><h3 id="Heparin_and_derivative_substances">Heparin and derivative substances</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=6" title="Edit section: Heparin and derivative substances">edit</a>]</div> Heparin is the most widely used intravenous clinical anticoagulant worldwide.<a href="#cite_note-82">[82]</a> <a href="/wiki/Heparin" title="Heparin">Heparin</a> is a naturally occurring <a href="/wiki/Glycosaminoglycan" title="Glycosaminoglycan">glycosaminoglycan</a>. There are three major categories of heparin: unfractionated heparin (UFH), low molecular weight heparin (LMWH), and ultra-low-molecular weight heparin (ULMWH).<a href="#cite_note-Heparin_and_anticoagulation-83">[83]</a> Unfractionated heparin is usually derived from <a href="/wiki/Pig" title="Pig">pig</a> intestines and bovine lungs.<a href="#cite_note-84">[84]</a> UFH binds to the enzyme inhibitor <a href="/wiki/Antithrombin" title="Antithrombin">antithrombin</a> III (AT), causing a conformational change that results in its activation.<a href="#cite_note-85">[85]</a> The activated AT then inactivates <a href="/wiki/Factor_Xa" class="mw-redirect" title="Factor Xa">factor Xa</a>, <a href="/wiki/Thrombin" title="Thrombin">thrombin</a>, and other coagulation factors.<a href="#cite_note-86">[86]</a> Heparin can be used <a href="/wiki/In_vivo" title="In vivo">in vivo</a> (by injection), and also <a href="/wiki/In_vitro" title="In vitro">in vitro</a> to prevent blood or plasma clotting in or on medical devices. In <a href="/wiki/Venipuncture" title="Venipuncture">venipuncture</a>, <a href="/wiki/Vacutainer" title="Vacutainer">Vacutainer</a> brand blood collecting tubes containing heparin usually have a green cap.<a href="#cite_note-87">[87]</a> <div class="mw-heading mw-heading4"><h4 id="Low_molecular_weight_heparin_(LMWH)">Low molecular weight heparin (LMWH)</h4>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=7" title="Edit section: Low molecular weight heparin (LMWH)">edit</a>]</div> <a href="/wiki/Low_molecular_weight_heparin" class="mw-redirect" title="Low molecular weight heparin">Low molecular weight heparin</a> (LMWH) is produced through a controlled depolymerization of unfractionated heparin.<a href="#cite_note-Heparin_and_anticoagulation-83">[83]</a> LMWH exhibits a higher anti-Xa/anti-IIa activity ratio and is useful as it does not require monitoring of the <a href="/wiki/APTT" class="mw-redirect" title="APTT">APTT</a> <a href="/wiki/Coagulation" title="Coagulation">coagulation</a> parameter and has fewer side effects.<a href="#cite_note-Heparin_and_anticoagulation-83">[83]</a> <div class="mw-heading mw-heading3"><h3 id="Synthetic_pentasaccharide_inhibitors_of_factor_Xa">Synthetic pentasaccharide inhibitors of factor Xa</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=8" title="Edit section: Synthetic pentasaccharide inhibitors of factor Xa">edit</a>]</div> <ul><li><a href="/wiki/Fondaparinux" title="Fondaparinux">Fondaparinux</a> is a synthetic sugar composed of the five sugars (pentasaccharides) in heparin that bind to antithrombin. It is a smaller molecule than low molecular-weight heparin.</li> <li><a href="/wiki/Idraparinux" title="Idraparinux">Idraparinux</a></li> <li><a href="/wiki/Idrabiotaparinux" class="mw-redirect" title="Idrabiotaparinux">Idrabiotaparinux</a></li></ul> <div class="mw-heading mw-heading3"><h3 id="Direct_oral">Direct oral</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=9" title="Edit section: Direct oral">edit</a>]</div> The direct oral anticoagulants (DOACs) were introduced in and after 2008.<a href="#cite_note-88">[88]</a> There are five DOACs currently on the market: <a href="/wiki/Dabigatran" title="Dabigatran">dabigatran</a>, <a href="/wiki/Rivaroxaban" title="Rivaroxaban">rivaroxaban</a>, <a href="/wiki/Apixaban" title="Apixaban">apixaban</a>, <a href="/wiki/Edoxaban" title="Edoxaban">edoxaban</a> and <a href="/wiki/Betrixaban" title="Betrixaban">betrixaban</a>.<a href="#cite_note-DOAC2018-89">[89]</a> They were also previously referred to as "new/novel" and "non-vitamin K antagonist" oral anticoagulants (NOACs).<a href="#cite_note-udayachalerm-90">[90]</a> Compared to warfarin, DOACs have a rapid onset action and relatively short half-lives; hence, they carry out their function more rapidly and effectively, allowing drugs to reduce their anticoagulation effects quickly.<a href="#cite_note-:1-91">[91]</a> Routine monitoring and dose adjustments of DOACs are less important than for warfarin, as they have better predictable anticoagulation activity.<a href="#cite_note-:3-92">[92]</a> DOAC monitoring, including laboratory monitoring and a complete medication review, should generally be conducted before initiation of a DOAC, 1–3 months after initiation, and then every 6–12 months afterwards.<a href="#cite_note-:4-93">[93]</a> Both DOACs and warfarin are equivalently effective, but compared to warfarin, DOACs have fewer drug interactions, no known dietary interactions, a wider therapeutic index, and have conventional dosing that does not require dose adjustments with constant monitoring.<a href="#cite_note-:0-94">[94]</a><a href="#cite_note-:3-92">[92]</a> However, there is no countermeasure for most DOACs, unlike for warfarin; nonetheless, the short half-lives of DOACs will allow their effects to recede swiftly. A reversal agent for dabigatran, <a href="/wiki/Idarucizumab" title="Idarucizumab">idarucizumab</a>, is currently available and approved for use by the FDA. Rates of adherence to DOACs are only modestly higher than adherence to warfarin among patients prescribed these drugs. Thus, adherence to anticoagulation is often poor despite hopes that DOACs would lead to higher adherence rates.<a href="#cite_note-95">[95]</a> DOACs are significantly more expensive than warfarin, but the patients on DOACs may experience reduced lab costs as they do not need to monitor their INR.<a href="#cite_note-:4-93">[93]</a> <div class="mw-heading mw-heading4"><h4 id="Direct_factor_Xa_inhibitors">Direct factor Xa inhibitors</h4>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=10" title="Edit section: Direct factor Xa inhibitors">edit</a>]</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Direct_Xa_inhibitor" class="mw-redirect" title="Direct Xa inhibitor">Direct Xa inhibitor</a></div> Drugs such as <a href="/wiki/Rivaroxaban" title="Rivaroxaban">rivaroxaban</a>, <a href="/wiki/Apixaban" title="Apixaban">apixaban</a> and <a href="/wiki/Edoxaban" title="Edoxaban">edoxaban</a> work by inhibiting factor Xa directly (unlike heparins and fondaparinux, which work via antithrombin activation). Also included in this category are <a href="/wiki/Betrixaban" title="Betrixaban">betrixaban</a> from Portola Pharmaceuticals, the discontinued <a href="/wiki/Darexaban" title="Darexaban">darexaban</a> (YM150) from Astellas, and, more recently, the discontinued <a href="/w/index.php?title=Letaxaban&action=edit&redlink=1" class="new" title="Letaxaban (page does not exist)">letaxaban</a> (TAK-442) from Takeda and <a href="/w/index.php?title=Eribaxaban&action=edit&redlink=1" class="new" title="Eribaxaban (page does not exist)">eribaxaban</a> (PD0348292) from Pfizer. Betrixaban is significant as it was in 2018, the only oral factor Xa inhibitor approved by the FDA for use in acutely medically ill patients.<a href="#cite_note-96">[96]</a> Darexaban development was discontinued in September 2011; in a trial for prevention of recurrences of myocardial infarction in addition to dual antiplatelet therapy (DAPT), the drug did not demonstrate effectiveness, and the risk of bleeding was increased by approximately 300%.<a href="#cite_note-Steg-97">[97]</a> The development of letaxaban for acute coronary syndrome was discontinued in May 2011 following negative results from a Phase II study.<a href="#cite_note-98">[98]</a> <div class="mw-heading mw-heading4"><h4 id="Direct_thrombin_inhibitors">Direct thrombin inhibitors</h4>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=11" title="Edit section: Direct thrombin inhibitors">edit</a>]</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Direct_thrombin_inhibitor" title="Direct thrombin inhibitor">Direct thrombin inhibitor</a></div> Another type of anticoagulant is the <a href="/wiki/Direct_thrombin_inhibitor" title="Direct thrombin inhibitor">direct thrombin inhibitor</a>.<a href="#cite_note-pmid16148288-99">[99]</a> Current members of this class include the bivalent drugs <a href="/wiki/Hirudin" title="Hirudin">hirudin</a>, <a href="/wiki/Lepirudin" title="Lepirudin">lepirudin</a>, and <a href="/wiki/Bivalirudin" title="Bivalirudin">bivalirudin</a> and the monovalent drugs <a href="/wiki/Argatroban" title="Argatroban">argatroban</a> and <a href="/wiki/Dabigatran" title="Dabigatran">dabigatran</a>. An oral direct thrombin inhibitor, <a href="/wiki/Ximelagatran" title="Ximelagatran">ximelagatran</a> (Exanta), was denied approval by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) in September 2004<a href="#cite_note-100">[100]</a> and was pulled from the market entirely in February 2006 after reports of severe liver damage and heart attacks.<a href="#cite_note-101">[101]</a> In November 2010, <a href="/wiki/Dabigatran_Etexilate" class="mw-redirect" title="Dabigatran Etexilate">dabigatran etexilate</a> was approved by the FDA to prevent thrombosis in <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">atrial fibrillation</a>. <div class="mw-heading mw-heading4"><h4 id="Relevance_to_dental_treatments">Relevance to dental treatments</h4>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=12" title="Edit section: Relevance to dental treatments">edit</a>]</div> As in any invasive procedure, patients on anticoagulation therapy have an increased risk for bleeding, and caution should be used along with local <a href="/wiki/Hemostasis" title="Hemostasis">hemostatic</a> methods to minimize bleeding risk during the operation as well as postoperatively.<a href="#cite_note-102">[102]</a> However, with regards to DOACs and invasive dental treatments, there has not been enough clinical evidence and experience to prove any reliable adverse effects, relevance or interaction between these two.<a href="#cite_note-103">[103]</a> Further clinical prospective studies on DOACs are required to investigate the bleeding risk and hemostasis associated with surgical and dental procedures.<a href="#cite_note-104">[104]</a> Recommendations of modifications to the usage/dosage of DOACs before dental treatments are made based on the balance of the bleeding risk of each procedure and also the individual's own bleeding risks and renal functionality.<a href="#cite_note-105">[105]</a> With low-bleeding-risk dental procedures, it is recommended that DOACs be continued by the patient to avoid any increase in the risk of a thromboembolic event.<a href="#cite_note-106">[106]</a><a href="#cite_note-107">[107]</a> For dental procedures with a higher risk of bleeding complications (i.e. complex extractions, adjacent extractions leading to a large wound, or more than three extractions), the recommended practice is for the patient to miss or delay a dose of their DOAC before such procedures to minimize the effect on bleeding risk.<a href="#cite_note-108">[108]</a> <div class="mw-heading mw-heading3"><h3 id="Antithrombin_protein_therapeutics">Antithrombin protein therapeutics</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=13" title="Edit section: Antithrombin protein therapeutics">edit</a>]</div> The antithrombin protein is used as a <a href="/wiki/Biologic_medical_product" class="mw-redirect" title="Biologic medical product">protein therapeutic</a> that can be purified from human plasma<a href="#cite_note-ThrombateLabel-109">[109]</a> or produced recombinantly (for example, Atryn, produced in the milk of <a href="/wiki/Genetic_engineering" title="Genetic engineering">genetically modified</a> goats).<a href="#cite_note-110">[110]</a><a href="#cite_note-ATrynLabel-111">[111]</a> The FDA approves Antithrombin as an anticoagulant for preventing clots before, during, or after surgery or birthing in patients with hereditary antithrombin deficiency.<a href="#cite_note-ThrombateLabel-109">[109]</a><a href="#cite_note-ATrynLabel-111">[111]</a> <div class="mw-heading mw-heading3"><h3 id="Other">Other</h3>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=14" title="Edit section: Other">edit</a>]</div> Many other anticoagulants exist in <a href="/wiki/Research_and_development" title="Research and development">research and development</a>, <a href="/wiki/Diagnostics" class="mw-redirect" title="Diagnostics">diagnostics</a>, or as drug candidates. <ul><li><a href="/wiki/Batroxobin" title="Batroxobin">Batroxobin</a>, a <a href="/wiki/Toxin" title="Toxin">toxin</a> from <a href="/wiki/Snake" title="Snake">snake</a> <a href="/wiki/Venom" title="Venom">venom</a>, clots platelet-rich plasma without affecting <a href="/wiki/Platelet" title="Platelet">platelet</a> functions (cleaves <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a>).</li> <li><a href="/wiki/Hementin" title="Hementin">Hementin</a> is an anticoagulant protease from the salivary glands of the giant Amazon leech, <a href="/wiki/Haementeria_ghilianii" title="Haementeria ghilianii">Haementeria ghilianii</a>.</li> <li><a href="/wiki/Vitamin_E" title="Vitamin E">Vitamin E</a></li> <li><a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">Alcoholic beverage</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="Reversal_agents">Reversal agents</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=15" title="Edit section: Reversal agents">edit</a>]</div> With the growing number of patients taking oral anticoagulation therapy, studies into reversal agents are gaining increasing interest due to major bleeding events and the need for urgent anticoagulant reversal therapy.<a href="#cite_note-Tornkvist_22–31-112">[112]</a> Reversal agents for warfarin are more widely studied, and established guidelines for reversal exist due to a longer history of use of warfarin and the ability to get a more accurate measurement of anticoagulation effect in a patient via measuring the INR (International Normalized Ratio).<a href="#cite_note-113">[113]</a> In general, vitamin K is most commonly used to reverse the effect of warfarin in non-urgent settings.<a href="#cite_note-114">[114]</a> However, in urgent settings or settings with extremely high INR (INR >20), hemostatic reversal agents such as fresh frozen plasma (FFP), <a href="/wiki/Recombinant_factor_VIIa" title="Recombinant factor VIIa">recombinant factor VIIa</a>, and prothrombin complex concentrate (PCC) have been utilized with proven efficacy.<a href="#cite_note-115">[115]</a> Specifically with warfarin, four-factor PCC (4F-PCC) has been shown to have superior safety and mortality benefits compared to FPP in lowering INR levels.<a href="#cite_note-Tornkvist_22–31-112">[112]</a> Although specific antidotes and reversal agents for DOACs are not as widely studied, <a href="/wiki/Idarucizumab" title="Idarucizumab">idarucizumab</a> (for dabigatran) and <a href="/wiki/Andexanet_alfa" title="Andexanet alfa">andexanet alfa</a> (for factor Xa inhibitor) have been used in clinical settings with varying efficacy.<a href="#cite_note-udayachalerm-90">[90]</a> Idarucizumab is a monoclonal antibody, approved by the US FDA in 2015, that reverses the effect of dabigatran by binding to both free and thrombin-bound dabigatran.<a href="#cite_note-116">[116]</a><a href="#cite_note-117">[117]</a> Andexanet alfa is a recombinant modified human factor Xa decoy that reverses the effect of factor Xa inhibitors by binding at the active sites of factor Xa inhibitor and making it catalytically inactive.<a href="#cite_note-118">[118]</a><a href="#cite_note-119">[119]</a> Andexanet alfa was approved by the US FDA in 2018.<a href="#cite_note-120">[120]</a> Another drug called ciraparantag, a potential reversal agent for direct factor Xa inhibitors, is still under investigation.<a href="#cite_note-121">[121]</a> Additionally, hemostatic reversal agents have also been used with varying efficacy to reverse the effects of DOACs.<a href="#cite_note-122">[122]</a><a href="#cite_note-123">[123]</a> <div class="mw-heading mw-heading2"><h2 id="Coagulation_inhibitor_measurement">Coagulation inhibitor measurement</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=16" title="Edit section: Coagulation inhibitor measurement">edit</a>]</div> A Bethesda unit (BU) is a measure of blood <a href="/wiki/Coagulation_inhibitor" class="mw-redirect" title="Coagulation inhibitor">coagulation inhibitor</a> activity. It is the amount of inhibitor that will inactivate half of a <a href="/wiki/Coagulation" title="Coagulation">coagulant</a> during the incubation period.<a href="#cite_note-124">[124]</a> It is the standard measure used in the United States and is so named because it was adopted as a standard at a conference in <a href="/wiki/Bethesda,_Maryland" title="Bethesda, Maryland">Bethesda, Maryland</a>.<a href="#cite_note-125">[125]</a> <div class="mw-heading mw-heading2"><h2 id="Laboratory_use">Laboratory use</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=17" title="Edit section: Laboratory use">edit</a>]</div> If blood is allowed to clot, <a href="/wiki/Medical_laboratory" title="Medical laboratory">laboratory</a> instruments, blood transfusion bags, and medical and surgical equipment will get clogged up and non-operational. In addition, test tubes used for laboratory blood tests will have chemicals added to stop blood clotting. Besides heparin, most of these chemicals <a href="/wiki/Chelation" title="Chelation">bind</a> <a href="/wiki/Calcium" title="Calcium">calcium</a> ions, preventing the coagulation proteins from using them. <ul><li><a href="/wiki/Ethylenediaminetetraacetic_acid" title="Ethylenediaminetetraacetic acid">Ethylenediaminetetraacetic acid</a> (EDTA) strongly and irreversibly chelates (binds) calcium ions, preventing blood from clotting.</li> <li><a href="/wiki/Citrate" class="mw-redirect" title="Citrate">Citrate</a> is in liquid form in the tube and is used for coagulation tests and blood transfusion bags. It binds calcium but not as strongly as EDTA. The correct proportion of this anticoagulant to blood is crucial because of the dilution, which can be reversed with the addition of calcium. Formulations include plain <a href="/wiki/Monosodium_citrate" title="Monosodium citrate">sodium citrate</a>, <a href="/wiki/Acid-citrate-dextrose" title="Acid-citrate-dextrose">acid-citrate-dextrose</a>, and more.</li> <li><a href="/wiki/Oxalate" title="Oxalate">Oxalate</a> has a mechanism similar to that of citrate. It is the anticoagulant used in fluoride/oxalate tubes to determine glucose and lactate levels. The fluoride inhibits <a href="/wiki/Glycolysis" title="Glycolysis">glycolysis</a>, which can throw off blood sugar measurements. Citrate/fluoride/EDTA tubes work better in this regard.<a href="#cite_note-126">[126]</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="Dental_considerations_for_long-term_users">Dental considerations for long-term users</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=18" title="Edit section: Dental considerations for long-term users">edit</a>]</div> Dental practitioners play an important role in the early detection of anticoagulant overdose through oral manifestations, as the patient does not show any symptoms. Dental treatment of patients taking anticoagulant or antiplatelet medication raises safety concerns in terms of the potential risk of bleeding complications following invasive dental procedures. Therefore, certain guidelines for the dental care of patients taking these drugs are needed. <big>Detecting overdose</big> An overdose of anticoagulants usually occurs in people who have heart problems and need to take anticoagulants in the long term to reduce the risk of stroke from their high blood pressure. An <a href="/wiki/Prothrombin_time" title="Prothrombin time">International Normalised Ratio (INR)</a> test would be recommended to confirm the overdose so that the dosage can be adjusted to an acceptable standard. The INR test measures the time it takes for a clot to form in a blood sample relative to a standard. An INR value of 1 indicates a level of coagulation equivalent to that of an average patient not taking warfarin, and values greater than 1 indicate a longer clotting time and, thus, a longer bleeding time. <big>Assessing bleeding risk</big> There are two main parts to the assessment of bleeding risk: <ul><li>Assessment of the likely risk of bleeding associated with the required dental procedure</li> <li>Assessment of the patient's individual-level bleeding risk</li></ul> <big>Managing bleeding risk</big> A patient who is on anticoagulants or <a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">antiplatelet</a> medications may undergo dental treatments which are unlikely to cause bleeding, such as local anesthesia injection, basic gum charting, removal of plaque, calculus and stain above the gum level, direct or indirect fillings which are above the gingiva, <a href="/wiki/Root_canal_treatment" title="Root canal treatment">root canal treatment</a>, taking impression for denture or crown and fitting or adjustment of <a href="/wiki/Orthodontics" title="Orthodontics">orthodontic appliances</a>.  For all these procedures, it is recommended that the dentist treat the patient following the normal standard procedure and taking care to avoid any bleeding. For a patient who needs to undergo dental treatments which are more likely to cause bleeding, such as simple tooth extractions (1-3 teeth with small wound size), drainage of swelling inside the mouth, periodontal charting, <a href="/wiki/Scaling_and_root_planing" title="Scaling and root planing">root planing</a>,  direct or indirect filling which extends below the gingiva, complex filling, flap raising procedure, gingival recontouring and biopsies, the dentist needs to take extra precautions apart from the standard procedure. The recommendations<a href="#cite_note-127">[127]</a> are as follows: <ul><li>if the patient has another medical condition or is taking other medication that may increase bleeding risk, consult the patient's general medical practitioner or specialist</li> <li>if the patient is on a short course of anticoagulant or antiplatelet therapy, delay the non-urgent, invasive procedure until the medication has been discontinued</li> <li>plan treatment for early in the day and week, where possible, to allow time for the management of prolonged bleeding or re-bleeding if it occurs</li> <li>perform the procedure as traumatically as possible, use appropriate local measures and only discharge the patient once <a href="/wiki/Hemostasis" title="Hemostasis">hemostasis</a> has been confirmed</li> <li>if travel time to emergency care is a concern, place particular emphasis at the time of the initial treatment on the use of measures to avoid complications</li> <li>advise the patient to take <a href="/wiki/Paracetamol" title="Paracetamol">paracetamol</a>, unless contraindicated, for pain relief rather than <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">NSAIDs</a> such as <a href="/wiki/Aspirin" title="Aspirin">aspirin</a>, <a href="/wiki/Ibuprofen" title="Ibuprofen">ibuprofen</a>, <a href="/wiki/Diclofenac" title="Diclofenac">diclofenac</a> or <a href="/wiki/Naproxen" title="Naproxen">naproxen</a></li> <li>provide the patient with written post-treatment advice and emergency contact details</li> <li>follow the specific recommendations and advice given for the management of patients taking different anticoagulants or antiplatelet drugs</li></ul> There is general agreement that in most cases, treatment regimens with older anticoagulants (e.g., warfarin) and antiplatelet agents (e.g., <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a>, <a href="/wiki/Ticlopidine" title="Ticlopidine">ticlopidine</a>, <a href="/wiki/Prasugrel" title="Prasugrel">prasugrel</a>, <a href="/wiki/Ticagrelor" title="Ticagrelor">ticagrelor</a>, and/or aspirin) should not be altered before dental procedures. The risks of stopping or reducing these medication regimens (i.e., <a href="/wiki/Venous_thrombosis" title="Venous thrombosis">thromboembolism</a>, <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a>) far outweigh the consequences of prolonged bleeding, which can be controlled with local measures. In patients with other existing medical conditions that can increase the risk of prolonged bleeding after dental treatment or receiving other therapy that can increase bleeding risk, dental practitioners may wish to consult the patient's physician to determine whether care can safely be delivered in a primary care office. Any suggested modification to the medication regimen before dental surgery should be done in consultation and on the advice of the patient's physician. Based on limited evidence, the consensus appears to be that in most patients who are receiving the newer direct-acting oral anticoagulants (i.e., dabigatran, rivaroxaban, apixaban, or edoxaban) and undergoing dental treatment (in conjunction with usual local measures to control bleeding), no change to the anticoagulant regimen is required. In patients deemed to be at higher risk of bleeding (e.g., patients with other medical conditions or undergoing more extensive procedures associated with higher bleeding risk), consideration may be given, in consultation with and on advice of the patient's physician, to postponing the timing of the daily dose of the anticoagulant until after the procedure; timing the dental intervention as late as possible after last dose of anticoagulant; or temporarily interrupting drug therapy for 24 to 48 hours. <div class="mw-heading mw-heading2"><h2 id="Research">Research</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=19" title="Edit section: Research">edit</a>]</div> A substantial number of compounds are being investigated for use as anticoagulants. The most promising ones act on the <a href="/wiki/Contact_activation_system" title="Contact activation system">contact activation system</a> (<a href="/wiki/Factor_XII" title="Factor XII">factor XIIa</a> and <a href="/wiki/Factor_XI" title="Factor XI">factor XIa</a>); it is anticipated that this may provide agents that prevent thrombosis without conferring a risk of bleeding.<a href="#cite_note-128">[128]</a> As of November 2021<a class="external text" href="https://en.wikipedia.org/w/index.php?title=Anticoagulant&action=edit">[update]</a>, the direct factor XIa inhibitor <a href="/wiki/Milvexian" title="Milvexian">milvexian</a> is in Phase II clinical trials for the prevention of an embolism after surgery.<a href="#cite_note-129">[129]</a> <div class="mw-heading mw-heading2"><h2 id="See_also">See also</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=20" title="Edit section: See also">edit</a>]</div> <ul><li><a href="/wiki/Hypercoagulability_in_pregnancy" title="Hypercoagulability in pregnancy">Hypercoagulability in pregnancy</a></li> <li><a href="/wiki/CHADS2_score" class="mw-redirect" title="CHADS2 score">CHADS2 score</a></li> <li><a href="/wiki/Direct_factor_Xa_inhibitors" title="Direct factor Xa inhibitors">Direct factor Xa inhibitors</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="References">References</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=21" title="Edit section: References">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist"> <div class="mw-references-wrap mw-references-columns"><ol class="references"> <li id="cite_note-1"><a href="#cite_ref-1">^</a> <style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nhs.uk/conditions/anticoagulants/">"Overview: Anticoagulant medicines"</a>. Health A to Z. <a href="/wiki/National_Health_Service" title="National Health Service">NHS</a>. 26 July 2021. Retrieved 2 June 2023.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Health+A+to+Z&rft.atitle=Overview%3A+Anticoagulant+medicines&rft.date=2021-07-26&rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fanticoagulants%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-2"><a href="#cite_ref-2">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAzzopardiWhitakerRozenNaderi2011" class="citation journal cs1">Azzopardi EA, Whitaker IS, Rozen WM, Naderi N, Kon M (October 2011). <a rel="nofollow" class="external text" href="https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0031-1284233">"Chemical and mechanical alternatives to leech therapy: a systematic review and critical appraisal"</a>. Journal of Reconstructive Microsurgery. 27 (8). <a href="/wiki/Thieme_Medical_Publishers" title="Thieme Medical Publishers">Thieme Medical Publishers</a>: 481–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0031-1284233">10.1055/s-0031-1284233</a>. <a href="/wiki/EISSN_(identifier)" class="mw-redirect" title="EISSN (identifier)">eISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0743-684X">0743-684X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21780018">21780018</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:260192613">260192613</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Reconstructive+Microsurgery&rft.atitle=Chemical+and+mechanical+alternatives+to+leech+therapy%3A+a+systematic+review+and+critical+appraisal&rft.volume=27&rft.issue=8&rft.pages=481-6&rft.date=2011-10&rft_id=info%3Apmid%2F21780018&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A260192613%23id-name%3DS2CID&rft.eissn=0743-684X&rft_id=info%3Adoi%2F10.1055%2Fs-0031-1284233&rft.aulast=Azzopardi&rft.aufirst=EA&rft.au=Whitaker%2C+IS&rft.au=Rozen%2C+WM&rft.au=Naderi%2C+N&rft.au=Kon%2C+M&rft_id=https%3A%2F%2Fwww.thieme-connect.de%2Fproducts%2Fejournals%2Fabstract%2F10.1055%2Fs-0031-1284233&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-3"><a href="#cite_ref-3">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHaOhSeoKim2014" class="citation journal cs1">Ha YR, Oh SR, Seo ES, Kim BH, Lee DK, Lee SJ (April 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028456">"Detection of heparin in the salivary gland and midgut of Aedes togoi"</a>. The Korean Journal of Parasitology. 52 (2). The Korean Society for Parasitology and Tropical Medicine: 183–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3347%2Fkjp.2014.52.2.183">10.3347/kjp.2014.52.2.183</a>. <a href="/wiki/EISSN_(identifier)" class="mw-redirect" title="EISSN (identifier)">eISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2982-6799">2982-6799</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028456">4028456</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24850962">24850962</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Korean+Journal+of+Parasitology&rft.atitle=Detection+of+heparin+in+the+salivary+gland+and+midgut+of+Aedes+togoi&rft.volume=52&rft.issue=2&rft.pages=183-8&rft.date=2014-04&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4028456%23id-name%3DPMC&rft_id=info%3Apmid%2F24850962&rft.eissn=2982-6799&rft_id=info%3Adoi%2F10.3347%2Fkjp.2014.52.2.183&rft.aulast=Ha&rft.aufirst=YR&rft.au=Oh%2C+SR&rft.au=Seo%2C+ES&rft.au=Kim%2C+BH&rft.au=Lee%2C+DK&rft.au=Lee%2C+SJ&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4028456&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-4"><a href="#cite_ref-4">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYooNunes-NogueiraBoasPJ2020" class="citation journal cs1">Yoo HH, Nunes-Nogueira VS, Boas, PJ (7 February 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004894">"Anticoagulant treatment for subsegmental pulmonary embolism"</a>. <a href="/wiki/Cochrane_Library" title="Cochrane Library">The Cochrane Database of Systematic Reviews</a>. 2020 (2): CD010222. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD010222.pub4">10.1002/14651858.CD010222.pub4</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004894">7004894</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32030721">32030721</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&rft.atitle=Anticoagulant+treatment+for+subsegmental+pulmonary+embolism&rft.volume=2020&rft.issue=2&rft.pages=CD010222&rft.date=2020-02-07&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004894%23id-name%3DPMC&rft.issn=1469-493X&rft_id=info%3Apmid%2F32030721&rft_id=info%3Adoi%2F10.1002%2F14651858.CD010222.pub4&rft.aulast=Yoo&rft.aufirst=HH&rft.au=Nunes-Nogueira%2C+VS&rft.au=Boas&rft.au=PJ&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004894&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-5"><a href="#cite_ref-5">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCohenHamiltonMitchellPhatak2015" class="citation journal cs1">Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, et al. (2015-12-30). ten Cate H (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696796">"Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis"</a>. <a href="/wiki/PLOS_One" title="PLOS One">PLOS One</a>. 10 (12): e0144856. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2015PLoSO..1044856C">2015PLoSO..1044856C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0144856">10.1371/journal.pone.0144856</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696796">4696796</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26716830">26716830</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=PLOS+One&rft.atitle=Comparison+of+the+Novel+Oral+Anticoagulants+Apixaban%2C+Dabigatran%2C+Edoxaban%2C+and+Rivaroxaban+in+the+Initial+and+Long-Term+Treatment+and+Prevention+of+Venous+Thromboembolism%3A+Systematic+Review+and+Network+Meta-Analysis&rft.volume=10&rft.issue=12&rft.pages=e0144856&rft.date=2015-12-30&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4696796%23id-name%3DPMC&rft_id=info%3Apmid%2F26716830&rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0144856&rft_id=info%3Abibcode%2F2015PLoSO..1044856C&rft.aulast=Cohen&rft.aufirst=AT&rft.au=Hamilton%2C+M&rft.au=Mitchell%2C+SA&rft.au=Phatak%2C+H&rft.au=Liu%2C+X&rft.au=Bird%2C+A&rft.au=Tushabe%2C+D&rft.au=Batson%2C+S&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4696796&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-6"><a href="#cite_ref-6">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAlmutairiZhouGelladLee2017" class="citation journal cs1">Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, et al. (July 2017). <a rel="nofollow" class="external text" href="https://www.clinicaltherapeutics.com/article/S0149-2918(17)30699-9/fulltext">"Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses"</a>. <a href="/wiki/Clinical_Therapeutics" title="Clinical Therapeutics">Clinical Therapeutics</a>. 39 (7): 1456–1478.e36. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinthera.2017.05.358">10.1016/j.clinthera.2017.05.358</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28668628">28668628</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Therapeutics&rft.atitle=Effectiveness+and+Safety+of+Non-vitamin+K+Antagonist+Oral+Anticoagulants+for+Atrial+Fibrillation+and+Venous+Thromboembolism%3A+A+Systematic+Review+and+Meta-analyses&rft.volume=39&rft.issue=7&rft.pages=1456-1478.e36&rft.date=2017-07&rft_id=info%3Adoi%2F10.1016%2Fj.clinthera.2017.05.358&rft_id=info%3Apmid%2F28668628&rft.aulast=Almutairi&rft.aufirst=AR&rft.au=Zhou%2C+L&rft.au=Gellad%2C+WF&rft.au=Lee%2C+JK&rft.au=Slack%2C+MK&rft.au=Martin%2C+JR&rft.au=Lo-Ciganic%2C+WH&rft_id=https%3A%2F%2Fwww.clinicaltherapeutics.com%2Farticle%2FS0149-2918%2817%2930699-9%2Ffulltext&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-7"><a href="#cite_ref-7">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBanfiSalvagnoLippi2007" class="citation journal cs1">Banfi G, Salvagno GL, Lippi G (2007-01-01). <a rel="nofollow" class="external text" href="https://www.degruyter.com/document/doi/10.1515/CCLM.2007.110/">"The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes"</a>. <a href="/wiki/Clinical_Chemistry_and_Laboratory_Medicine" title="Clinical Chemistry and Laboratory Medicine">Clinical Chemistry and Laboratory Medicine</a>. 45 (5): 565–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1515%2FCCLM.2007.110">10.1515/CCLM.2007.110</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17484616">17484616</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23824484">23824484</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Chemistry+and+Laboratory+Medicine&rft.atitle=The+role+of+ethylenediamine+tetraacetic+acid+%28EDTA%29+as+in+vitro+anticoagulant+for+diagnostic+purposes&rft.volume=45&rft.issue=5&rft.pages=565-76&rft.date=2007-01-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23824484%23id-name%3DS2CID&rft_id=info%3Apmid%2F17484616&rft_id=info%3Adoi%2F10.1515%2FCCLM.2007.110&rft.aulast=Banfi&rft.aufirst=G&rft.au=Salvagno%2C+GL&rft.au=Lippi%2C+G&rft_id=https%3A%2F%2Fwww.degruyter.com%2Fdocument%2Fdoi%2F10.1515%2FCCLM.2007.110%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-8"><a href="#cite_ref-8">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDobrovolskaiaMcNeil2015" class="citation journal cs1">Dobrovolskaia MA, McNeil SE (May 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437941">"Safe anticoagulation when heart and lungs are "on vacation""</a>. <a href="/wiki/Annals_of_Translational_Medicine" class="mw-redirect" title="Annals of Translational Medicine">Annals of Translational Medicine</a>. 3 (Suppl 1): S11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3978%2Fj.issn.2305-5839.2015.02.03">10.3978/j.issn.2305-5839.2015.02.03</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437941">4437941</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26046056">26046056</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Translational+Medicine&rft.atitle=Safe+anticoagulation+when+heart+and+lungs+are+%22on+vacation%22&rft.volume=3&rft.issue=Suppl+1&rft.pages=S11&rft.date=2015-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4437941%23id-name%3DPMC&rft_id=info%3Apmid%2F26046056&rft_id=info%3Adoi%2F10.3978%2Fj.issn.2305-5839.2015.02.03&rft.aulast=Dobrovolskaia&rft.aufirst=MA&rft.au=McNeil%2C+SE&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4437941&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-9"><a href="#cite_ref-9">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPirmohamed2006" class="citation journal cs1"><a href="/wiki/Munir_Pirmohamed" title="Munir Pirmohamed">Pirmohamed M</a> (November 2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885167">"Warfarin: almost 60 years old and still causing problems"</a>. <a href="/wiki/British_Journal_of_Clinical_Pharmacology" title="British Journal of Clinical Pharmacology">British Journal of Clinical Pharmacology</a>. 62 (5): 509–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2125.2006.02806.x">10.1111/j.1365-2125.2006.02806.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885167">1885167</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17061959">17061959</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=British+Journal+of+Clinical+Pharmacology&rft.atitle=Warfarin%3A+almost+60+years+old+and+still+causing+problems&rft.volume=62&rft.issue=5&rft.pages=509-11&rft.date=2006-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1885167%23id-name%3DPMC&rft_id=info%3Apmid%2F17061959&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.2006.02806.x&rft.aulast=Pirmohamed&rft.aufirst=M&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1885167&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-10"><a href="#cite_ref-10">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPatelSinghPreussPatel2020" class="citation journal cs1">Patel S, Singh R, Preuss CV, Patel N (2020). <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK470313/">"Warfarin"</a>. StatPearls. StatPearls Publishing. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29261922">29261922</a>. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=StatPearls&rft.atitle=Warfarin&rft.date=2020&rft_id=info%3Apmid%2F29261922&rft.aulast=Patel&rft.aufirst=S.&rft.au=Singh%2C+R.&rft.au=Preuss%2C+C.+V.&rft.au=Patel%2C+N.&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK470313%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-11"><a href="#cite_ref-11">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFIqbalLopezHai2020" class="citation book cs1">Iqbal AM, Lopez RA, Hai O (2020). <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK537062/">"Antiplatelet Medications"</a>. StatPearls. StatPearls Publishing. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30725747">30725747</a>. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Antiplatelet+Medications&rft.btitle=StatPearls&rft.pub=StatPearls+Publishing&rft.date=2020&rft_id=info%3Apmid%2F30725747&rft.aulast=Iqbal&rft.aufirst=AM&rft.au=Lopez%2C+RA&rft.au=Hai%2C+O&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK537062%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-12"><a href="#cite_ref-12">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHarterLevineHenderson2015" class="citation journal cs1">Harter K, Levine M, Henderson SO (January 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307693">"Anticoagulation drug therapy: a review"</a>. The Western Journal of Emergency Medicine. 16 (1): 11–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5811%2Fwestjem.2014.12.22933">10.5811/westjem.2014.12.22933</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307693">4307693</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25671002">25671002</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Western+Journal+of+Emergency+Medicine&rft.atitle=Anticoagulation+drug+therapy%3A+a+review&rft.volume=16&rft.issue=1&rft.pages=11-7&rft.date=2015-01&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4307693%23id-name%3DPMC&rft_id=info%3Apmid%2F25671002&rft_id=info%3Adoi%2F10.5811%2Fwestjem.2014.12.22933&rft.aulast=Harter&rft.aufirst=K&rft.au=Levine%2C+M&rft.au=Henderson%2C+SO&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4307693&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-WSJOct2007-13"><a href="#cite_ref-WSJOct2007_13-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWinslowJohnson2007" class="citation news cs1">Winslow R, Johnson A (2007-12-10). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB119725064671318856">"Race Is on for the Next Blood Thinner"</a>. <a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a>. p. A12. Retrieved 2008-01-06. <q>...in a market now dominated by one of the oldest mainstay pills in medicine: the blood thinner warfarin. At least five next-generation blood thinners are in advanced testing to treat or prevent potentially debilitating or life-threatening blood clots in surgery and heart patients. First candidates could reach the market in 2009.</q></cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Wall+Street+Journal&rft.atitle=Race+Is+on+for+the+Next+Blood+Thinner&rft.pages=A12&rft.date=2007-12-10&rft.aulast=Winslow&rft.aufirst=Ron&rft.au=Johnson%2C+Avery&rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB119725064671318856&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-14"><a href="#cite_ref-14">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDjulbegovicLee2018" class="citation journal cs1">Djulbegovic M, Lee AI (September 2018). "An Update on the "Novel" and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy". Clinics in Chest Medicine. 39 (3): 583–593. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ccm.2018.04.010">10.1016/j.ccm.2018.04.010</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30122182">30122182</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52039169">52039169</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinics+in+Chest+Medicine&rft.atitle=An+Update+on+the+%22Novel%22+and+Direct+Oral+Anticoagulants%2C+and+Long-Term+Anticoagulant+Therapy&rft.volume=39&rft.issue=3&rft.pages=583-593&rft.date=2018-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52039169%23id-name%3DS2CID&rft_id=info%3Apmid%2F30122182&rft_id=info%3Adoi%2F10.1016%2Fj.ccm.2018.04.010&rft.aulast=Djulbegovic&rft.aufirst=M&rft.au=Lee%2C+AI&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Parks_514–524-15">^ <a href="#cite_ref-Parks_514–524_15-0">a</a> <a href="#cite_ref-Parks_514–524_15-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFParksFang2017" class="citation journal cs1">Parks AL, Fang MC (July 2017). "Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding". Seminars in Thrombosis and Hemostasis. 43 (5): 514–524. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0037-1598061">10.1055/s-0037-1598061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28359135">28359135</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1981707">1981707</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Seminars+in+Thrombosis+and+Hemostasis&rft.atitle=Scoring+Systems+for+Estimating+the+Risk+of+Anticoagulant-Associated+Bleeding&rft.volume=43&rft.issue=5&rft.pages=514-524&rft.date=2017-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1981707%23id-name%3DS2CID&rft_id=info%3Apmid%2F28359135&rft_id=info%3Adoi%2F10.1055%2Fs-0037-1598061&rft.aulast=Parks&rft.aufirst=AL&rft.au=Fang%2C+MC&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-16"><a href="#cite_ref-16">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZhu2017" class="citation journal cs1">Zhu X (February 2017). <a rel="nofollow" class="external text" href="http://www.minervamedica.it/index2.php?show=R38Y2017N01A0053">"The hemorrhage risk of prophylactic external ventricular drain insertion in aneurysmal subarachnoid hemorrhage patients requiring endovascular aneurysm treatment: a systematic review and meta-analysis"</a>. Journal of Neurosurgical Sciences. 61 (1): 53–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.23736%2FS0390-5616.16.03244-6">10.23736/S0390-5616.16.03244-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25963956">25963956</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Neurosurgical+Sciences&rft.atitle=The+hemorrhage+risk+of+prophylactic+external+ventricular+drain+insertion+in+aneurysmal+subarachnoid+hemorrhage+patients+requiring+endovascular+aneurysm+treatment%3A+a+systematic+review+and+meta-analysis&rft.volume=61&rft.issue=1&rft.pages=53-63&rft.date=2017-02&rft_id=info%3Adoi%2F10.23736%2FS0390-5616.16.03244-6&rft_id=info%3Apmid%2F25963956&rft.aulast=Zhu&rft.aufirst=X&rft_id=http%3A%2F%2Fwww.minervamedica.it%2Findex2.php%3Fshow%3DR38Y2017N01A0053&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-17"><a href="#cite_ref-17">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBanerjeePoddarMickWhite2017" class="citation journal cs1">Banerjee K, Poddar K, Mick S, White J, Krishnaswamy A, Johnston D, et al. (November 2017). "Meta-Analysis of Usefulness of Anticoagulation After Transcatheter Aortic Valve Implantation". The American Journal of Cardiology. 120 (9): 1612–1617. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjcard.2017.07.059">10.1016/j.amjcard.2017.07.059</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28844512">28844512</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+American+Journal+of+Cardiology&rft.atitle=Meta-Analysis+of+Usefulness+of+Anticoagulation+After+Transcatheter+Aortic+Valve+Implantation&rft.volume=120&rft.issue=9&rft.pages=1612-1617&rft.date=2017-11&rft_id=info%3Adoi%2F10.1016%2Fj.amjcard.2017.07.059&rft_id=info%3Apmid%2F28844512&rft.aulast=Banerjee&rft.aufirst=K&rft.au=Poddar%2C+K&rft.au=Mick%2C+S&rft.au=White%2C+J&rft.au=Krishnaswamy%2C+A&rft.au=Johnston%2C+D&rft.au=Rodriguez%2C+L&rft.au=Tuzcu%2C+EM&rft.au=Kapadia%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-18"><a href="#cite_ref-18">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://medlineplus.gov/bloodthinners.html">"Blood Thinners"</a>. medlineplus.gov. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=medlineplus.gov&rft.atitle=Blood+Thinners&rft_id=https%3A%2F%2Fmedlineplus.gov%2Fbloodthinners.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-19"><a href="#cite_ref-19">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSharmaCorneliusPatelDavies2015" class="citation journal cs1">Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M (July 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765082">"Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis"</a>. Circulation. 132 (3): 194–204. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.114.013267">10.1161/CIRCULATIONAHA.114.013267</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765082">4765082</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25995317">25995317</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=Efficacy+and+Harms+of+Direct+Oral+Anticoagulants+in+the+Elderly+for+Stroke+Prevention+in+Atrial+Fibrillation+and+Secondary+Prevention+of+Venous+Thromboembolism%3A+Systematic+Review+and+Meta-Analysis&rft.volume=132&rft.issue=3&rft.pages=194-204&rft.date=2015-07&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4765082%23id-name%3DPMC&rft_id=info%3Apmid%2F25995317&rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.114.013267&rft.aulast=Sharma&rft.aufirst=M&rft.au=Cornelius%2C+VR&rft.au=Patel%2C+JP&rft.au=Davies%2C+JG&rft.au=Molokhia%2C+M&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4765082&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-20"><a href="#cite_ref-20">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMoustafaRuziehEltahawyKarim2019" class="citation journal cs1">Moustafa A, Ruzieh M, Eltahawy E, Karim S (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796304">"Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease"</a>. Avicenna Journal of Medicine. 9 (4): 123–128. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4103%2Fajm.AJM_73_19">10.4103/ajm.AJM_73_19</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796304">6796304</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31903386">31903386</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Avicenna+Journal+of+Medicine&rft.atitle=Antithrombotic+therapy+in+patients+with+atrial+fibrillation+and+coronary+artery+disease&rft.volume=9&rft.issue=4&rft.pages=123-128&rft.date=2019&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6796304%23id-name%3DPMC&rft_id=info%3Apmid%2F31903386&rft_id=info%3Adoi%2F10.4103%2Fajm.AJM_73_19&rft.aulast=Moustafa&rft.aufirst=A&rft.au=Ruzieh%2C+M&rft.au=Eltahawy%2C+E&rft.au=Karim%2C+S&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6796304&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-21"><a href="#cite_ref-21">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKearonAklOrnelasBlaivas2016" class="citation journal cs1">Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. (February 2016). "Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report". Chest. 149 (2): 315–352. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.chest.2015.11.026">10.1016/j.chest.2015.11.026</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26867832">26867832</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Chest&rft.atitle=Antithrombotic+Therapy+for+VTE+Disease%3A+CHEST+Guideline+and+Expert+Panel+Report&rft.volume=149&rft.issue=2&rft.pages=315-352&rft.date=2016-02&rft_id=info%3Adoi%2F10.1016%2Fj.chest.2015.11.026&rft_id=info%3Apmid%2F26867832&rft.aulast=Kearon&rft.aufirst=C&rft.au=Akl%2C+EA&rft.au=Ornelas%2C+J&rft.au=Blaivas%2C+A&rft.au=Jimenez%2C+D&rft.au=Bounameaux%2C+H&rft.au=Huisman%2C+M&rft.au=King%2C+CS&rft.au=Morris%2C+TA&rft.au=Sood%2C+N&rft.au=Stevens%2C+SM&rft.au=Vintch%2C+JR&rft.au=Wells%2C+P&rft.au=Woller%2C+SC&rft.au=Moores%2C+L&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-22"><a href="#cite_ref-22">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKapilDattaAlakbarovaBershad2017" class="citation journal cs1">Kapil N, Datta YH, Alakbarova N, Bershad E, Selim M, Liebeskind DS, et al. (May 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1076029616660762">"Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke"</a>. Clinical and Applied Thrombosis/Hemostasis. 23 (4): 301–318. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1076029616660762">10.1177/1076029616660762</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27461564">27461564</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43296498">43296498</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+and+Applied+Thrombosis%2FHemostasis&rft.atitle=Antiplatelet+and+Anticoagulant+Therapies+for+Prevention+of+Ischemic+Stroke&rft.volume=23&rft.issue=4&rft.pages=301-318&rft.date=2017-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43296498%23id-name%3DS2CID&rft_id=info%3Apmid%2F27461564&rft_id=info%3Adoi%2F10.1177%2F1076029616660762&rft.aulast=Kapil&rft.aufirst=N&rft.au=Datta%2C+YH&rft.au=Alakbarova%2C+N&rft.au=Bershad%2C+E&rft.au=Selim%2C+M&rft.au=Liebeskind%2C+DS&rft.au=Bachour%2C+O&rft.au=Rao%2C+GH&rft.au=Divani%2C+AA&rft_id=https%3A%2F%2Fdoi.org%2F10.1177%252F1076029616660762&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-23"><a href="#cite_ref-23">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSkelleyWhiteThomason2017" class="citation journal cs1">Skelley JW, White CW, Thomason AR (January 2017). "The use of direct oral anticoagulants in inherited thrombophilia". Journal of Thrombosis and Thrombolysis. 43 (1): 24–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11239-016-1428-2">10.1007/s11239-016-1428-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27734187">27734187</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24650202">24650202</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Thrombosis+and+Thrombolysis&rft.atitle=The+use+of+direct+oral+anticoagulants+in+inherited+thrombophilia&rft.volume=43&rft.issue=1&rft.pages=24-30&rft.date=2017-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24650202%23id-name%3DS2CID&rft_id=info%3Apmid%2F27734187&rft_id=info%3Adoi%2F10.1007%2Fs11239-016-1428-2&rft.aulast=Skelley&rft.aufirst=JW&rft.au=White%2C+CW&rft.au=Thomason%2C+AR&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-24"><a href="#cite_ref-24">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPoliAntonucciPengoMigliaccio2018" class="citation journal cs1">Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani C, et al. (September 2018). "Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study". International Journal of Cardiology. 267: 68–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijcard.2018.04.042">10.1016/j.ijcard.2018.04.042</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29957264">29957264</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:49588203">49588203</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Cardiology&rft.atitle=Mechanical+prosthetic+heart+valves%3A+Quality+of+anticoagulation+and+thromboembolic+risk.+The+observational+multicenter+PLECTRUM+study&rft.volume=267&rft.pages=68-73&rft.date=2018-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A49588203%23id-name%3DS2CID&rft_id=info%3Apmid%2F29957264&rft_id=info%3Adoi%2F10.1016%2Fj.ijcard.2018.04.042&rft.aulast=Poli&rft.aufirst=D&rft.au=Antonucci%2C+E&rft.au=Pengo%2C+V&rft.au=Migliaccio%2C+L&rft.au=Testa%2C+S&rft.au=Lodigiani%2C+C&rft.au=Coffetti%2C+N&rft.au=Facchinetti%2C+R&rft.au=Serricchio%2C+G&rft.au=Falco%2C+P&rft.au=Mangione%2C+C&rft.au=Masottini%2C+S&rft.au=Ruocco%2C+L&rft.au=De+Caterina%2C+R&rft.au=Palareti%2C+G&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-25"><a href="#cite_ref-25">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAlmonyLefkovitsTopol1996" class="citation journal cs1">Almony GT, Lefkovits J, Topol EJ (May 1996). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fclc.4960190506">"Antiplatelet and anticoagulant use after myocardial infarction"</a>. Clinical Cardiology. 19 (5): 357–65. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fclc.4960190506">10.1002/clc.4960190506</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8723593">8723593</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:103327">103327</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Cardiology&rft.atitle=Antiplatelet+and+anticoagulant+use+after+myocardial+infarction&rft.volume=19&rft.issue=5&rft.pages=357-65&rft.date=1996-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A103327%23id-name%3DS2CID&rft_id=info%3Apmid%2F8723593&rft_id=info%3Adoi%2F10.1002%2Fclc.4960190506&rft.aulast=Almony&rft.aufirst=GT&rft.au=Lefkovits%2C+J&rft.au=Topol%2C+EJ&rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fclc.4960190506&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-26"><a href="#cite_ref-26">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKonstantinidesBarcoLankeitMeyer2016" class="citation journal cs1">Konstantinides SV, Barco S, Lankeit M, Meyer G (March 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2015.11.061">"Management of Pulmonary Embolism: An Update"</a>. Journal of the American College of Cardiology. 67 (8): 976–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2015.11.061">10.1016/j.jacc.2015.11.061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26916489">26916489</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.atitle=Management+of+Pulmonary+Embolism%3A+An+Update&rft.volume=67&rft.issue=8&rft.pages=976-90&rft.date=2016-03&rft_id=info%3Adoi%2F10.1016%2Fj.jacc.2015.11.061&rft_id=info%3Apmid%2F26916489&rft.aulast=Konstantinides&rft.aufirst=SV&rft.au=Barco%2C+S&rft.au=Lankeit%2C+M&rft.au=Meyer%2C+G&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jacc.2015.11.061&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-27"><a href="#cite_ref-27">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDongZheng2017" class="citation journal cs1">Dong Z, Zheng J (September 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldx018">"Anticoagulation after coronary stenting: a systemic review"</a>. British Medical Bulletin. 123 (1): 79–89. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldx018">10.1093/bmb/ldx018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28910988">28910988</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3800129">3800129</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=British+Medical+Bulletin&rft.atitle=Anticoagulation+after+coronary+stenting%3A+a+systemic+review&rft.volume=123&rft.issue=1&rft.pages=79-89&rft.date=2017-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3800129%23id-name%3DS2CID&rft_id=info%3Apmid%2F28910988&rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldx018&rft.aulast=Dong&rft.aufirst=Z&rft.au=Zheng%2C+J&rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fbmb%252Fldx018&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-28"><a href="#cite_ref-28">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLanderZammertFitzGerald2016" class="citation journal cs1">Lander H, Zammert M, FitzGerald D (September 2016). "Anticoagulation management during cross-clamping and bypass". Best Practice & Research. Clinical Anaesthesiology. 30 (3): 359–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bpa.2016.07.002">10.1016/j.bpa.2016.07.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27650345">27650345</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Best+Practice+%26+Research.+Clinical+Anaesthesiology&rft.atitle=Anticoagulation+management+during+cross-clamping+and+bypass&rft.volume=30&rft.issue=3&rft.pages=359-70&rft.date=2016-09&rft_id=info%3Adoi%2F10.1016%2Fj.bpa.2016.07.002&rft_id=info%3Apmid%2F27650345&rft.aulast=Lander&rft.aufirst=H&rft.au=Zammert%2C+M&rft.au=FitzGerald%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-29"><a href="#cite_ref-29">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThomasEncisoSilvaSchlueterGreenberg2016" class="citation cs2">Thomas I, EncisoSilva J, Schlueter M, Greenberg B (2016), Bauersachs J, Butler J, Sandner P (eds.), "Anticoagulation Therapy and NOACs in Heart Failure", Heart Failure, vol. 243, Springer International Publishing, pp. 515–535, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F164_2016_126">10.1007/164_2016_126</a>, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-319-59658-7" title="Special:BookSources/978-3-319-59658-7"><bdi>978-3-319-59658-7</bdi></a>, <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28233177">28233177</a></cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Heart+Failure&rft.atitle=Anticoagulation+Therapy+and+NOACs+in+Heart+Failure&rft.volume=243&rft.pages=515-535&rft.date=2016&rft_id=info%3Apmid%2F28233177&rft_id=info%3Adoi%2F10.1007%2F164_2016_126&rft.isbn=978-3-319-59658-7&rft.aulast=Thomas&rft.aufirst=Isac&rft.au=EncisoSilva%2C+Jorge&rft.au=Schlueter%2C+Michelle&rft.au=Greenberg%2C+Barry&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-30"><a href="#cite_ref-30">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRaschiBianchinDe_PontiDe_Ponti2017" class="citation journal cs1">Raschi E, Bianchin M, De Ponti R, De Ponti F, Ageno W (June 2017). "Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective". Pharmacological Research. 120: 206–218. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.phrs.2017.03.026">10.1016/j.phrs.2017.03.026</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28366835">28366835</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36716760">36716760</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmacological+Research&rft.atitle=Emerging+therapeutic+uses+of+direct-acting+oral+anticoagulants%3A+An+evidence-based+perspective&rft.volume=120&rft.pages=206-218&rft.date=2017-06&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36716760%23id-name%3DS2CID&rft_id=info%3Apmid%2F28366835&rft_id=info%3Adoi%2F10.1016%2Fj.phrs.2017.03.026&rft.aulast=Raschi&rft.aufirst=E&rft.au=Bianchin%2C+M&rft.au=De+Ponti%2C+R&rft.au=De+Ponti%2C+F&rft.au=Ageno%2C+W&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-urlHAS-BLED_Score-31"><a href="#cite_ref-urlHAS-BLED_Score_31-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.mdcalc.com/has-bled-score-for-major-bleeding-risk/">"HAS-BLED Score for Major Bleeding risk"</a>. MDCalc. Retrieved 2014-08-15.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=HAS-BLED+Score+for+Major+Bleeding+risk&rft.pub=MDCalc&rft_id=http%3A%2F%2Fwww.mdcalc.com%2Fhas-bled-score-for-major-bleeding-risk%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-urlATRIA_Bleeding_Risk-32"><a href="#cite_ref-urlATRIA_Bleeding_Risk_32-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.mdcalc.com/atria-bleeding-risk-score/">"ATRIA Bleeding Risk"</a>. MDCalc. Retrieved 2014-08-15.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=ATRIA+Bleeding+Risk&rft.pub=MDCalc&rft_id=http%3A%2F%2Fwww.mdcalc.com%2Fatria-bleeding-risk-score%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-33"><a href="#cite_ref-33">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mdcalc.com/hemorr2hages-score-major-bleeding-risk">"HEMORR₂HAGES Score for Major Bleeding Risk"</a>. MDCalc. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=MDCalc&rft.atitle=HEMORR%E2%82%82HAGES+Score+for+Major+Bleeding+Risk&rft_id=https%3A%2F%2Fwww.mdcalc.com%2Fhemorr2hages-score-major-bleeding-risk&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-urlCHA2DS2-VASc-34"><a href="#cite_ref-urlCHA2DS2-VASc_34-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.mdcalc.com/cha2ds2-vasc-score-for-atrial-fibrillation-stroke-risk/">"CHA2DS2-VASc"</a>. MDCalc. Retrieved 2014-08-15.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=CHA2DS2-VASc&rft.pub=MDCalc&rft_id=http%3A%2F%2Fwww.mdcalc.com%2Fcha2ds2-vasc-score-for-atrial-fibrillation-stroke-risk%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-35"><a href="#cite_ref-35">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZhuHeGuoWang2015" class="citation journal cs1">Zhu W, He W, Guo L, Wang X, Hong K (September 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490831">"The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis"</a>. Clinical Cardiology. 38 (9): 555–61. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fclc.22435">10.1002/clc.22435</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490831">6490831</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26418409">26418409</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Cardiology&rft.atitle=The+HAS-BLED+Score+for+Predicting+Major+Bleeding+Risk+in+Anticoagulated+Patients+With+Atrial+Fibrillation%3A+A+Systematic+Review+and+Meta-analysis&rft.volume=38&rft.issue=9&rft.pages=555-61&rft.date=2015-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6490831%23id-name%3DPMC&rft_id=info%3Apmid%2F26418409&rft_id=info%3Adoi%2F10.1002%2Fclc.22435&rft.aulast=Zhu&rft.aufirst=W&rft.au=He%2C+W&rft.au=Guo%2C+L&rft.au=Wang%2C+X&rft.au=Hong%2C+K&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6490831&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-36"><a href="#cite_ref-36">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKwanHafdiChiangMyint2022" class="citation journal cs1">Kwan J, Hafdi M, Chiang LL, Myint PK, Wong LS, Quinn TJ (2022-07-13). Cochrane Dementia and Cognitive Improvement Group (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281623">"Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia"</a>. Cochrane Database of Systematic Reviews. 2022 (7): CD012269. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD012269.pub2">10.1002/14651858.CD012269.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281623">9281623</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35833913">35833913</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cochrane+Database+of+Systematic+Reviews&rft.atitle=Antithrombotic+therapy+to+prevent+cognitive+decline+in+people+with+small+vessel+disease+on+neuroimaging+but+without+dementia&rft.volume=2022&rft.issue=7&rft.pages=CD012269&rft.date=2022-07-13&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9281623%23id-name%3DPMC&rft_id=info%3Apmid%2F35833913&rft_id=info%3Adoi%2F10.1002%2F14651858.CD012269.pub2&rft.aulast=Kwan&rft.aufirst=Joseph&rft.au=Hafdi%2C+Melanie&rft.au=Chiang%2C+Lorraine+L+W&rft.au=Myint%2C+Phyo+K&rft.au=Wong%2C+Li+Siang&rft.au=Quinn%2C+Terry+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9281623&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-37"><a href="#cite_ref-37">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYeeKaide2019" class="citation journal cs1">Yee J, Kaide CG (August 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754204">"Emergency Reversal of Anticoagulation"</a>. The Western Journal of Emergency Medicine. 20 (5): 770–783. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5811%2Fwestjem.2018.5.38235">10.5811/westjem.2018.5.38235</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754204">6754204</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31539334">31539334</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Western+Journal+of+Emergency+Medicine&rft.atitle=Emergency+Reversal+of+Anticoagulation&rft.volume=20&rft.issue=5&rft.pages=770-783&rft.date=2019-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6754204%23id-name%3DPMC&rft_id=info%3Apmid%2F31539334&rft_id=info%3Adoi%2F10.5811%2Fwestjem.2018.5.38235&rft.aulast=Yee&rft.aufirst=J&rft.au=Kaide%2C+CG&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6754204&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-38"><a href="#cite_ref-38">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZarehDavisHenderson2011" class="citation journal cs1">Zareh M, Davis A, Henderson S (November 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236169">"Reversal of warfarin-induced hemorrhage in the emergency department"</a>. The Western Journal of Emergency Medicine. 12 (4): 386–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5811%2Fwestjem.2011.3.2051">10.5811/westjem.2011.3.2051</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236169">3236169</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22224125">22224125</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Western+Journal+of+Emergency+Medicine&rft.atitle=Reversal+of+warfarin-induced+hemorrhage+in+the+emergency+department&rft.volume=12&rft.issue=4&rft.pages=386-92&rft.date=2011-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3236169%23id-name%3DPMC&rft_id=info%3Apmid%2F22224125&rft_id=info%3Adoi%2F10.5811%2Fwestjem.2011.3.2051&rft.aulast=Zareh&rft.aufirst=M&rft.au=Davis%2C+A&rft.au=Henderson%2C+S&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3236169&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Breadth_of_complications_of_long-te-39">^ <a href="#cite_ref-Breadth_of_complications_of_long-te_39-0">a</a> <a href="#cite_ref-Breadth_of_complications_of_long-te_39-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAgenoDonadini2018" class="citation journal cs1">Ageno W, Donadini M (November 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245998">"Breadth of complications of long-term oral anticoagulant care"</a>. Hematology. American Society of Hematology. Education Program. 2018 (1): 432–438. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1182%2Fasheducation-2018.1.432">10.1182/asheducation-2018.1.432</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245998">6245998</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30504343">30504343</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hematology.+American+Society+of+Hematology.+Education+Program&rft.atitle=Breadth+of+complications+of+long-term+oral+anticoagulant+care&rft.volume=2018&rft.issue=1&rft.pages=432-438&rft.date=2018-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6245998%23id-name%3DPMC&rft_id=info%3Apmid%2F30504343&rft_id=info%3Adoi%2F10.1182%2Fasheducation-2018.1.432&rft.aulast=Ageno&rft.aufirst=W&rft.au=Donadini%2C+M&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6245998&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-40"><a href="#cite_ref-40">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAgenoMantovaniHaasKreutz2016" class="citation journal cs1">Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, et al. (January 2016). "Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study". The Lancet. Haematology. 3 (1): e12-21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS2352-3026%2815%2900257-4">10.1016/S2352-3026(15)00257-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26765643">26765643</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Lancet.+Haematology&rft.atitle=Safety+and+effectiveness+of+oral+rivaroxaban+versus+standard+anticoagulation+for+the+treatment+of+symptomatic+deep-vein+thrombosis+%28XALIA%29%3A+an+international%2C+prospective%2C+non-interventional+study&rft.volume=3&rft.issue=1&rft.pages=e12-21&rft.date=2016-01&rft_id=info%3Adoi%2F10.1016%2FS2352-3026%2815%2900257-4&rft_id=info%3Apmid%2F26765643&rft.aulast=Ageno&rft.aufirst=W&rft.au=Mantovani%2C+LG&rft.au=Haas%2C+S&rft.au=Kreutz%2C+R&rft.au=Monje%2C+D&rft.au=Schneider%2C+J&rft.au=van+Eickels%2C+M&rft.au=Gebel%2C+M&rft.au=Zell%2C+E&rft.au=Turpie%2C+AG&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-pmid17515465-41"><a href="#cite_ref-pmid17515465_41-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHylekEvans-MolinaSheaHenault2007" class="citation journal cs1">Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (May 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.106.653048">"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation"</a>. Circulation. 115 (21): 2689–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.106.653048">10.1161/CIRCULATIONAHA.106.653048</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17515465">17515465</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8881388">8881388</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=Major+hemorrhage+and+tolerability+of+warfarin+in+the+first+year+of+therapy+among+elderly+patients+with+atrial+fibrillation&rft.volume=115&rft.issue=21&rft.pages=2689-96&rft.date=2007-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8881388%23id-name%3DS2CID&rft_id=info%3Apmid%2F17515465&rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.106.653048&rft.aulast=Hylek&rft.aufirst=EM&rft.au=Evans-Molina%2C+C&rft.au=Shea%2C+C&rft.au=Henault%2C+LE&rft.au=Regan%2C+S&rft_id=https%3A%2F%2Fdoi.org%2F10.1161%252FCIRCULATIONAHA.106.653048&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-42"><a href="#cite_ref-42">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTurpiePurdhamCiaccia2017" class="citation journal cs1">Turpie AG, Purdham D, Ciaccia A (September 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562140">"Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment"</a>. Therapeutic Advances in Cardiovascular Disease. 11 (9): 243–256. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1753944717714921">10.1177/1753944717714921</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562140">5562140</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28651452">28651452</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Therapeutic+Advances+in+Cardiovascular+Disease&rft.atitle=Nonvitamin+K+antagonist+oral+anticoagulant+use+in+patients+with+renal+impairment&rft.volume=11&rft.issue=9&rft.pages=243-256&rft.date=2017-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5562140%23id-name%3DPMC&rft_id=info%3Apmid%2F28651452&rft_id=info%3Adoi%2F10.1177%2F1753944717714921&rft.aulast=Turpie&rft.aufirst=AG&rft.au=Purdham%2C+D&rft.au=Ciaccia%2C+A&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5562140&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-43"><a href="#cite_ref-43">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWeirKreutz2018" class="citation journal cs1">Weir MR, Kreutz R (October 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mayocp.2018.06.018">"Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non-Vitamin K Antagonist Oral Anticoagulants"</a>. Mayo Clinic Proceedings. 93 (10): 1503–1519. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mayocp.2018.06.018">10.1016/j.mayocp.2018.06.018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30286834">30286834</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52922296">52922296</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Mayo+Clinic+Proceedings&rft.atitle=Influence+of+Renal+Function+on+the+Pharmacokinetics%2C+Pharmacodynamics%2C+Efficacy%2C+and+Safety+of+Non-Vitamin+K+Antagonist+Oral+Anticoagulants&rft.volume=93&rft.issue=10&rft.pages=1503-1519&rft.date=2018-10&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52922296%23id-name%3DS2CID&rft_id=info%3Apmid%2F30286834&rft_id=info%3Adoi%2F10.1016%2Fj.mayocp.2018.06.018&rft.aulast=Weir&rft.aufirst=MR&rft.au=Kreutz%2C+R&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.mayocp.2018.06.018&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-:2-44">^ <a href="#cite_ref-:2_44-0">a</a> <a href="#cite_ref-:2_44-1">b</a> <a href="#cite_ref-:2_44-2">c</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKahaleHakoumTsolakianMatar2017" class="citation journal cs1">Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Barba M, Yosuico VE, et al. (2017-12-29). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389337">"Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation"</a>. Cochrane Database of Systematic Reviews. 12 (12): CD006466. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.cd006466.pub6">10.1002/14651858.cd006466.pub6</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1465-1858">1465-1858</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389337">6389337</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29285754">29285754</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cochrane+Database+of+Systematic+Reviews&rft.atitle=Oral+anticoagulation+in+people+with+cancer+who+have+no+therapeutic+or+prophylactic+indication+for+anticoagulation&rft.volume=12&rft.issue=12&rft.pages=CD006466&rft.date=2017-12-29&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6389337%23id-name%3DPMC&rft.issn=1465-1858&rft_id=info%3Apmid%2F29285754&rft_id=info%3Adoi%2F10.1002%2F14651858.cd006466.pub6&rft.aulast=Kahale&rft.aufirst=Lara+A&rft.au=Hakoum%2C+Maram+B&rft.au=Tsolakian%2C+Ibrahim+G&rft.au=Matar%2C+Charbel+F&rft.au=Barba%2C+Maddalena&rft.au=Yosuico%2C+Victor+ED&rft.au=Terrenato%2C+Irene&rft.au=Sperati%2C+Francesca&rft.au=Sch%C3%BCnemann%2C+Holger&rft.au=Akl%2C+Elie+A&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6389337&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Oral_anticoagulant_therapy:_Antithr-45">^ <a href="#cite_ref-Oral_anticoagulant_therapy:_Antithr_45-0">a</a> <a href="#cite_ref-Oral_anticoagulant_therapy:_Antithr_45-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAgenoGallusWittkowskyCrowther2012" class="citation journal cs1">Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (February 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278051">"Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines"</a>. Chest. 141 (2 Suppl): e44S–e88S. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1378%2Fchest.11-2292">10.1378/chest.11-2292</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278051">3278051</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22315269">22315269</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Chest&rft.atitle=Oral+anticoagulant+therapy%3A+Antithrombotic+Therapy+and+Prevention+of+Thrombosis%2C+9th+ed%3A+American+College+of+Chest+Physicians+Evidence-Based+Clinical+Practice+Guidelines&rft.volume=141&rft.issue=2+Suppl&rft.pages=e44S-e88S&rft.date=2012-02&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3278051%23id-name%3DPMC&rft_id=info%3Apmid%2F22315269&rft_id=info%3Adoi%2F10.1378%2Fchest.11-2292&rft.aulast=Ageno&rft.aufirst=W&rft.au=Gallus%2C+AS&rft.au=Wittkowsky%2C+A&rft.au=Crowther%2C+M&rft.au=Hylek%2C+EM&rft.au=Palareti%2C+G&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3278051&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-46"><a href="#cite_ref-46">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVerhagen2009" class="citation journal cs1">Verhagen H (2009-04-24). "Local haemorrhage and necrosis of the skin and underlying tissues, during anti-coagulant therapy with dicumarol or dicumacyl". Acta Medica Scandinavica. 148 (6): 453–67. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.0954-6820.1954.tb01741.x">10.1111/j.0954-6820.1954.tb01741.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13171021">13171021</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Acta+Medica+Scandinavica&rft.atitle=Local+haemorrhage+and+necrosis+of+the+skin+and+underlying+tissues%2C+during+anti-coagulant+therapy+with+dicumarol+or+dicumacyl&rft.volume=148&rft.issue=6&rft.pages=453-67&rft.date=2009-04-24&rft_id=info%3Adoi%2F10.1111%2Fj.0954-6820.1954.tb01741.x&rft_id=info%3Apmid%2F13171021&rft.aulast=Verhagen&rft.aufirst=H&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-47"><a href="#cite_ref-47">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWeinbergLieskovskyMcGeheeSkinner1983" class="citation journal cs1">Weinberg AC, Lieskovsky G, McGehee WG, Skinner DG (August 1983). "Warfarin necrosis of the skin and subcutaneous tissue of the male external genitalia". The Journal of Urology. 130 (2): 352–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-5347%2817%2951147-7">10.1016/S0022-5347(17)51147-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6876290">6876290</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Urology&rft.atitle=Warfarin+necrosis+of+the+skin+and+subcutaneous+tissue+of+the+male+external+genitalia&rft.volume=130&rft.issue=2&rft.pages=352-4&rft.date=1983-08&rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2817%2951147-7&rft_id=info%3Apmid%2F6876290&rft.aulast=Weinberg&rft.aufirst=AC&rft.au=Lieskovsky%2C+G&rft.au=McGehee%2C+WG&rft.au=Skinner%2C+DG&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-48"><a href="#cite_ref-48">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBroekmansBertinaLoeligerHofmann1983" class="citation journal cs1">Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG (June 1983). "Protein C and the development of skin necrosis during anticoagulant therapy". Thrombosis and Haemostasis. 49 (3): 251. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0038-1657378">10.1055/s-0038-1657378</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6688309">6688309</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38261767">38261767</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Protein+C+and+the+development+of+skin+necrosis+during+anticoagulant+therapy&rft.volume=49&rft.issue=3&rft.pages=251&rft.date=1983-06&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38261767%23id-name%3DS2CID&rft_id=info%3Apmid%2F6688309&rft_id=info%3Adoi%2F10.1055%2Fs-0038-1657378&rft.aulast=Broekmans&rft.aufirst=AW&rft.au=Bertina%2C+RM&rft.au=Loeliger%2C+EA&rft.au=Hofmann%2C+V&rft.au=Klingemann%2C+HG&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-49"><a href="#cite_ref-49">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGrimaudoGueissazHauertSarraj1989" class="citation journal cs1">Grimaudo V, Gueissaz F, Hauert J, Sarraj A, Kruithof EK, Bachmann F (January 1989). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1835547">"Necrosis of skin induced by coumarin in a patient deficient in protein S"</a>. BMJ. 298 (6668): 233–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.298.6668.233">10.1136/bmj.298.6668.233</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1835547">1835547</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2522326">2522326</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Necrosis+of+skin+induced+by+coumarin+in+a+patient+deficient+in+protein+S&rft.volume=298&rft.issue=6668&rft.pages=233-4&rft.date=1989-01&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1835547%23id-name%3DPMC&rft_id=info%3Apmid%2F2522326&rft_id=info%3Adoi%2F10.1136%2Fbmj.298.6668.233&rft.aulast=Grimaudo&rft.aufirst=V&rft.au=Gueissaz%2C+F&rft.au=Hauert%2C+J&rft.au=Sarraj%2C+A&rft.au=Kruithof%2C+EK&rft.au=Bachmann%2C+F&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1835547&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-50"><a href="#cite_ref-50">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTalmadgeSpyropoulos2003" class="citation journal cs1">Talmadge DB, Spyropoulos AC (May 2003). "Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome". Pharmacotherapy. 23 (5): 674–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1592%2Fphco.23.5.674.32200">10.1592/phco.23.5.674.32200</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12741443">12741443</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28632135">28632135</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmacotherapy&rft.atitle=Purple+toes+syndrome+associated+with+warfarin+therapy+in+a+patient+with+antiphospholipid+syndrome&rft.volume=23&rft.issue=5&rft.pages=674-7&rft.date=2003-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28632135%23id-name%3DS2CID&rft_id=info%3Apmid%2F12741443&rft_id=info%3Adoi%2F10.1592%2Fphco.23.5.674.32200&rft.aulast=Talmadge&rft.aufirst=DB&rft.au=Spyropoulos%2C+AC&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-51"><a href="#cite_ref-51">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRajCollinsRangarajan2001" class="citation journal cs1">Raj K, Collins B, Rangarajan S (September 2001). "Purple toe syndrome following anticoagulant therapy". British Journal of Haematology. 114 (4): 740. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1365-2141.2001.03107.x">10.1046/j.1365-2141.2001.03107.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11564060">11564060</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20482173">20482173</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=British+Journal+of+Haematology&rft.atitle=Purple+toe+syndrome+following+anticoagulant+therapy&rft.volume=114&rft.issue=4&rft.pages=740&rft.date=2001-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20482173%23id-name%3DS2CID&rft_id=info%3Apmid%2F11564060&rft_id=info%3Adoi%2F10.1046%2Fj.1365-2141.2001.03107.x&rft.aulast=Raj&rft.aufirst=K&rft.au=Collins%2C+B&rft.au=Rangarajan%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Adams2005-52"><a href="#cite_ref-Adams2005_52-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAdamsPepping2005" class="citation journal cs1">Adams J, Pepping J (August 2005). <a rel="nofollow" class="external text" href="http://www.scicompdf.se/osteolis/adams_2005.pdf">"Vitamin K in the treatment and prevention of osteoporosis and arterial calcification"</a> (PDF). American Journal of Health-System Pharmacy. 62 (15): 1574–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2146%2Fajhp040357">10.2146/ajhp040357</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16030366">16030366</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Health-System+Pharmacy&rft.atitle=Vitamin+K+in+the+treatment+and+prevention+of+osteoporosis+and+arterial+calcification&rft.volume=62&rft.issue=15&rft.pages=1574-81&rft.date=2005-08&rft_id=info%3Adoi%2F10.2146%2Fajhp040357&rft_id=info%3Apmid%2F16030366&rft.aulast=Adams&rft.aufirst=J&rft.au=Pepping%2C+J&rft_id=http%3A%2F%2Fwww.scicompdf.se%2Fosteolis%2Fadams_2005.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-53"><a href="#cite_ref-53">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDanziger2008" class="citation journal cs1">Danziger J (September 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571144">"Vitamin K-dependent proteins, warfarin, and vascular calcification"</a>. Clinical Journal of the American Society of Nephrology. 3 (5): 1504–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2215%2FCJN.00770208">10.2215/CJN.00770208</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571144">4571144</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18495950">18495950</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Journal+of+the+American+Society+of+Nephrology&rft.atitle=Vitamin+K-dependent+proteins%2C+warfarin%2C+and+vascular+calcification&rft.volume=3&rft.issue=5&rft.pages=1504-10&rft.date=2008-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4571144%23id-name%3DPMC&rft_id=info%3Apmid%2F18495950&rft_id=info%3Adoi%2F10.2215%2FCJN.00770208&rft.aulast=Danziger&rft.aufirst=J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4571144&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-54"><a href="#cite_ref-54">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPettiforBenson1975" class="citation journal cs1">Pettifor JM, Benson R (March 1975). "Congenital malformations associated with the administration of oral anticoagulants during pregnancy". The Journal of Pediatrics. 86 (3): 459–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-3476%2875%2980986-3">10.1016/S0022-3476(75)80986-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1113236">1113236</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Pediatrics&rft.atitle=Congenital+malformations+associated+with+the+administration+of+oral+anticoagulants+during+pregnancy&rft.volume=86&rft.issue=3&rft.pages=459-62&rft.date=1975-03&rft_id=info%3Adoi%2F10.1016%2FS0022-3476%2875%2980986-3&rft_id=info%3Apmid%2F1113236&rft.aulast=Pettifor&rft.aufirst=JM&rft.au=Benson%2C+R&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-55"><a href="#cite_ref-55">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHallPauliWilson1980" class="citation journal cs1">Hall JG, Pauli RM, Wilson KM (January 1980). "Maternal and fetal sequelae of anticoagulation during pregnancy". The American Journal of Medicine. 68 (1): 122–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0002-9343%2880%2990181-3">10.1016/0002-9343(80)90181-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6985765">6985765</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+American+Journal+of+Medicine&rft.atitle=Maternal+and+fetal+sequelae+of+anticoagulation+during+pregnancy&rft.volume=68&rft.issue=1&rft.pages=122-40&rft.date=1980-01&rft_id=info%3Adoi%2F10.1016%2F0002-9343%2880%2990181-3&rft_id=info%3Apmid%2F6985765&rft.aulast=Hall&rft.aufirst=JG&rft.au=Pauli%2C+RM&rft.au=Wilson%2C+KM&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-56"><a href="#cite_ref-56">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGageBirman-DeychRadfordNilasena2006" class="citation journal cs1">Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (January 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinte.166.2.241">"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2"</a>. Archives of Internal Medicine. 166 (2): 241–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinte.166.2.241">10.1001/archinte.166.2.241</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16432096">16432096</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Archives+of+Internal+Medicine&rft.atitle=Risk+of+osteoporotic+fracture+in+elderly+patients+taking+warfarin%3A+results+from+the+National+Registry+of+Atrial+Fibrillation+2&rft.volume=166&rft.issue=2&rft.pages=241-6&rft.date=2006-01&rft_id=info%3Adoi%2F10.1001%2Farchinte.166.2.241&rft_id=info%3Apmid%2F16432096&rft.aulast=Gage&rft.aufirst=BF&rft.au=Birman-Deych%2C+E&rft.au=Radford%2C+MJ&rft.au=Nilasena%2C+DS&rft.au=Binder%2C+EF&rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Farchinte.166.2.241&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Heparin-induced_thrombocytopenia-57">^ <a href="#cite_ref-Heparin-induced_thrombocytopenia_57-0">a</a> <a href="#cite_ref-Heparin-induced_thrombocytopenia_57-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBarolettiGoldhaber2006" class="citation journal cs1">Baroletti SA, Goldhaber SZ (August 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.106.632653">"Heparin-induced thrombocytopenia"</a>. Circulation. 114 (8): e355-6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.106.632653">10.1161/CIRCULATIONAHA.106.632653</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16923760">16923760</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=Heparin-induced+thrombocytopenia&rft.volume=114&rft.issue=8&rft.pages=e355-6&rft.date=2006-08&rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.106.632653&rft_id=info%3Apmid%2F16923760&rft.aulast=Baroletti&rft.aufirst=SA&rft.au=Goldhaber%2C+SZ&rft_id=https%3A%2F%2Fdoi.org%2F10.1161%252FCIRCULATIONAHA.106.632653&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-58"><a href="#cite_ref-58">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWarkentinGreinacherKosterLincoff2008" class="citation journal cs1">Warkentin TE, Greinacher A, Koster A, Lincoff AM (June 2008). "Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest. 133 (6 Suppl): 340S–380S. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1378%2Fchest.08-0677">10.1378/chest.08-0677</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18574270">18574270</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Chest&rft.atitle=Treatment+and+prevention+of+heparin-induced+thrombocytopenia%3A+American+College+of+Chest+Physicians+Evidence-Based+Clinical+Practice+Guidelines+%288th+Edition%29&rft.volume=133&rft.issue=6+Suppl&rft.pages=340S-380S&rft.date=2008-06&rft_id=info%3Adoi%2F10.1378%2Fchest.08-0677&rft_id=info%3Apmid%2F18574270&rft.aulast=Warkentin&rft.aufirst=TE&rft.au=Greinacher%2C+A&rft.au=Koster%2C+A&rft.au=Lincoff%2C+AM&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-59"><a href="#cite_ref-59">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLinkinsHuWarkentin2018" class="citation journal cs1">Linkins LA, Hu G, Warkentin TE (October 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178656">"Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials"</a>. Research and Practice in Thrombosis and Haemostasis. 2 (4): 678–683. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Frth2.12145">10.1002/rth2.12145</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178656">6178656</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30349886">30349886</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Research+and+Practice+in+Thrombosis+and+Haemostasis&rft.atitle=Systematic+review+of+fondaparinux+for+heparin-induced+thrombocytopenia%3A+When+there+are+no+randomized+controlled+trials&rft.volume=2&rft.issue=4&rft.pages=678-683&rft.date=2018-10&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6178656%23id-name%3DPMC&rft_id=info%3Apmid%2F30349886&rft_id=info%3Adoi%2F10.1002%2Frth2.12145&rft.aulast=Linkins&rft.aufirst=LA&rft.au=Hu%2C+G&rft.au=Warkentin%2C+TE&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6178656&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-pmid11711691-60"><a href="#cite_ref-pmid11711691_60-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWittkowsky2001" class="citation journal cs1">Wittkowsky AK (September 2001). "Drug interactions update: drugs, herbs, and oral anticoagulation". Journal of Thrombosis and Thrombolysis. 12 (1): 67–71. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1023%2FA%3A1012742628628">10.1023/A:1012742628628</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11711691">11711691</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22447084">22447084</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Thrombosis+and+Thrombolysis&rft.atitle=Drug+interactions+update%3A+drugs%2C+herbs%2C+and+oral+anticoagulation&rft.volume=12&rft.issue=1&rft.pages=67-71&rft.date=2001-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22447084%23id-name%3DS2CID&rft_id=info%3Apmid%2F11711691&rft_id=info%3Adoi%2F10.1023%2FA%3A1012742628628&rft.aulast=Wittkowsky&rft.aufirst=AK&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-61"><a href="#cite_ref-61">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRuiZhangQiaoHuang2016" class="citation journal cs1">Rui TQ, Zhang L, Qiao HZ, Huang P, Qian S, Li JS, et al. (January 2016). "Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation". Journal of Pharmaceutical Sciences. 105 (1): 242–249. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.xphs.2015.10.002">10.1016/j.xphs.2015.10.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26852855">26852855</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Pharmaceutical+Sciences&rft.atitle=Preparation+and+Physicochemical+and+Pharmacokinetic+Characterization+of+Ginkgo+Lactone+Nanosuspensions+for+Antiplatelet+Aggregation&rft.volume=105&rft.issue=1&rft.pages=242-249&rft.date=2016-01&rft_id=info%3Adoi%2F10.1016%2Fj.xphs.2015.10.002&rft_id=info%3Apmid%2F26852855&rft.aulast=Rui&rft.aufirst=Tian-Qi&rft.au=Zhang%2C+Liang&rft.au=Qiao%2C+Hong-Zhi&rft.au=Huang%2C+Ping&rft.au=Qian%2C+Shuai&rft.au=Li%2C+Jun-Song&rft.au=Chen%2C+Zhi-Peng&rft.au=Fu%2C+Ting-Ming&rft.au=Di%2C+Liu-Qing&rft.au=Cai%2C+Baochang&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-62"><a href="#cite_ref-62">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYunDoKoRyu2001" class="citation journal cs1">Yun YP, Do JH, Ko SR, Ryu SY, Kim JH, Song HC, et al. (October 2001). "Effects of Korean red ginseng and its mixed prescription on the high molecular weight dextran-induced blood stasis in rats and human platelet aggregation". Journal of Ethnopharmacology. 77 (2–3): 259–264. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0378-8741%2801%2900303-8">10.1016/S0378-8741(01)00303-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11535373">11535373</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Ethnopharmacology&rft.atitle=Effects+of+Korean+red+ginseng+and+its+mixed+prescription+on+the+high+molecular+weight+dextran-induced+blood+stasis+in+rats+and+human+platelet+aggregation&rft.volume=77&rft.issue=2%E2%80%933&rft.pages=259-264&rft.date=2001-10&rft_id=info%3Adoi%2F10.1016%2FS0378-8741%2801%2900303-8&rft_id=info%3Apmid%2F11535373&rft.aulast=Yun&rft.aufirst=Yeo-Pyo&rft.au=Do%2C+Jae-Ho&rft.au=Ko%2C+Sung-Ryong&rft.au=Ryu%2C+Shi-Yong&rft.au=Kim%2C+Jung-Hyo&rft.au=Song%2C+Ho-Cheol&rft.au=Park%2C+Young-Doo&rft.au=Ahn%2C+Kyoo-Seok&rft.au=Kim%2C+Sung-Hoon&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-63"><a href="#cite_ref-63">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChoiOhJerng2017" class="citation journal cs1">Choi S, Oh DS, Jerng UM (2017-08-10). Borrelli F (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552262">"A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin"</a>. PLOS ONE. 12 (8): e0182794. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2017PLoSO..1282794C">2017PLoSO..1282794C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0182794">10.1371/journal.pone.0182794</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1932-6203">1932-6203</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552262">5552262</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28797065">28797065</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=PLOS+ONE&rft.atitle=A+systematic+review+of+the+pharmacokinetic+and+pharmacodynamic+interactions+of+herbal+medicine+with+warfarin&rft.volume=12&rft.issue=8&rft.pages=e0182794&rft.date=2017-08-10&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5552262%23id-name%3DPMC&rft_id=info%3Abibcode%2F2017PLoSO..1282794C&rft_id=info%3Apmid%2F28797065&rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0182794&rft.issn=1932-6203&rft.aulast=Choi&rft.aufirst=Songie&rft.au=Oh%2C+Dal-Seok&rft.au=Jerng%2C+Ui+Min&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5552262&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-64"><a href="#cite_ref-64">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKurnikLubetskyLoebsteinAlmog2003" class="citation journal cs1">Kurnik D, Lubetsky A, Loebstein R, Almog S, Halkin H (November 2003). "Multivitamin Supplements May Affect Warfarin Anticoagulation in Susceptible Patients". Annals of Pharmacotherapy. 37 (11): 1603–1606. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1345%2Faph.1D102">10.1345/aph.1D102</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1060-0280">1060-0280</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14565795">14565795</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43777757">43777757</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Pharmacotherapy&rft.atitle=Multivitamin+Supplements+May+Affect+Warfarin+Anticoagulation+in+Susceptible+Patients&rft.volume=37&rft.issue=11&rft.pages=1603-1606&rft.date=2003-11&rft.issn=1060-0280&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43777757%23id-name%3DS2CID&rft_id=info%3Apmid%2F14565795&rft_id=info%3Adoi%2F10.1345%2Faph.1D102&rft.aulast=Kurnik&rft.aufirst=Daniel&rft.au=Lubetsky%2C+Aharon&rft.au=Loebstein%2C+Ronen&rft.au=Almog%2C+Shlomo&rft.au=Halkin%2C+Hillel&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-65"><a href="#cite_ref-65">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHarderThürmann1996" class="citation journal cs1">Harder S, Thürmann P (June 1996). "Clinically Important Drug Interactions with Anticoagulants: An Update". Clinical Pharmacokinetics. 30 (6): 416–444. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00003088-199630060-00002">10.2165/00003088-199630060-00002</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0312-5963">0312-5963</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8792056">8792056</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22389544">22389544</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Pharmacokinetics&rft.atitle=Clinically+Important+Drug+Interactions+with+Anticoagulants%3A+An+Update&rft.volume=30&rft.issue=6&rft.pages=416-444&rft.date=1996-06&rft.issn=0312-5963&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22389544%23id-name%3DS2CID&rft_id=info%3Apmid%2F8792056&rft_id=info%3Adoi%2F10.2165%2F00003088-199630060-00002&rft.aulast=Harder&rft.aufirst=Sebastian&rft.au=Th%C3%BCrmann%2C+Petra&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-66"><a href="#cite_ref-66">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLippiMattiuzziFranchini2016" class="citation journal cs1">Lippi G, Mattiuzzi C, Franchini M (April 2016). "Vegetables intake and venous thromboembolism: a systematic review". Blood Coagulation & Fibrinolysis. 27 (3): 242–245. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMBC.0000000000000427">10.1097/MBC.0000000000000427</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0957-5235">0957-5235</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27023878">27023878</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33380206">33380206</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Blood+Coagulation+%26+Fibrinolysis&rft.atitle=Vegetables+intake+and+venous+thromboembolism%3A+a+systematic+review&rft.volume=27&rft.issue=3&rft.pages=242-245&rft.date=2016-04&rft.issn=0957-5235&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A33380206%23id-name%3DS2CID&rft_id=info%3Apmid%2F27023878&rft_id=info%3Adoi%2F10.1097%2FMBC.0000000000000427&rft.aulast=Lippi&rft.aufirst=Giuseppe&rft.au=Mattiuzzi%2C+Camilla&rft.au=Franchini%2C+Massimo&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-67"><a href="#cite_ref-67">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.rxlist.com/avocado/supplements.htm">"Avocado: Health Benefits, Uses, Side Effects, Dosage & Interactions"</a>. RxList. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=RxList&rft.atitle=Avocado%3A+Health+Benefits%2C+Uses%2C+Side+Effects%2C+Dosage+%26+Interactions&rft_id=https%3A%2F%2Fwww.rxlist.com%2Favocado%2Fsupplements.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-68"><a href="#cite_ref-68">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDentaliCrowtherGalliPomero2016" class="citation journal cs1">Dentali F, Crowther M, Galli M, Pomero F, Garcia D, Clark N, et al. (2016-05-27). "Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature". Seminars in Thrombosis and Hemostasis. 42 (6): 671–681. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0036-1581105">10.1055/s-0036-1581105</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0094-6176">0094-6176</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27232386">27232386</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24822900">24822900</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Seminars+in+Thrombosis+and+Hemostasis&rft.atitle=Effect+of+Vitamin+K+Intake+on+the+Stability+of+Treatment+with+Vitamin+K+Antagonists%3A+A+Systematic+Review+of+the+Literature&rft.volume=42&rft.issue=6&rft.pages=671-681&rft.date=2016-05-27&rft.issn=0094-6176&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24822900%23id-name%3DS2CID&rft_id=info%3Apmid%2F27232386&rft_id=info%3Adoi%2F10.1055%2Fs-0036-1581105&rft.aulast=Dentali&rft.aufirst=Francesco&rft.au=Crowther%2C+Mark&rft.au=Galli%2C+Matteo&rft.au=Pomero%2C+Fulvio&rft.au=Garcia%2C+David&rft.au=Clark%2C+Nathan&rft.au=Spadafora%2C+Laura&rft.au=Witt%2C+Daniel&rft.au=Ageno%2C+Walter&rft.au=for+the+WARPED+Investigators&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-69"><a href="#cite_ref-69">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/warfarin.html">"Warfarin Uses, Dosage, Side Effects"</a>. Drugs.com. Retrieved 2020-01-23.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Drugs.com&rft.atitle=Warfarin+Uses%2C+Dosage%2C+Side+Effects&rft_id=https%3A%2F%2Fwww.drugs.com%2Fwarfarin.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-70"><a href="#cite_ref-70">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSullivanFordBoyden1998" class="citation journal cs1">Sullivan DM, Ford MA, Boyden TW (1998-08-01). "Grapefruit juice and the response to warfarin". American Journal of Health-System Pharmacy. 55 (15): 1581–1583. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fajhp%2F55.15.1581">10.1093/ajhp/55.15.1581</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1079-2082">1079-2082</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9706183">9706183</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Health-System+Pharmacy&rft.atitle=Grapefruit+juice+and+the+response+to+warfarin&rft.volume=55&rft.issue=15&rft.pages=1581-1583&rft.date=1998-08-01&rft.issn=1079-2082&rft_id=info%3Apmid%2F9706183&rft_id=info%3Adoi%2F10.1093%2Fajhp%2F55.15.1581&rft.aulast=Sullivan&rft.aufirst=Dawn+M.&rft.au=Ford%2C+Marjorie+A.&rft.au=Boyden%2C+Thomas+W.&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-71"><a href="#cite_ref-71">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDi_Nisiovan_EsBüller2016" class="citation journal cs1">Di Nisio M, van Es N, Büller HR (December 2016). "Deep vein thrombosis and pulmonary embolism". The Lancet. 388 (10063): 3060–3073. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2816%2930514-1">10.1016/S0140-6736(16)30514-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27375038">27375038</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25712161">25712161</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Lancet&rft.atitle=Deep+vein+thrombosis+and+pulmonary+embolism&rft.volume=388&rft.issue=10063&rft.pages=3060-3073&rft.date=2016-12&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25712161%23id-name%3DS2CID&rft_id=info%3Apmid%2F27375038&rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2816%2930514-1&rft.aulast=Di+Nisio&rft.aufirst=Marcello&rft.au=van+Es%2C+Nick&rft.au=B%C3%BCller%2C+Harry+R&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-72"><a href="#cite_ref-72">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKoehlHayesAl-SamkariRosovsky2020" class="citation journal cs1">Koehl JL, Hayes BD, Al-Samkari H, Rosovsky R (2020-01-23). "A comprehensive evaluation of apixaban in the treatment of venous thromboembolism". Expert Review of Hematology. 13 (2): 155–173. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17474086.2020.1711731">10.1080/17474086.2020.1711731</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1747-4086">1747-4086</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31958251">31958251</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:210842354">210842354</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Review+of+Hematology&rft.atitle=A+comprehensive+evaluation+of+apixaban+in+the+treatment+of+venous+thromboembolism&rft.volume=13&rft.issue=2&rft.pages=155-173&rft.date=2020-01-23&rft.issn=1747-4086&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A210842354%23id-name%3DS2CID&rft_id=info%3Apmid%2F31958251&rft_id=info%3Adoi%2F10.1080%2F17474086.2020.1711731&rft.aulast=Koehl&rft.aufirst=Jennifer+L&rft.au=Hayes%2C+Bryan+D.&rft.au=Al-Samkari%2C+Hanny&rft.au=Rosovsky%2C+Rachel&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-APTAfive-73">^ <a href="#cite_ref-APTAfive_73-0">a</a> <a href="#cite_ref-APTAfive_73-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAmerican_Physical_Therapy_Association2014" class="citation cs2"><a href="/wiki/American_Physical_Therapy_Association" title="American Physical Therapy Association">American Physical Therapy Association</a> (15 September 2014), <a rel="nofollow" class="external text" href="http://www.choosingwisely.org/doctor-patient-lists/american-physical-therapy-association/">"Five Things Physicians and Patients Should Question"</a>, <a href="/wiki/Choosing_Wisely" title="Choosing Wisely">Choosing Wisely</a>: an initiative of the <a href="/wiki/ABIM_Foundation" class="mw-redirect" title="ABIM Foundation">ABIM Foundation</a>, American Physical Therapy Association, retrieved 15 September 2014</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Choosing+Wisely%3A+an+initiative+of+the+ABIM+Foundation&rft.atitle=Five+Things+Physicians+and+Patients+Should+Question&rft.date=2014-09-15&rft.au=American+Physical+Therapy+Association&rft_id=http%3A%2F%2Fwww.choosingwisely.org%2Fdoctor-patient-lists%2Famerican-physical-therapy-association%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988">, which cites <ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAissaouiMartinsMoulyWeber2009" class="citation journal cs1">Aissaoui N, Martins E, Mouly S, Weber S, Meune C (September 2009). "A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both". International Journal of Cardiology. 137 (1): 37–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijcard.2008.06.020">10.1016/j.ijcard.2008.06.020</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18691773">18691773</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Cardiology&rft.atitle=A+meta-analysis+of+bed+rest+versus+early+ambulation+in+the+management+of+pulmonary+embolism%2C+deep+vein+thrombosis%2C+or+both&rft.volume=137&rft.issue=1&rft.pages=37-41&rft.date=2009-09&rft_id=info%3Adoi%2F10.1016%2Fj.ijcard.2008.06.020&rft_id=info%3Apmid%2F18691773&rft.aulast=Aissaoui&rft.aufirst=N&rft.au=Martins%2C+E&rft.au=Mouly%2C+S&rft.au=Weber%2C+S&rft.au=Meune%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAndersonOverendGodwinSealy2009" class="citation journal cs1">Anderson CM, Overend TJ, Godwin J, Sealy C, Sunderji A (2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787576">"Ambulation after deep vein thrombosis: a systematic review"</a>. Physiotherapy Canada. 61 (3): 133–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3138%2Fphysio.61.3.133">10.3138/physio.61.3.133</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787576">2787576</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20514175">20514175</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Physiotherapy+Canada&rft.atitle=Ambulation+after+deep+vein+thrombosis%3A+a+systematic+review&rft.volume=61&rft.issue=3&rft.pages=133-40&rft.date=2009&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2787576%23id-name%3DPMC&rft_id=info%3Apmid%2F20514175&rft_id=info%3Adoi%2F10.3138%2Fphysio.61.3.133&rft.aulast=Anderson&rft.aufirst=CM&rft.au=Overend%2C+TJ&rft.au=Godwin%2C+J&rft.au=Sealy%2C+C&rft.au=Sunderji%2C+A&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2787576&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"></li></ul> </li> <li id="cite_note-74"><a href="#cite_ref-74">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDi_MinnoFrigerioSpadarellaRavani2017" class="citation journal cs1">Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, et al. (July 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.blre.2017.02.001">"Old and new oral anticoagulants: Food, herbal medicines and drug interactions"</a>. Blood Reviews. 31 (4): 193–203. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.blre.2017.02.001">10.1016/j.blre.2017.02.001</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/2434%2F476466">2434/476466</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28196633">28196633</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Blood+Reviews&rft.atitle=Old+and+new+oral+anticoagulants%3A+Food%2C+herbal+medicines+and+drug+interactions&rft.volume=31&rft.issue=4&rft.pages=193-203&rft.date=2017-07&rft_id=info%3Ahdl%2F2434%2F476466&rft_id=info%3Apmid%2F28196633&rft_id=info%3Adoi%2F10.1016%2Fj.blre.2017.02.001&rft.aulast=Di+Minno&rft.aufirst=Alessandro&rft.au=Frigerio%2C+Beatrice&rft.au=Spadarella%2C+Gaia&rft.au=Ravani%2C+Alessio&rft.au=Sansaro%2C+Daniela&rft.au=Amato%2C+Mauro&rft.au=Kitzmiller%2C+Joseph+P.&rft.au=Pepi%2C+Mauro&rft.au=Tremoli%2C+Elena&rft.au=Baldassarre%2C+Damiano&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.blre.2017.02.001&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-75"><a href="#cite_ref-75">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAlmarshadAlaklabiBakhshPathan2018" class="citation journal cs1">Almarshad F, Alaklabi A, Bakhsh E, Pathan A, Almegren M (December 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334188">"Use of direct oral anticoagulants in daily practice"</a>. American Journal of Blood Research. 8 (4): 57–72. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334188">6334188</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30697449">30697449</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Blood+Research&rft.atitle=Use+of+direct+oral+anticoagulants+in+daily+practice&rft.volume=8&rft.issue=4&rft.pages=57-72&rft.date=2018-12&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6334188%23id-name%3DPMC&rft_id=info%3Apmid%2F30697449&rft.aulast=Almarshad&rft.aufirst=Feras&rft.au=Alaklabi%2C+Ali&rft.au=Bakhsh%2C+Ebtisam&rft.au=Pathan%2C+Aslam&rft.au=Almegren%2C+Mosaad&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6334188&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-76"><a href="#cite_ref-76">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVerdecchiaAngeliAitaBartolini2016" class="citation journal cs1">Verdecchia P, Angeli F, Aita A, Bartolini C, Reboldi G (April 2016). "Why switch from warfarin to NOACs?". Internal and Emergency Medicine. 11 (3): 289–293. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11739-016-1411-0">10.1007/s11739-016-1411-0</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1828-0447">1828-0447</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26972708">26972708</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25807727">25807727</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Internal+and+Emergency+Medicine&rft.atitle=Why+switch+from+warfarin+to+NOACs%3F&rft.volume=11&rft.issue=3&rft.pages=289-293&rft.date=2016-04&rft.issn=1828-0447&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25807727%23id-name%3DS2CID&rft_id=info%3Apmid%2F26972708&rft_id=info%3Adoi%2F10.1007%2Fs11739-016-1411-0&rft.aulast=Verdecchia&rft.aufirst=Paolo&rft.au=Angeli%2C+Fabio&rft.au=Aita%2C+Adolfo&rft.au=Bartolini%2C+Claudia&rft.au=Reboldi%2C+Gianpaolo&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-77"><a href="#cite_ref-77">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDienerNtaiosO'DonnellEaston2018" class="citation journal cs1">Diener HC, Ntaios G, O'Donnell M, Easton JD (2018-09-22). "Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke". Expert Opinion on Pharmacotherapy. 19 (14): 1597–1602. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14656566.2018.1515913">10.1080/14656566.2018.1515913</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1465-6566">1465-6566</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30152249">30152249</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52099757">52099757</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Pharmacotherapy&rft.atitle=Non-vitamin-K+oral+anticoagulants+%28NOACs%29+for+the+prevention+of+secondary+stroke&rft.volume=19&rft.issue=14&rft.pages=1597-1602&rft.date=2018-09-22&rft.issn=1465-6566&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52099757%23id-name%3DS2CID&rft_id=info%3Apmid%2F30152249&rft_id=info%3Adoi%2F10.1080%2F14656566.2018.1515913&rft.aulast=Diener&rft.aufirst=Hans-Christoph&rft.au=Ntaios%2C+George&rft.au=O%27Donnell%2C+Martin&rft.au=Easton%2C+J.+Donald&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-78"><a href="#cite_ref-78">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPolCurtisRamkumarBittinger2019" class="citation journal cs1">Pol D, Curtis C, Ramkumar S, Bittinger L (April 2019). "NOACs Now Mainstream for the Use of Anticoagulation in Non-Valvular Atrial Fibrillation in Australia". Heart, Lung and Circulation. 28 (4): e40–e42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.hlc.2018.03.010">10.1016/j.hlc.2018.03.010</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29861320">29861320</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:44103560">44103560</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Heart%2C+Lung+and+Circulation&rft.atitle=NOACs+Now+Mainstream+for+the+Use+of+Anticoagulation+in+Non-Valvular+Atrial+Fibrillation+in+Australia&rft.volume=28&rft.issue=4&rft.pages=e40-e42&rft.date=2019-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A44103560%23id-name%3DS2CID&rft_id=info%3Apmid%2F29861320&rft_id=info%3Adoi%2F10.1016%2Fj.hlc.2018.03.010&rft.aulast=Pol&rft.aufirst=Derk&rft.au=Curtis%2C+Claire&rft.au=Ramkumar%2C+Satish&rft.au=Bittinger%2C+Logan&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-79"><a href="#cite_ref-79">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWerdanBraun-DullaeusPresek2013" class="citation journal cs1">Werdan K, Braun-Dullaeus R, Presek P (August 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782018">"Anticoagulation in atrial fibrillation: NOAC's the word"</a>. Deutsches Ärzteblatt International. 110 (31–32): 523–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3238%2Farztebl.2013.0523">10.3238/arztebl.2013.0523</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782018">3782018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24069072">24069072</a>. <q>Things have changed dramatically with the introduction of the new oral anticoagulants (NOACs) — dabigatran, a factor IIa (thrombin) inhibitor, and the factor Xa inhibitors rivaroxaban and apixaban. Clinical trials have shown them therapeutically superior, or at least non-inferior, to VKAs, with less serious side effects.</q></cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Deutsches+%C3%84rzteblatt+International&rft.atitle=Anticoagulation+in+atrial+fibrillation%3A+NOAC%27s+the+word&rft.volume=110&rft.issue=31%E2%80%9332&rft.pages=523-4&rft.date=2013-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3782018%23id-name%3DPMC&rft_id=info%3Apmid%2F24069072&rft_id=info%3Adoi%2F10.3238%2Farztebl.2013.0523&rft.aulast=Werdan&rft.aufirst=K&rft.au=Braun-Dullaeus%2C+R&rft.au=Presek%2C+P&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3782018&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-80"><a href="#cite_ref-80">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHeineBrandenburgSchirmer2018" class="citation journal cs1">Heine GH, Brandenburg V, Schirmer SH (2018-04-27). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974258">"Orale Antikoagulation bei chronischer Nierenerkrankung und Vorhofflimmern"</a>. Deutsches Ärzteblatt Online. 115 (17): 287–294. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3238%2Farztebl.2018.0287">10.3238/arztebl.2018.0287</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1866-0452">1866-0452</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974258">5974258</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29789105">29789105</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Deutsches+%C3%84rzteblatt+Online&rft.atitle=Orale+Antikoagulation+bei+chronischer+Nierenerkrankung+und+Vorhofflimmern&rft.volume=115&rft.issue=17&rft.pages=287-294&rft.date=2018-04-27&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5974258%23id-name%3DPMC&rft.issn=1866-0452&rft_id=info%3Apmid%2F29789105&rft_id=info%3Adoi%2F10.3238%2Farztebl.2018.0287&rft.aulast=Heine&rft.aufirst=Gunnar+H.&rft.au=Brandenburg%2C+Vincent&rft.au=Schirmer%2C+Stephan+H.&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5974258&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-81"><a href="#cite_ref-81">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEfirdChaslerAlexanderMcGuire2016" class="citation journal cs1">Efird LE, Chasler J, Alexander GC, McGuire M (Jun 21, 2016). <a rel="nofollow" class="external text" href="https://www.pharmacytimes.com/view/prescribing-patterns-of-novel-anticoagulants-within-a-statewide-multispecialty-practice">"Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty Practice"</a>. American Journal of Pharmacy Benefits. 8 (3): 97–102.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Pharmacy+Benefits&rft.atitle=Prescribing+Patterns+of+Novel+Anticoagulants+Within+a+Statewide+Multispecialty+Practice&rft.volume=8&rft.issue=3&rft.pages=97-102&rft.date=2016-06-21&rft.aulast=Efird&rft.aufirst=LE&rft.au=Chasler%2C+J&rft.au=Alexander%2C+GC&rft.au=McGuire%2C+M&rft_id=https%3A%2F%2Fwww.pharmacytimes.com%2Fview%2Fprescribing-patterns-of-novel-anticoagulants-within-a-statewide-multispecialty-practice&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-82"><a href="#cite_ref-82">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLinhardt2003" class="citation journal cs1">Linhardt RJ (June 2003). "2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity". Journal of Medicinal Chemistry. 46 (13): 2551–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fjm030176m">10.1021/jm030176m</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12801218">12801218</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Medicinal+Chemistry&rft.atitle=2003+Claude+S.+Hudson+Award+address+in+carbohydrate+chemistry.+Heparin%3A+structure+and+activity&rft.volume=46&rft.issue=13&rft.pages=2551-64&rft.date=2003-06&rft_id=info%3Adoi%2F10.1021%2Fjm030176m&rft_id=info%3Apmid%2F12801218&rft.aulast=Linhardt&rft.aufirst=RJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Heparin_and_anticoagulation-83">^ <a href="#cite_ref-Heparin_and_anticoagulation_83-0">a</a> <a href="#cite_ref-Heparin_and_anticoagulation_83-1">b</a> <a href="#cite_ref-Heparin_and_anticoagulation_83-2">c</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOnishiSt_AngeDordickLinhardt2016" class="citation journal cs1">Onishi A, St Ange K, Dordick JS, Linhardt RJ (June 2016). "Heparin and anticoagulation". Frontiers in Bioscience. 21 (7): 1372–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2741%2F4462">10.2741/4462</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27100512">27100512</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Frontiers+in+Bioscience&rft.atitle=Heparin+and+anticoagulation&rft.volume=21&rft.issue=7&rft.pages=1372-92&rft.date=2016-06&rft_id=info%3Adoi%2F10.2741%2F4462&rft_id=info%3Apmid%2F27100512&rft.aulast=Onishi&rft.aufirst=A&rft.au=St+Ange%2C+K&rft.au=Dordick%2C+JS&rft.au=Linhardt%2C+RJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-84"><a href="#cite_ref-84">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCasuNaggiTorri2015" class="citation journal cs1">Casu B, Naggi A, Torri G (February 2015). "Re-visiting the structure of heparin". Carbohydrate Research. 403: 60–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.carres.2014.06.023">10.1016/j.carres.2014.06.023</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25088334">25088334</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Carbohydrate+Research&rft.atitle=Re-visiting+the+structure+of+heparin&rft.volume=403&rft.pages=60-8&rft.date=2015-02&rft_id=info%3Adoi%2F10.1016%2Fj.carres.2014.06.023&rft_id=info%3Apmid%2F25088334&rft.aulast=Casu&rft.aufirst=B&rft.au=Naggi%2C+A&rft.au=Torri%2C+G&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-85"><a href="#cite_ref-85">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSeoAndayaLeary2012" class="citation journal cs1">Seo Y, Andaya A, Leary JA (March 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296823">"Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry"</a>. Analytical Chemistry. 84 (5): 2416–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fac203190k">10.1021/ac203190k</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296823">3296823</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22283665">22283665</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Analytical+Chemistry&rft.atitle=Preparation%2C+separation%2C+and+conformational+analysis+of+differentially+sulfated+heparin+octasaccharide+isomers+using+ion+mobility+mass+spectrometry&rft.volume=84&rft.issue=5&rft.pages=2416-23&rft.date=2012-03&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3296823%23id-name%3DPMC&rft_id=info%3Apmid%2F22283665&rft_id=info%3Adoi%2F10.1021%2Fac203190k&rft.aulast=Seo&rft.aufirst=Y&rft.au=Andaya%2C+A&rft.au=Leary%2C+JA&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3296823&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-86"><a href="#cite_ref-86">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAllingstrupWetterslevRavnMøller2016" class="citation journal cs1">Allingstrup M, Wetterslev J, Ravn FB, Møller AM, Afshari A (April 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137061">"Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis"</a>. Intensive Care Medicine. 42 (4): 505–520. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00134-016-4225-7">10.1007/s00134-016-4225-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137061">2137061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26862016">26862016</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Intensive+Care+Medicine&rft.atitle=Antithrombin+III+for+critically+ill+patients%3A+a+systematic+review+with+meta-analysis+and+trial+sequential+analysis&rft.volume=42&rft.issue=4&rft.pages=505-520&rft.date=2016-04&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2137061%23id-name%3DPMC&rft_id=info%3Apmid%2F26862016&rft_id=info%3Adoi%2F10.1007%2Fs00134-016-4225-7&rft.aulast=Allingstrup&rft.aufirst=M&rft.au=Wetterslev%2C+J&rft.au=Ravn%2C+FB&rft.au=M%C3%B8ller%2C+AM&rft.au=Afshari%2C+A&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2137061&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-87"><a href="#cite_ref-87">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBrizzeeStonePalmer2020" class="citation journal cs1">Brizzee L, Stone A, Palmer MC (May 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213950">"False lithium toxicity secondary to lithium heparin test tube: A case report and review"</a>. Ment Health Clin. 10 (3): 90–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.9740%2Fmhc.2020.05.090">10.9740/mhc.2020.05.090</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213950">7213950</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32420006">32420006</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ment+Health+Clin&rft.atitle=False+lithium+toxicity+secondary+to+lithium+heparin+test+tube%3A+A+case+report+and+review&rft.volume=10&rft.issue=3&rft.pages=90-94&rft.date=2020-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7213950%23id-name%3DPMC&rft_id=info%3Apmid%2F32420006&rft_id=info%3Adoi%2F10.9740%2Fmhc.2020.05.090&rft.aulast=Brizzee&rft.aufirst=L&rft.au=Stone%2C+A&rft.au=Palmer%2C+MC&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7213950&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-88"><a href="#cite_ref-88">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation journal cs1">"Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Arthroplasty, Replacement,Venous Thromboembolism, Date of authorisation: 17/03/2008, Revision: 29, Status: Authorised". Case Medical Research. 2019-07-16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.31525%2Fcmr-1321569">10.31525/cmr-1321569</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2643-4652">2643-4652</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:241319098">241319098</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Case+Medical+Research&rft.atitle=Human+medicines+European+public+assessment+report+%28EPAR%29%3A+Pradaxa%2C+dabigatran+etexilate%2C+Arthroplasty%2C+Replacement%2CVenous+Thromboembolism%2C+Date+of+authorisation%3A+17%2F03%2F2008%2C+Revision%3A+29%2C+Status%3A+Authorised&rft.date=2019-07-16&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A241319098%23id-name%3DS2CID&rft.issn=2643-4652&rft_id=info%3Adoi%2F10.31525%2Fcmr-1321569&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-DOAC2018-89"><a href="#cite_ref-DOAC2018_89-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDouxfilsAgenoSamamaLessire2018" class="citation journal cs1">Douxfils J, Ageno W, Samama CM, Lessire S, Ten Cate H, Verhamme P, et al. (February 2018). <a rel="nofollow" class="external text" href="https://lirias.kuleuven.be/handle/123456789/611680">"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians"</a>. Journal of Thrombosis and Haemostasis. 16 (2): 209–219. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjth.13912">10.1111/jth.13912</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29193737">29193737</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:46865986">46865986</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Thrombosis+and+Haemostasis&rft.atitle=Laboratory+testing+in+patients+treated+with+direct+oral+anticoagulants%3A+a+practical+guide+for+clinicians&rft.volume=16&rft.issue=2&rft.pages=209-219&rft.date=2018-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A46865986%23id-name%3DS2CID&rft_id=info%3Apmid%2F29193737&rft_id=info%3Adoi%2F10.1111%2Fjth.13912&rft.aulast=Douxfils&rft.aufirst=J&rft.au=Ageno%2C+W&rft.au=Samama%2C+CM&rft.au=Lessire%2C+S&rft.au=Ten+Cate%2C+H&rft.au=Verhamme%2C+P&rft.au=Dogn%C3%A9%2C+JM&rft.au=Mullier%2C+F&rft_id=https%3A%2F%2Flirias.kuleuven.be%2Fhandle%2F123456789%2F611680&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-udayachalerm-90">^ <a href="#cite_ref-udayachalerm_90-0">a</a> <a href="#cite_ref-udayachalerm_90-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFUdayachalermRattanasiriAngkananardAttia2018" class="citation journal cs1">Udayachalerm S, Rattanasiri S, Angkananard T, Attia J, Sansanayudh N, Thakkinstian A (September 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714855">"The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis"</a>. Clinical and Applied Thrombosis/Hemostasis. 24 (9_suppl): 117S–126S. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1076029618796339">10.1177/1076029618796339</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714855">6714855</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30176738">30176738</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+and+Applied+Thrombosis%2FHemostasis&rft.atitle=The+Reversal+of+Bleeding+Caused+by+New+Oral+Anticoagulants+%28NOACs%29%3A+A+Systematic+Review+and+Meta-Analysis&rft.volume=24&rft.issue=9_suppl&rft.pages=117S-126S&rft.date=2018-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6714855%23id-name%3DPMC&rft_id=info%3Apmid%2F30176738&rft_id=info%3Adoi%2F10.1177%2F1076029618796339&rft.aulast=Udayachalerm&rft.aufirst=S&rft.au=Rattanasiri%2C+S&rft.au=Angkananard%2C+T&rft.au=Attia%2C+J&rft.au=Sansanayudh%2C+N&rft.au=Thakkinstian%2C+A&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6714855&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-:1-91"><a href="#cite_ref-:1_91-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20170328223906/http://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf">"Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs"</a> (PDF). Scottish Dental Clinical Effectiveness Programme. August 2015. Archived from <a rel="nofollow" class="external text" href="http://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf">the original</a> (PDF) on 2017-03-28. Retrieved 2016-03-09.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Management+of+Dental+Patients+Taking+Anticoagulants+or+Antiplatelet+Drugs&rft.pub=Scottish+Dental+Clinical+Effectiveness+Programme&rft.date=2015-08&rft_id=http%3A%2F%2Fwww.sdcep.org.uk%2Fwp-content%2Fuploads%2F2015%2F09%2FSDCEP-Anticoagulants-Guidance.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-:3-92">^ <a href="#cite_ref-:3_92-0">a</a> <a href="#cite_ref-:3_92-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFClark2018" class="citation journal cs1">Clark NP (November 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246023">"Role of the anticoagulant monitoring service in 2018: beyond warfarin"</a>. Hematology. American Society of Hematology. Education Program. 2018 (1): 348–352. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1182%2Fasheducation-2018.1.348">10.1182/asheducation-2018.1.348</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246023">6246023</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30504331">30504331</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hematology.+American+Society+of+Hematology.+Education+Program&rft.atitle=Role+of+the+anticoagulant+monitoring+service+in+2018%3A+beyond+warfarin&rft.volume=2018&rft.issue=1&rft.pages=348-352&rft.date=2018-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6246023%23id-name%3DPMC&rft_id=info%3Apmid%2F30504331&rft_id=info%3Adoi%2F10.1182%2Fasheducation-2018.1.348&rft.aulast=Clark&rft.aufirst=NP&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6246023&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-:4-93">^ <a href="#cite_ref-:4_93-0">a</a> <a href="#cite_ref-:4_93-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChenSteckerA._Warden2020" class="citation journal cs1">Chen A, Stecker E, A Warden B (2020-06-15). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670541">"Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges"</a>. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 9 (13): e017559. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FJAHA.120.017559">10.1161/JAHA.120.017559</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2047-9980">2047-9980</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670541">7670541</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32538234">32538234</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Heart+Association%3A+Cardiovascular+and+Cerebrovascular+Disease&rft.atitle=Direct+Oral+Anticoagulant+Use%3A+A+Practical+Guide+to+Common+Clinical+Challenges&rft.volume=9&rft.issue=13&rft.pages=e017559&rft.date=2020-06-15&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7670541%23id-name%3DPMC&rft.issn=2047-9980&rft_id=info%3Apmid%2F32538234&rft_id=info%3Adoi%2F10.1161%2FJAHA.120.017559&rft.aulast=Chen&rft.aufirst=Ashley&rft.au=Stecker%2C+Eric&rft.au=A.+Warden%2C+Bruce&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7670541&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-:0-94"><a href="#cite_ref-:0_94-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20171026222846/https://www.bhf.org.uk/heart-matters-magazine/medical/drug-cabinet/novel-anticoagulants">"Novel anticoagulants"</a>. Heart Matters Magazine. British Heart Foundation. Archived from <a rel="nofollow" class="external text" href="https://www.bhf.org.uk/heart-matters-magazine/medical/drug-cabinet/novel-anticoagulants">the original</a> on 2017-10-26. Retrieved 2016-03-09.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Heart+Matters+Magazine&rft.atitle=Novel+anticoagulants&rft_id=https%3A%2F%2Fwww.bhf.org.uk%2Fheart-matters-magazine%2Fmedical%2Fdrug-cabinet%2Fnovel-anticoagulants&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-95"><a href="#cite_ref-95">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOzakiChoiLeKo2020" class="citation journal cs1">Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, et al. (2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCOUTCOMES.119.005969">"Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis"</a>. Circulation: Cardiovascular Quality and Outcomes. 13 (3): e005969. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCOUTCOMES.119.005969">10.1161/CIRCOUTCOMES.119.005969</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1941-7705">1941-7705</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32148102">32148102</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:212640015">212640015</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation%3A+Cardiovascular+Quality+and+Outcomes&rft.atitle=Real-World+Adherence+and+Persistence+to+Direct+Oral+Anticoagulants+in+Patients+With+Atrial+Fibrillation%3A+A+Systematic+Review+and+Meta-Analysis&rft.volume=13&rft.issue=3&rft.pages=e005969&rft.date=2020&rft.issn=1941-7705&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A212640015%23id-name%3DS2CID&rft_id=info%3Apmid%2F32148102&rft_id=info%3Adoi%2F10.1161%2FCIRCOUTCOMES.119.005969&rft.aulast=Ozaki&rft.aufirst=Aya+F.&rft.au=Choi%2C+Austin+S.&rft.au=Le%2C+Quan+T.&rft.au=Ko%2C+Dennis+T.&rft.au=Han%2C+Janet+K.&rft.au=Park%2C+Sandy+S.&rft.au=Jackevicius%2C+Cynthia+A.&rft_id=https%3A%2F%2Fdoi.org%2F10.1161%252FCIRCOUTCOMES.119.005969&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-96"><a href="#cite_ref-96">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLekuraKalus2018" class="citation journal cs1">Lekura J, Kalus JS (August 2018). "Overview of betrixaban and its role in clinical practice". American Journal of Health-System Pharmacy. 75 (15): 1095–1102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2146%2Fajhp170785">10.2146/ajhp170785</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29941506">29941506</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:49418996">49418996</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Health-System+Pharmacy&rft.atitle=Overview+of+betrixaban+and+its+role+in+clinical+practice&rft.volume=75&rft.issue=15&rft.pages=1095-1102&rft.date=2018-08&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A49418996%23id-name%3DS2CID&rft_id=info%3Apmid%2F29941506&rft_id=info%3Adoi%2F10.2146%2Fajhp170785&rft.aulast=Lekura&rft.aufirst=J&rft.au=Kalus%2C+JS&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Steg-97"><a href="#cite_ref-Steg_97-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStegMehtaJukemaLip2011" class="citation journal cs1">Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, et al. (October 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295208">"RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome"</a>. European Heart Journal. 32 (20): 2541–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehr334">10.1093/eurheartj/ehr334</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295208">3295208</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21878434">21878434</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Heart+Journal&rft.atitle=RUBY-1%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial+of+the+safety+and+tolerability+of+the+novel+oral+factor+Xa+inhibitor+darexaban+%28YM150%29+following+acute+coronary+syndrome&rft.volume=32&rft.issue=20&rft.pages=2541-54&rft.date=2011-10&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3295208%23id-name%3DPMC&rft_id=info%3Apmid%2F21878434&rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehr334&rft.aulast=Steg&rft.aufirst=PG&rft.au=Mehta%2C+SR&rft.au=Jukema%2C+JW&rft.au=Lip%2C+GY&rft.au=Gibson%2C+CM&rft.au=Kovar%2C+F&rft.au=Kala%2C+P&rft.au=Garcia-Hernandez%2C+A&rft.au=Renfurm%2C+RW&rft.au=Granger%2C+CB&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3295208&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-98"><a href="#cite_ref-98">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDwyerWalsh2013" class="citation web cs1">Dwyer J, Walsh C (May 2013). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140719173801/http://decisionresources.com/The-Decision-Resources-Blog/May-2013/European-Approval-for-Xarelto-in-ACS-052913">"First Time European Approval for Xarelto in ACS"</a>. Decision Resources. Archived from <a rel="nofollow" class="external text" href="http://decisionresources.com/The-Decision-Resources-Blog/May-2013/European-Approval-for-Xarelto-in-ACS-052913">the original</a> on 2014-07-19.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=First+Time+European+Approval+for+Xarelto+in+ACS&rft.pub=Decision+Resources&rft.date=2013-05&rft.aulast=Dwyer&rft.aufirst=Joseph&rft.au=Walsh%2C+Conor&rft_id=http%3A%2F%2Fdecisionresources.com%2FThe-Decision-Resources-Blog%2FMay-2013%2FEuropean-Approval-for-Xarelto-in-ACS-052913&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-pmid16148288-99"><a href="#cite_ref-pmid16148288_99-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDi_NisioMiddeldorpBüller2005" class="citation journal cs1">Di Nisio M, Middeldorp S, Büller HR (September 2005). <a rel="nofollow" class="external text" href="https://pure.uva.nl/ws/files/4020551/45334_205943y.pdf">"Direct thrombin inhibitors"</a> (PDF). The New England Journal of Medicine. 353 (10): 1028–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMra044440">10.1056/NEJMra044440</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16148288">16148288</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+England+Journal+of+Medicine&rft.atitle=Direct+thrombin+inhibitors&rft.volume=353&rft.issue=10&rft.pages=1028-40&rft.date=2005-09&rft_id=info%3Adoi%2F10.1056%2FNEJMra044440&rft_id=info%3Apmid%2F16148288&rft.aulast=Di+Nisio&rft.aufirst=M&rft.au=Middeldorp%2C+S&rft.au=B%C3%BCller%2C+HR&rft_id=https%3A%2F%2Fpure.uva.nl%2Fws%2Ffiles%2F4020551%2F45334_205943y.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-100"><a href="#cite_ref-100">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110525194419/http://www.fvleiden.org/ask/73.html">"Exanta"</a>. Ask Dr. Stephan Moll. The Thrombophilia Awareness Project. Archived from <a rel="nofollow" class="external text" href="http://www.fvleiden.org/ask/73.html">the original</a> on 25 May 2011.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Ask+Dr.+Stephan+Moll&rft.atitle=Exanta&rft_id=http%3A%2F%2Fwww.fvleiden.org%2Fask%2F73.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-101"><a href="#cite_ref-101">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://archive.today/20060318061448/http://www.astrazenecaclinicaltrials.com/article/512052.aspx">"Exanta™ (ximelagatran) Study report summaries"</a>. AstraZeneca Clinical Trials. Archived from <a rel="nofollow" class="external text" href="http://www.astrazenecaclinicaltrials.com/article/512052.aspx">the original</a> on 2006-03-18.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=AstraZeneca+Clinical+Trials&rft.atitle=Exanta%E2%84%A2+%28ximelagatran%29+Study+report+summaries&rft_id=http%3A%2F%2Fwww.astrazenecaclinicaltrials.com%2Farticle%2F512052.aspx&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-102"><a href="#cite_ref-102">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFManfrediDavePercudaniChristoforou2019" class="citation journal cs1">Manfredi M, Dave B, Percudani D, Christoforou J, Karasneh J, Diz Dios P, et al. (June 2019). "World workshop on oral medicine VII: Direct anticoagulant agents management for invasive oral procedures: A systematic review and meta-analysis". Oral Diseases. 25 (S1): 157–173. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fodi.13086">10.1111/odi.13086</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31140701">31140701</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:169034257">169034257</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Oral+Diseases&rft.atitle=World+workshop+on+oral+medicine+VII%3A+Direct+anticoagulant+agents+management+for+invasive+oral+procedures%3A+A+systematic+review+and+meta-analysis&rft.volume=25&rft.issue=S1&rft.pages=157-173&rft.date=2019-06&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A169034257%23id-name%3DS2CID&rft_id=info%3Apmid%2F31140701&rft_id=info%3Adoi%2F10.1111%2Fodi.13086&rft.aulast=Manfredi&rft.aufirst=M&rft.au=Dave%2C+B&rft.au=Percudani%2C+D&rft.au=Christoforou%2C+J&rft.au=Karasneh%2C+J&rft.au=Diz+Dios%2C+P&rft.au=Glick%2C+M&rft.au=Kumar%2C+N&rft.au=Lockhart%2C+PB&rft.au=Patton%2C+LL&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-103"><a href="#cite_ref-103">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBensiBelliParadisoLomurno2018" class="citation journal cs1">Bensi C, Belli S, Paradiso D, Lomurno G (July 2018). "Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis". International Journal of Oral and Maxillofacial Surgery. 47 (7): 923–932. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijom.2018.03.016">10.1016/j.ijom.2018.03.016</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29627150">29627150</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4697607">4697607</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Oral+and+Maxillofacial+Surgery&rft.atitle=Postoperative+bleeding+risk+of+direct+oral+anticoagulants+after+oral+surgery+procedures%3A+a+systematic+review+and+meta-analysis&rft.volume=47&rft.issue=7&rft.pages=923-932&rft.date=2018-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4697607%23id-name%3DS2CID&rft_id=info%3Apmid%2F29627150&rft_id=info%3Adoi%2F10.1016%2Fj.ijom.2018.03.016&rft.aulast=Bensi&rft.aufirst=C&rft.au=Belli%2C+S&rft.au=Paradiso%2C+D&rft.au=Lomurno%2C+G&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-104"><a href="#cite_ref-104">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCostantinidesRizzoPascazioMaglione2016" class="citation journal cs1">Costantinides F, Rizzo R, Pascazio L, Maglione M (January 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731944">"Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications"</a>. BMC Oral Health. 16: 5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12903-016-0170-7">10.1186/s12903-016-0170-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731944">4731944</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26822674">26822674</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMC+Oral+Health&rft.atitle=Managing+patients+taking+novel+oral+anticoagulants+%28NOAs%29+in+dentistry%3A+a+discussion+paper+on+clinical+implications&rft.volume=16&rft.pages=5&rft.date=2016-01&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4731944%23id-name%3DPMC&rft_id=info%3Apmid%2F26822674&rft_id=info%3Adoi%2F10.1186%2Fs12903-016-0170-7&rft.aulast=Costantinides&rft.aufirst=F&rft.au=Rizzo%2C+R&rft.au=Pascazio%2C+L&rft.au=Maglione%2C+M&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4731944&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-105"><a href="#cite_ref-105">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKosyfakiAttStrub2011" class="citation journal cs1">Kosyfaki P, Att W, Strub JR (August 2011). "The dental patient on oral anticoagulant medication: a literature review". Journal of Oral Rehabilitation. 38 (8): 615–33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2842.2010.02184.x">10.1111/j.1365-2842.2010.02184.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21073495">21073495</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Oral+Rehabilitation&rft.atitle=The+dental+patient+on+oral+anticoagulant+medication%3A+a+literature+review&rft.volume=38&rft.issue=8&rft.pages=615-33&rft.date=2011-08&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2842.2010.02184.x&rft_id=info%3Apmid%2F21073495&rft.aulast=Kosyfaki&rft.aufirst=P&rft.au=Att%2C+W&rft.au=Strub%2C+JR&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-106"><a href="#cite_ref-106">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFvan_Diermenvan_der_WaalHoogstraten2013" class="citation journal cs1">van Diermen DE, van der Waal I, Hoogstraten J (December 2013). "Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 116 (6): 709–16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.oooo.2013.07.026">10.1016/j.oooo.2013.07.026</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24120910">24120910</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Oral+Surgery%2C+Oral+Medicine%2C+Oral+Pathology+and+Oral+Radiology&rft.atitle=Management+recommendations+for+invasive+dental+treatment+in+patients+using+oral+antithrombotic+medication%2C+including+novel+oral+anticoagulants&rft.volume=116&rft.issue=6&rft.pages=709-16&rft.date=2013-12&rft_id=info%3Adoi%2F10.1016%2Fj.oooo.2013.07.026&rft_id=info%3Apmid%2F24120910&rft.aulast=van+Diermen&rft.aufirst=DE&rft.au=van+der+Waal%2C+I&rft.au=Hoogstraten%2C+J&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-107"><a href="#cite_ref-107">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShiXuZhangZhang2017" class="citation journal cs1">Shi Q, Xu J, Zhang T, Zhang B, Liu H (2017-02-08). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296357">"Post-operative Bleeding Risk in Dental Surgery for Patients on Oral Anticoagulant Therapy: A Meta-analysis of Observational Studies"</a>. Frontiers in Pharmacology. 8: 58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffphar.2017.00058">10.3389/fphar.2017.00058</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296357">5296357</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28228727">28228727</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Frontiers+in+Pharmacology&rft.atitle=Post-operative+Bleeding+Risk+in+Dental+Surgery+for+Patients+on+Oral+Anticoagulant+Therapy%3A+A+Meta-analysis+of+Observational+Studies&rft.volume=8&rft.pages=58&rft.date=2017-02-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5296357%23id-name%3DPMC&rft_id=info%3Apmid%2F28228727&rft_id=info%3Adoi%2F10.3389%2Ffphar.2017.00058&rft.aulast=Shi&rft.aufirst=Q&rft.au=Xu%2C+J&rft.au=Zhang%2C+T&rft.au=Zhang%2C+B&rft.au=Liu%2C+H&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5296357&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-108"><a href="#cite_ref-108">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20170328223906/http://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf">"Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs: Dental Clinical Guidance"</a> (PDF). Scottish Dental Clinical Effectiveness Programme. Archived from <a rel="nofollow" class="external text" href="https://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf">the original</a> (PDF) on 2017-03-28. Retrieved 2020-01-09.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Scottish+Dental+Clinical+Effectiveness+Programme&rft.atitle=Management+of+Dental+Patients+Taking+Anticoagulants+or+Antiplatelet+Drugs%3A+Dental+Clinical+Guidance&rft_id=https%3A%2F%2Fwww.sdcep.org.uk%2Fwp-content%2Fuploads%2F2015%2F09%2FSDCEP-Anticoagulants-Guidance.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-ThrombateLabel-109">^ <a href="#cite_ref-ThrombateLabel_109-0">a</a> <a href="#cite_ref-ThrombateLabel_109-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20121115050430/http://www.talecris-pi.info/inserts/thrombate.pdf">"Thrombate III label"</a> (PDF). Archived from <a rel="nofollow" class="external text" href="http://www.talecris-pi.info/inserts/thrombate.pdf">the original</a> (PDF) on 2012-11-15.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Thrombate+III+label&rft_id=http%3A%2F%2Fwww.talecris-pi.info%2Finserts%2Fthrombate.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-110"><a href="#cite_ref-110">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCenter_for_Biologics_Evaluation_and_Research2019" class="citation web cs1">Center for Biologics Evaluation and Research (24 April 2019). <a rel="nofollow" class="external text" href="https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm134042.htm">"Fractionated Plasma Products - ATryn"</a>. www.fda.gov.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=www.fda.gov&rft.atitle=Fractionated+Plasma+Products+-+ATryn&rft.date=2019-04-24&rft.au=Center+for+Biologics+Evaluation+and+Research&rft_id=https%3A%2F%2Fwww.fda.gov%2FBiologicsBloodVaccines%2FBloodBloodProducts%2FApprovedProducts%2FLicensedProductsBLAs%2FFractionatedPlasmaProducts%2Fucm134042.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-ATrynLabel-111">^ <a href="#cite_ref-ATrynLabel_111-0">a</a> <a href="#cite_ref-ATrynLabel_111-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM134045.pdf">"Antithrombin (Recombinant) US Package Insert ATryn for Injection February 3, 2009"</a> (PDF). <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Food+and+Drug+Administration&rft.atitle=Antithrombin+%28Recombinant%29+US+Package+Insert+ATryn+for+Injection+February+3%2C+2009&rft_id=https%3A%2F%2Fwww.fda.gov%2Fdownloads%2FBiologicsBloodVaccines%2FBloodBloodProducts%2FApprovedProducts%2FLicensedProductsBLAs%2FFractionatedPlasmaProducts%2FUCM134045.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-Tornkvist_22–31-112">^ <a href="#cite_ref-Tornkvist_22–31_112-0">a</a> <a href="#cite_ref-Tornkvist_22–31_112-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTornkvistSmithLabaf2018" class="citation journal cs1">Tornkvist M, Smith JG, Labaf A (February 2018). "Current evidence of oral anticoagulant reversal: A systematic review". Thrombosis Research. 162: 22–31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.thromres.2017.12.003">10.1016/j.thromres.2017.12.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29258056">29258056</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+Research&rft.atitle=Current+evidence+of+oral+anticoagulant+reversal%3A+A+systematic+review&rft.volume=162&rft.pages=22-31&rft.date=2018-02&rft_id=info%3Adoi%2F10.1016%2Fj.thromres.2017.12.003&rft_id=info%3Apmid%2F29258056&rft.aulast=Tornkvist&rft.aufirst=Max&rft.au=Smith%2C+J.+Gustav&rft.au=Labaf%2C+Ashkan&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-113"><a href="#cite_ref-113">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHanley2004" class="citation journal cs1">Hanley JP (2004-11-01). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770479">"Warfarin reversal"</a>. Journal of Clinical Pathology. 57 (11): 1132–1139. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjcp.2003.008904">10.1136/jcp.2003.008904</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0021-9746">0021-9746</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770479">1770479</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15509671">15509671</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Clinical+Pathology&rft.atitle=Warfarin+reversal&rft.volume=57&rft.issue=11&rft.pages=1132-1139&rft.date=2004-11-01&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1770479%23id-name%3DPMC&rft.issn=0021-9746&rft_id=info%3Apmid%2F15509671&rft_id=info%3Adoi%2F10.1136%2Fjcp.2003.008904&rft.aulast=Hanley&rft.aufirst=J+P&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1770479&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-114"><a href="#cite_ref-114">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMakrisGreavesPhillipsKitchen1997" class="citation journal cs1">Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF (March 1997). "Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy". Thrombosis and Haemostasis. 77 (3): 477–480. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0038-1655992">10.1055/s-0038-1655992</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0340-6245">0340-6245</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9065997">9065997</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45458169">45458169</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Emergency+oral+anticoagulant+reversal%3A+the+relative+efficacy+of+infusions+of+fresh+frozen+plasma+and+clotting+factor+concentrate+on+correction+of+the+coagulopathy&rft.volume=77&rft.issue=3&rft.pages=477-480&rft.date=1997-03&rft.issn=0340-6245&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45458169%23id-name%3DS2CID&rft_id=info%3Apmid%2F9065997&rft_id=info%3Adoi%2F10.1055%2Fs-0038-1655992&rft.aulast=Makris&rft.aufirst=M.&rft.au=Greaves%2C+M.&rft.au=Phillips%2C+W.+S.&rft.au=Kitchen%2C+S.&rft.au=Rosendaal%2C+F.+R.&rft.au=Preston%2C+E.+F.&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-115"><a href="#cite_ref-115">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChai-AdisaksophaHillisSiegalMovilla2016" class="citation journal cs1">Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, et al. (September 2016). "Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis". Thrombosis and Haemostasis. 116 (11): 879–890. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1160%2FTH16-04-0266">10.1160/TH16-04-0266</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0340-6245">0340-6245</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27488143">27488143</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4733615">4733615</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Prothrombin+complex+concentrates+versus+fresh+frozen+plasma+for+warfarin+reversal+A+systematic+review+and+meta-analysis&rft.volume=116&rft.issue=11&rft.pages=879-890&rft.date=2016-09&rft.issn=0340-6245&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4733615%23id-name%3DS2CID&rft_id=info%3Apmid%2F27488143&rft_id=info%3Adoi%2F10.1160%2FTH16-04-0266&rft.aulast=Chai-Adisaksopha&rft.aufirst=Chatree&rft.au=Hillis%2C+Christopher&rft.au=Siegal%2C+Deborah+M.&rft.au=Movilla%2C+Ron&rft.au=Heddle%2C+Nancy&rft.au=Iorio%2C+Alfonso&rft.au=Crowther%2C+Mark&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-116"><a href="#cite_ref-116">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPakraftar2014" class="citation journal cs1">Pakraftar S (2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133427">"Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plans"</a>. World Journal of Clinical Cases. 2 (8): 362–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12998%2Fwjcc.v2.i8.362">10.12998/wjcc.v2.i8.362</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2307-8960">2307-8960</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133427">4133427</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25133148">25133148</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=World+Journal+of+Clinical+Cases&rft.atitle=Dabigatran+etixilate+and+traumatic+brain+injury%3A+Evolving+anticoagulants+require+evolving+care+plans&rft.volume=2&rft.issue=8&rft.pages=362-6&rft.date=2014&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4133427%23id-name%3DPMC&rft.issn=2307-8960&rft_id=info%3Apmid%2F25133148&rft_id=info%3Adoi%2F10.12998%2Fwjcc.v2.i8.362&rft.aulast=Pakraftar&rft.aufirst=Sam&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4133427&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-117"><a href="#cite_ref-117">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRynStangierHaertterLiesenfeld2010" class="citation journal cs1">Ryn Jv, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, et al. (2010). "Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity". Thrombosis and Haemostasis. 103 (6): 1116–1127. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1160%2FTH09-11-0758">10.1160/TH09-11-0758</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0340-6245">0340-6245</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20352166">20352166</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:37404563">37404563</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Dabigatran+etexilate+%E2%80%93+a+novel%2C+reversible%2C+oral+direct+thrombin+inhibitor%3A+Interpretation+of+coagulation+assays+and+reversal+of+anticoagulant+activity&rft.volume=103&rft.issue=6&rft.pages=1116-1127&rft.date=2010&rft.issn=0340-6245&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A37404563%23id-name%3DS2CID&rft_id=info%3Apmid%2F20352166&rft_id=info%3Adoi%2F10.1160%2FTH09-11-0758&rft.aulast=Ryn&rft.aufirst=Joanne+van&rft.au=Stangier%2C+Joachim&rft.au=Haertter%2C+Sebastian&rft.au=Liesenfeld%2C+Karl-Heinz&rft.au=Wienen%2C+Wolfgang&rft.au=Feuring%2C+Martin&rft.au=Clemens%2C+Andreas&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-118"><a href="#cite_ref-118">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSiegalCurnutteConnollyLu2015" class="citation journal cs1">Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. (2015-12-17). <a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1510991">"Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity"</a>. New England Journal of Medicine. 373 (25): 2413–2424. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1510991">10.1056/NEJMoa1510991</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0028-4793">0028-4793</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26559317">26559317</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=New+England+Journal+of+Medicine&rft.atitle=Andexanet+Alfa+for+the+Reversal+of+Factor+Xa+Inhibitor+Activity&rft.volume=373&rft.issue=25&rft.pages=2413-2424&rft.date=2015-12-17&rft.issn=0028-4793&rft_id=info%3Apmid%2F26559317&rft_id=info%3Adoi%2F10.1056%2FNEJMoa1510991&rft.aulast=Siegal&rft.aufirst=Deborah+M.&rft.au=Curnutte%2C+John+T.&rft.au=Connolly%2C+Stuart+J.&rft.au=Lu%2C+Genmin&rft.au=Conley%2C+Pamela+B.&rft.au=Wiens%2C+Brian+L.&rft.au=Mathur%2C+Vandana+S.&rft.au=Castillo%2C+Janice&rft.au=Bronson%2C+Michele+D.&rft.au=Leeds%2C+Janet+M.&rft.au=Mar%2C+Florie+A.&rft_id=https%3A%2F%2Fdoi.org%2F10.1056%252FNEJMoa1510991&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-119"><a href="#cite_ref-119">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFConnollyMillingEikelboomGibson2016" class="citation journal cs1">Connolly SJ, Milling TJ, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, et al. (2016-09-22). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568772">"Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors"</a>. New England Journal of Medicine. 375 (12): 1131–1141. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1607887">10.1056/NEJMoa1607887</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0028-4793">0028-4793</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568772">5568772</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27573206">27573206</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=New+England+Journal+of+Medicine&rft.atitle=Andexanet+Alfa+for+Acute+Major+Bleeding+Associated+with+Factor+Xa+Inhibitors&rft.volume=375&rft.issue=12&rft.pages=1131-1141&rft.date=2016-09-22&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568772%23id-name%3DPMC&rft.issn=0028-4793&rft_id=info%3Apmid%2F27573206&rft_id=info%3Adoi%2F10.1056%2FNEJMoa1607887&rft.aulast=Connolly&rft.aufirst=Stuart+J.&rft.au=Milling%2C+Truman+J.&rft.au=Eikelboom%2C+John+W.&rft.au=Gibson%2C+C.+Michael&rft.au=Curnutte%2C+John+T.&rft.au=Gold%2C+Alex&rft.au=Bronson%2C+Michele+D.&rft.au=Lu%2C+Genmin&rft.au=Conley%2C+Pamela+B.&rft.au=Verhamme%2C+Peter&rft.au=Schmidt%2C+Jeannot&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568772&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-120"><a href="#cite_ref-120">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFReedTadiNicolas2020" class="citation cs2">Reed M, Tadi P, Nicolas D (2020), <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK519499/">"Andexanet Alfa"</a>, StatPearls, StatPearls Publishing, <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30137783">30137783</a>, retrieved 2020-01-23</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=StatPearls&rft.atitle=Andexanet+Alfa&rft.date=2020&rft_id=info%3Apmid%2F30137783&rft.aulast=Reed&rft.aufirst=Mirembe&rft.au=Tadi%2C+Prasanna&rft.au=Nicolas%2C+Diala&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK519499%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-121"><a href="#cite_ref-121">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAnsellBakhruLaulichtSteiner2017" class="citation journal cs1">Ansell JE, Bakhru SH, Laulicht BE, Steiner SS, Grosso MA, Brown K, et al. (February 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260118">"Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban"</a>. Thrombosis and Haemostasis. 117 (2): 238–245. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1160%2FTH16-03-0224">10.1160/TH16-03-0224</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0340-6245">0340-6245</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260118">6260118</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27853809">27853809</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Single-dose+ciraparantag+safely+and+completely+reverses+anticoagulant+effects+of+edoxaban&rft.volume=117&rft.issue=2&rft.pages=238-245&rft.date=2017-02&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6260118%23id-name%3DPMC&rft.issn=0340-6245&rft_id=info%3Apmid%2F27853809&rft_id=info%3Adoi%2F10.1160%2FTH16-03-0224&rft.aulast=Ansell&rft.aufirst=Jack+E.&rft.au=Bakhru%2C+Sasha+H.&rft.au=Laulicht%2C+Bryan+E.&rft.au=Steiner%2C+Solomon+S.&rft.au=Grosso%2C+Michael+A.&rft.au=Brown%2C+Karen&rft.au=Dishy%2C+Victor&rft.au=Lanz%2C+Hans+J.&rft.au=Mercuri%2C+Michele+F.&rft.au=Noveck%2C+Robert+J.&rft.au=Costin%2C+James+C.&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6260118&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-122"><a href="#cite_ref-122">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEerenbergKamphuisenSijpkensMeijers2011" class="citation journal cs1">Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M (2011-10-04). <a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.111.029017">"Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects"</a>. Circulation. 124 (14): 1573–1579. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.111.029017">10.1161/CIRCULATIONAHA.111.029017</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0009-7322">0009-7322</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21900088">21900088</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:961167">961167</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=Reversal+of+Rivaroxaban+and+Dabigatran+by+Prothrombin+Complex+Concentrate%3A+A+Randomized%2C+Placebo-Controlled%2C+Crossover+Study+in+Healthy+Subjects&rft.volume=124&rft.issue=14&rft.pages=1573-1579&rft.date=2011-10-04&rft.issn=0009-7322&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A961167%23id-name%3DS2CID&rft_id=info%3Apmid%2F21900088&rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.111.029017&rft.aulast=Eerenberg&rft.aufirst=Elise+S.&rft.au=Kamphuisen%2C+Pieter+W.&rft.au=Sijpkens%2C+Meertien+K.&rft.au=Meijers%2C+Joost+C.&rft.au=Buller%2C+Harry+R.&rft.au=Levi%2C+Marcel&rft_id=https%3A%2F%2Fdoi.org%2F10.1161%252FCIRCULATIONAHA.111.029017&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-123"><a href="#cite_ref-123">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMarluHodajParisAlbaladejo2012" class="citation journal cs1">Marlu R, Hodaj E, Paris A, Albaladejo P, Crackowski J, Pernod G (2012). "Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: A randomised crossover ex vivo study in healthy volunteers". Thrombosis and Haemostasis. 108 (8): 217–224. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1160%2FTH12-03-0179">10.1160/TH12-03-0179</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0340-6245">0340-6245</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22627883">22627883</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28694620">28694620</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Thrombosis+and+Haemostasis&rft.atitle=Effect+of+non-specific+reversal+agents+on+anticoagulant+activity+of+dabigatran+and+rivaroxaban%3A+A+randomised+crossover+ex+vivo+study+in+healthy+volunteers&rft.volume=108&rft.issue=8&rft.pages=217-224&rft.date=2012&rft.issn=0340-6245&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28694620%23id-name%3DS2CID&rft_id=info%3Apmid%2F22627883&rft_id=info%3Adoi%2F10.1160%2FTH12-03-0179&rft.aulast=Marlu&rft.aufirst=Raphael&rft.au=Hodaj%2C+Enkelejda&rft.au=Paris%2C+Adeline&rft.au=Albaladejo%2C+Pierre&rft.au=Crackowski%2C+Jean&rft.au=Pernod%2C+Gilles&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-124"><a href="#cite_ref-124">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.biology-online.org/dictionary/Bethesda_unit">"Bethesda unit"</a>. Biology Online. Retrieved 2009-02-14.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Biology+Online&rft.atitle=Bethesda+unit&rft_id=http%3A%2F%2Fwww.biology-online.org%2Fdictionary%2FBethesda_unit&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-125"><a href="#cite_ref-125">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSchumacher2000" class="citation book cs1">Schumacher HR (2000). Handbook of Hematologic Pathology. <a href="/wiki/Informa_Health_Care" class="mw-redirect" title="Informa Health Care">Informa Health Care</a>. p. 583. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-8247-0170-3" title="Special:BookSources/978-0-8247-0170-3"><bdi>978-0-8247-0170-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Handbook+of+Hematologic+Pathology&rft.pages=583&rft.pub=Informa+Health+Care&rft.date=2000&rft.isbn=978-0-8247-0170-3&rft.aulast=Schumacher&rft.aufirst=Harold+Robert&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-126"><a href="#cite_ref-126">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFNormanJones2014" class="citation journal cs1">Norman M, Jones I (May 2014). "The shift from fluoride/oxalate to acid citrate/fluoride blood collection tubes for glucose testing — The impact upon patient results". Clinical Biochemistry. 47 (7–8): 683–685. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinbiochem.2014.01.011">10.1016/j.clinbiochem.2014.01.011</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24463230">24463230</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Biochemistry&rft.atitle=The+shift+from+fluoride%2Foxalate+to+acid+citrate%2Ffluoride+blood+collection+tubes+for+glucose+testing+%E2%80%94+The+impact+upon+patient+results&rft.volume=47&rft.issue=7%E2%80%938&rft.pages=683-685&rft.date=2014-05&rft_id=info%3Adoi%2F10.1016%2Fj.clinbiochem.2014.01.011&rft_id=info%3Apmid%2F24463230&rft.aulast=Norman&rft.aufirst=Mikaela&rft.au=Jones%2C+Ian&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-127"><a href="#cite_ref-127">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.scottishdental.org/management-of-dental-patients-taking-anticoagulants-or-antiplatelet-drugs-new-guidance-from-sdcep/">"Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs – New guidance from SDCEP | Scottish Dental"</a>. 15 September 2015. Retrieved 2020-02-20.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Management+of+Dental+Patients+Taking+Anticoagulants+or+Antiplatelet+Drugs+%E2%80%93+New+guidance+from+SDCEP+%7C+Scottish+Dental&rft.date=2015-09-15&rft_id=https%3A%2F%2Fwww.scottishdental.org%2Fmanagement-of-dental-patients-taking-anticoagulants-or-antiplatelet-drugs-new-guidance-from-sdcep%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-128"><a href="#cite_ref-128">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFredenburghWeitz2020" class="citation journal cs1">Fredenburgh JC, Weitz JI (12 October 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjth.15126">"New Anticoagulants: Moving Beyond the Direct Oral Anticoagulants"</a>. Journal of Thrombosis and Haemostasis. 19 (1): 20–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjth.15126">10.1111/jth.15126</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33047462">33047462</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:222320654">222320654</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Thrombosis+and+Haemostasis&rft.atitle=New+Anticoagulants%3A+Moving+Beyond+the+Direct+Oral+Anticoagulants&rft.volume=19&rft.issue=1&rft.pages=20-29&rft.date=2020-10-12&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A222320654%23id-name%3DS2CID&rft_id=info%3Apmid%2F33047462&rft_id=info%3Adoi%2F10.1111%2Fjth.15126&rft.aulast=Fredenburgh&rft.aufirst=James+C&rft.au=Weitz%2C+Jeffrey+I&rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fjth.15126&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> <li id="cite_note-129"><a href="#cite_ref-129">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWeitzStronyAgenoGailani2021" class="citation journal cs1">Weitz JI, Strony J, Ageno W, Gailani D, Hylek EM, Lassen MR, et al. (November 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540352">"Milvexian for the Prevention of Venous Thromboembolism"</a>. The New England Journal of Medicine. 385 (23): 2161–2172. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa2113194">10.1056/NEJMoa2113194</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540352">9540352</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34780683">34780683</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:244132392">244132392</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+England+Journal+of+Medicine&rft.atitle=Milvexian+for+the+Prevention+of+Venous+Thromboembolism&rft.volume=385&rft.issue=23&rft.pages=2161-2172&rft.date=2021-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9540352%23id-name%3DPMC&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A244132392%23id-name%3DS2CID&rft_id=info%3Apmid%2F34780683&rft_id=info%3Adoi%2F10.1056%2FNEJMoa2113194&rft.aulast=Weitz&rft.aufirst=JI&rft.au=Strony%2C+J&rft.au=Ageno%2C+W&rft.au=Gailani%2C+D&rft.au=Hylek%2C+EM&rft.au=Lassen%2C+MR&rft.au=Mahaffey%2C+KW&rft.au=Notani%2C+RS&rft.au=Roberts%2C+R&rft.au=Segers%2C+A&rft.au=Raskob%2C+GE&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9540352&rfr_id=info%3Asid%2Fen.wikipedia.org%3AAnticoagulant" class="Z3988"> </li> </ol></div></div> <div class="mw-heading mw-heading2"><h2 id="External_links">External links</h2>[<a href="/w/index.php?title=Anticoagulant&action=edit&section=22" title="Edit section: External links">edit</a>]</div> <ul><li><a rel="nofollow" class="external text" href="https://www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/stayactive.html">Staying Active and Healthy with Blood Thinners</a> by the Agency for Healthcare Research and Quality</li></ul> <div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Antithrombotics" title="Template talk:Antithrombotics"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Antithrombotics" title="Special:EditPage/Template:Antithrombotics"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="font-size:114%;margin:0 4em"><a href="/wiki/Antithrombotic" title="Antithrombotic">Antithrombotics</a> (<a href="/wiki/Thrombolytic_drug" class="mw-redirect" title="Thrombolytic drug">thrombolytics</a>, <a class="mw-selflink selflink">anticoagulants</a> and <a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">antiplatelet drugs</a>) (<a href="/wiki/ATC_code_B01" title="ATC code B01">B01</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">Antiplatelet drugs</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Glycoprotein_IIb/IIIa_inhibitors" title="Glycoprotein IIb/IIIa inhibitors">Glycoprotein IIb/IIIa inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abciximab" title="Abciximab">Abciximab</a></li> <li><a href="/wiki/Eptifibatide" title="Eptifibatide">Eptifibatide</a></li> <li><a href="/w/index.php?title=Orbofiban&action=edit&redlink=1" class="new" title="Orbofiban (page does not exist)">Orbofiban</a></li> <li><a href="/w/index.php?title=Roxifiban&action=edit&redlink=1" class="new" title="Roxifiban (page does not exist)">Roxifiban</a></li> <li><a href="/wiki/Sibrafiban" title="Sibrafiban">Sibrafiban</a>§</li> <li><a href="/wiki/Tirofiban" title="Tirofiban">Tirofiban</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/P2Y12" title="P2Y12">ADP receptor/P2Y12</a> <a href="/wiki/Adenosine_diphosphate_receptor_inhibitor" title="Adenosine diphosphate receptor inhibitor">inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Thienopyridine" title="Thienopyridine">Thienopyridines</a> <ul><li><a href="/wiki/Clopidogrel" title="Clopidogrel">Clopidogrel</a></li> <li><a href="/wiki/Prasugrel" title="Prasugrel">Prasugrel</a></li> <li><a href="/wiki/Ticlopidine" title="Ticlopidine">Ticlopidine</a></li></ul></li> <li><a href="/wiki/Nucleotide" title="Nucleotide">Nucleotide</a>/<a href="/wiki/Nucleoside" title="Nucleoside">nucleoside</a> analogs <ul><li><a href="/wiki/Cangrelor" title="Cangrelor">Cangrelor</a></li> <li><a href="/wiki/Elinogrel" title="Elinogrel">Elinogrel</a></li> <li><a href="/wiki/Ticagrelor" title="Ticagrelor">Ticagrelor</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Prostaglandin_analogue" title="Prostaglandin analogue">Prostaglandin analogue</a> (<a href="/wiki/Prostacyclin" title="Prostacyclin">PGI2</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Beraprost" title="Beraprost">Beraprost</a></li> <li><a href="/wiki/Iloprost" title="Iloprost">Iloprost</a></li> <li><a href="/wiki/Prostacyclin" title="Prostacyclin">Prostacyclin</a></li> <li><a href="/wiki/Treprostinil" title="Treprostinil">Treprostinil</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mechanism_of_action_of_aspirin" title="Mechanism of action of aspirin">COX inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Aspirin" title="Aspirin">Acetylsalicylic acid/Aspirin</a>#</li> <li><a href="/wiki/Aloxiprin" title="Aloxiprin">Aloxiprin</a></li> <li><a href="/wiki/Carbasalate_calcium" title="Carbasalate calcium">Carbasalate calcium</a></li> <li><a href="/wiki/Indobufen" title="Indobufen">Indobufen</a></li> <li><a href="/wiki/Triflusal" title="Triflusal">Triflusal</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Thromboxane_inhibitors" class="mw-redirect" title="Thromboxane inhibitors">Thromboxane inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Thromboxane_synthase_inhibitors" class="mw-redirect" title="Thromboxane synthase inhibitors">Thromboxane synthase inhibitors</a> <ul><li><a href="/wiki/Dipyridamole" title="Dipyridamole">Dipyridamole</a> (<a href="/wiki/Acetylsalicylic_acid/dipyridamole" title="Acetylsalicylic acid/dipyridamole">+ aspirin</a>)</li> <li><a href="/wiki/Picotamide" title="Picotamide">Picotamide</a></li> <li><a href="/wiki/Terbogrel" title="Terbogrel">Terbogrel</a></li></ul></li> <li><a href="/wiki/Thromboxane_receptor_antagonist" class="mw-redirect" title="Thromboxane receptor antagonist">Receptor antagonists</a> <ul><li><a href="/wiki/Terbogrel" title="Terbogrel">Terbogrel</a></li> <li><a href="/wiki/Terutroban" title="Terutroban">Terutroban</a>§</li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">Phosphodiesterase inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Cilostazol" title="Cilostazol">Cilostazol</a></li> <li><a href="/wiki/Dipyridamole" title="Dipyridamole">Dipyridamole</a></li> <li><a href="/wiki/Triflusal" title="Triflusal">Triflusal</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Cloricromen" title="Cloricromen">Cloricromen</a></li> <li><a href="/wiki/Ditazole" title="Ditazole">Ditazole</a></li> <li><a href="/wiki/Vorapaxar" title="Vorapaxar">Vorapaxar</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">Anticoagulants</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Vitamin_K_antagonist" title="Vitamin K antagonist">Vitamin K antagonists</a> (inhibit <a href="/wiki/Thrombin" title="Thrombin">II</a>, <a href="/wiki/Factor_VII" title="Factor VII">VII</a>, <a href="/wiki/Factor_IX" title="Factor IX">IX</a>, <a href="/wiki/Factor_X" title="Factor X">X</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Coumarin" title="Coumarin">Coumarins</a>: <a href="/wiki/Acenocoumarol" title="Acenocoumarol">Acenocoumarol</a></li> <li><a href="/wiki/Coumatetralyl" title="Coumatetralyl">Coumatetralyl</a></li> <li><a href="/wiki/Dicoumarol" title="Dicoumarol">Dicoumarol</a></li> <li><a href="/wiki/Ethyl_biscoumacetate" title="Ethyl biscoumacetate">Ethyl biscoumacetate</a></li> <li><a href="/wiki/Phenprocoumon" title="Phenprocoumon">Phenprocoumon</a></li> <li><a href="/wiki/Warfarin" title="Warfarin">Warfarin</a>#</li> <li><a href="/wiki/1,3-Indandione" title="1,3-Indandione">1,3-Indandiones</a>: <a href="/wiki/Clorindione" title="Clorindione">Clorindione</a></li> <li><a href="/wiki/Diphenadione" title="Diphenadione">Diphenadione</a></li> <li><a href="/wiki/Phenindione" title="Phenindione">Phenindione</a></li> <li>Other: <a href="/wiki/Tioclomarol" title="Tioclomarol">Tioclomarol</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Factor_Xa" class="mw-redirect" title="Factor Xa">Factor Xa</a> inhibitors (with some II inhibition)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Heparin" title="Heparin">Heparin</a> group/ <a href="/wiki/Glycosaminoglycan" title="Glycosaminoglycan">glycosaminoglycans</a>/ (bind <a href="/wiki/Antithrombin" title="Antithrombin">antithrombin</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Low-molecular-weight_heparin" title="Low-molecular-weight heparin">Low-molecular-weight heparin</a> <ul><li><a href="/wiki/Bemiparin_sodium" title="Bemiparin sodium">Bemiparin</a></li> <li><a href="/wiki/Certoparin_sodium" title="Certoparin sodium">Certoparin</a></li> <li><a href="/wiki/Dalteparin_sodium" title="Dalteparin sodium">Dalteparin</a></li> <li><a href="/wiki/Enoxaparin_sodium" title="Enoxaparin sodium">Enoxaparin</a></li> <li><a href="/wiki/Nadroparin_calcium" title="Nadroparin calcium">Nadroparin</a></li> <li><a href="/wiki/Parnaparin_sodium" title="Parnaparin sodium">Parnaparin</a></li> <li><a href="/wiki/Reviparin_sodium" title="Reviparin sodium">Reviparin</a></li> <li><a href="/wiki/Tinzaparin_sodium" title="Tinzaparin sodium">Tinzaparin</a></li></ul></li> <li><a href="/wiki/Oligosaccharide" title="Oligosaccharide">Oligosaccharides</a> <ul><li><a href="/wiki/Fondaparinux" title="Fondaparinux">Fondaparinux</a></li> <li><a href="/wiki/Idraparinux" title="Idraparinux">Idraparinux</a>§</li></ul></li> <li><a href="/wiki/Heparinoid" title="Heparinoid">Heparinoids</a> <ul><li><a href="/wiki/Danaparoid" title="Danaparoid">Danaparoid</a></li> <li><a href="/wiki/Dermatan_sulfate" title="Dermatan sulfate">Dermatan sulfate</a></li> <li><a href="/wiki/Sulodexide" title="Sulodexide">Sulodexide</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Direct_factor_Xa_inhibitors" title="Direct factor Xa inhibitors">Direct Xa inhibitors</a> ("xabans")</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Apixaban" title="Apixaban">Apixaban</a></li> <li><a href="/wiki/Betrixaban" title="Betrixaban">Betrixaban</a></li> <li><a href="/wiki/Darexaban" title="Darexaban">Darexaban</a>§</li> <li><a href="/wiki/Edoxaban" title="Edoxaban">Edoxaban</a></li> <li><a href="/wiki/Otamixaban" title="Otamixaban">Otamixaban</a>§</li> <li><a href="/wiki/Rivaroxaban" title="Rivaroxaban">Rivaroxaban</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Direct_thrombin_inhibitor" title="Direct thrombin inhibitor">Direct thrombin (IIa) inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Direct_thrombin_inhibitor#Bivalent" title="Direct thrombin inhibitor">Bivalent</a>: <a href="/wiki/Hirudin" title="Hirudin">Hirudin</a> <ul><li><a href="/wiki/Bivalirudin" title="Bivalirudin">Bivalirudin</a></li> <li><a href="/wiki/Desirudin" class="mw-redirect" title="Desirudin">Desirudin</a></li> <li><a href="/wiki/Lepirudin" title="Lepirudin">Lepirudin</a>‡</li></ul></li> <li><a href="/wiki/Direct_thrombin_inhibitor#Univalent" title="Direct thrombin inhibitor">Univalent</a>: <a href="/wiki/Argatroban" title="Argatroban">Argatroban</a></li> <li><a href="/wiki/Dabigatran" title="Dabigatran">Dabigatran</a></li> <li><a href="/w/index.php?title=Efegatran&action=edit&redlink=1" class="new" title="Efegatran (page does not exist)">Efegatran</a></li> <li><a href="/wiki/Inogatran" title="Inogatran">Inogatran</a>§</li> <li><a href="/wiki/Melagatran" class="mw-redirect" title="Melagatran">Melagatran</a>‡</li> <li><a href="/wiki/Ximelagatran" title="Ximelagatran">Ximelagatran</a>‡</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abelacimab" title="Abelacimab">Abelacimab</a></li> <li><a href="/wiki/Antithrombin" title="Antithrombin">Antithrombin III</a></li> <li><a href="/wiki/Defibrotide" title="Defibrotide">Defibrotide</a></li> <li><a href="/wiki/Nafamostat" title="Nafamostat">Nafamostat</a></li> <li><a href="/wiki/Protein_C" title="Protein C">Protein C</a> <ul><li><a href="/wiki/Drotrecogin_alfa" title="Drotrecogin alfa">Drotrecogin alfa</a>‡</li></ul></li> <li><a href="/wiki/Ramatroban" title="Ramatroban">Ramatroban</a></li> <li><a href="/wiki/REG1" title="REG1">REG1</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Thrombolytic_drug" class="mw-redirect" title="Thrombolytic drug">Thrombolytic drugs</a>/ <a href="/wiki/Fibrinolytic" class="mw-redirect" title="Fibrinolytic">fibrinolytics</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Plasminogen_activator" title="Plasminogen activator">Plasminogen activators</a>: <a href="/wiki/Recombinant_tissue_plasminogen_activators" class="mw-redirect" title="Recombinant tissue plasminogen activators">r-tPA</a> <ul><li><a href="/wiki/Alteplase" title="Alteplase">Alteplase</a>#</li> <li><a href="/wiki/Reteplase" title="Reteplase">Reteplase</a></li> <li><a href="/wiki/Tenecteplase" title="Tenecteplase">Tenecteplase</a></li> <li><a href="/wiki/Desmoteplase" title="Desmoteplase">Desmoteplase</a>†</li></ul></li> <li>UPA <ul><li><a href="/wiki/Saruplase" title="Saruplase">Saruplase</a></li> <li><a href="/wiki/Urokinase" title="Urokinase">Urokinase</a></li></ul></li> <li><a href="/wiki/Anistreplase" title="Anistreplase">Anistreplase</a></li> <li><a href="/wiki/Monteplase" title="Monteplase">Monteplase</a></li> <li><a href="/wiki/Streptokinase" title="Streptokinase">Streptokinase</a>#</li> <li>Other <a href="/wiki/Serine_endopeptidase" class="mw-redirect" title="Serine endopeptidase">serine endopeptidases</a>: <a href="/wiki/Ancrod" title="Ancrod">Ancrod</a>‡</li> <li><a href="/wiki/Brinase" title="Brinase">Brinase</a></li> <li><a href="/wiki/Fibrinolysin" title="Fibrinolysin">Fibrinolysin</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">Non-medicinal</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Citrate" class="mw-redirect" title="Citrate">Citrate</a></li> <li><a href="/wiki/Ethylenediaminetetraacetic_acid" title="Ethylenediaminetetraacetic acid">EDTA</a></li> <li><a href="/wiki/Oxalate" title="Oxalate">Oxalate</a></li></ul> </div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist"> <ul><li>#<a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li>‡<a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li>†<a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li>§Never to phase III</li></ul></li></ul> </div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Major_chemical_drug_groups_–_based_upon_the_Anatomical_Therapeutic_Chemical_Classification_System" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Major_drug_groups" title="Template:Major drug groups"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Major_drug_groups" title="Template talk:Major drug groups"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Major_drug_groups" title="Special:EditPage/Template:Major drug groups"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Major_chemical_drug_groups_–_based_upon_the_Anatomical_Therapeutic_Chemical_Classification_System" style="font-size:114%;margin:0 4em">Major chemical drug groups – based upon the <a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">Anatomical Therapeutic Chemical Classification System</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_gastrointestinal_tract" class="mw-redirect" title="Human gastrointestinal tract">gastrointestinal tract</a> / <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> (<a href="/wiki/ATC_code_A" title="ATC code A">A</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>stomach acid <ul><li><a href="/wiki/Antacid" title="Antacid">Antacids</a></li> <li><a href="/wiki/H2_antagonist" class="mw-redirect" title="H2 antagonist">H2 antagonists</a></li> <li><a href="/wiki/Proton-pump_inhibitor" title="Proton-pump inhibitor">Proton-pump inhibitors</a></li></ul></li> <li><a href="/wiki/Antiemetic" title="Antiemetic">Antiemetics</a></li> <li><a href="/wiki/Laxative" title="Laxative">Laxatives</a></li> <li><a href="/wiki/Antidiarrhoeal" class="mw-redirect" title="Antidiarrhoeal">Antidiarrhoeals</a> / <a href="/wiki/Antipropulsive" title="Antipropulsive">Antipropulsives</a></li> <li><a href="/wiki/Anti-obesity_medication" title="Anti-obesity medication">Anti-obesity drugs</a></li> <li><a href="/wiki/Diabetes_medication" title="Diabetes medication">Diabetes medication</a></li> <li><a href="/wiki/Vitamin" title="Vitamin">Vitamins</a></li> <li><a href="/wiki/Dietary_mineral" class="mw-redirect" title="Dietary mineral">Dietary minerals</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Blood" title="Blood">blood</a> and blood forming organs (<a href="/wiki/ATC_code_B" title="ATC code B">B</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antithrombotic" title="Antithrombotic">Antithrombotics</a> <ul><li><a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">Antiplatelets</a></li> <li><a class="mw-selflink selflink">Anticoagulants</a></li> <li><a href="/wiki/Thrombolytic_drug" class="mw-redirect" title="Thrombolytic drug">Thrombolytics / fibrinolytics</a></li></ul></li> <li><a href="/wiki/Antihemorrhagic" title="Antihemorrhagic">Antihemorrhagics</a> <ul><li><a href="/wiki/Platelet" title="Platelet">Platelets</a></li> <li><a href="/wiki/Coagulation" title="Coagulation">Coagulants</a></li> <li><a href="/wiki/Antifibrinolytic" title="Antifibrinolytic">Antifibrinolytics</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Circulatory_system" title="Circulatory system">cardiovascular system</a> (<a href="/wiki/ATC_code_C" title="ATC code C">C</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>cardiac therapy / <a href="/wiki/Antianginal" title="Antianginal">antianginals</a> <ul><li><a href="/wiki/Cardiac_glycoside" title="Cardiac glycoside">Cardiac glycosides</a></li> <li><a href="/wiki/Antiarrhythmic_agent" title="Antiarrhythmic agent">Antiarrhythmics</a></li> <li><a href="/wiki/Cardiac_stimulant" title="Cardiac stimulant">Cardiac stimulants</a></li></ul></li> <li><a href="/wiki/Antihypertensive_drug" class="mw-redirect" title="Antihypertensive drug">Antihypertensives</a></li> <li><a href="/wiki/Diuretic" title="Diuretic">Diuretics</a></li> <li><a href="/wiki/Vasodilation" title="Vasodilation">Vasodilators</a></li> <li><a href="/wiki/Beta_blocker" title="Beta blocker">Beta blockers</a></li> <li><a href="/wiki/Calcium_channel_blocker" title="Calcium channel blocker">Calcium channel blockers</a></li> <li><a href="/wiki/Renin%E2%80%93angiotensin_system" title="Renin–angiotensin system">renin–angiotensin system</a> <ul><li><a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a></li> <li><a href="/wiki/Angiotensin_II_receptor_antagonist" class="mw-redirect" title="Angiotensin II receptor antagonist">Angiotensin II receptor antagonists</a></li> <li><a href="/wiki/Renin_inhibitor" title="Renin inhibitor">Renin inhibitors</a></li></ul></li> <li><a href="/wiki/Hypolipidemic_agent" class="mw-redirect" title="Hypolipidemic agent">Antihyperlipidemics</a> <ul><li><a href="/wiki/Statin" title="Statin">Statins</a></li> <li><a href="/wiki/Fibrate" title="Fibrate">Fibrates</a></li> <li><a href="/wiki/Bile_acid_sequestrant" title="Bile acid sequestrant">Bile acid sequestrants</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_skin" title="Human skin">skin</a> (<a href="/wiki/ATC_code_D" title="ATC code D">D</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Emollient" class="mw-redirect" title="Emollient">Emollients</a></li> <li><a href="/wiki/Cicatrizant" class="mw-redirect" title="Cicatrizant">Cicatrizants</a></li> <li><a href="/wiki/Antipruritic" title="Antipruritic">Antipruritics</a></li> <li><a href="/wiki/Antipsoriatic" class="mw-redirect" title="Antipsoriatic">Antipsoriatics</a></li> <li><a href="/wiki/ATC_code_D09" title="ATC code D09">Medicated dressings</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Genitourinary_system" title="Genitourinary system">genitourinary system</a> (<a href="/wiki/ATC_code_G" title="ATC code G">G</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Hormonal_contraception" title="Hormonal contraception">Hormonal contraception</a></li> <li><a href="/wiki/Fertility_medication" title="Fertility medication">Fertility agents</a></li> <li><a href="/wiki/Selective_estrogen_receptor_modulator" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></li> <li><a href="/wiki/Sex_steroid" class="mw-redirect" title="Sex steroid">Sex hormones</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Endocrine_system" title="Endocrine system">endocrine system</a> (<a href="/wiki/ATC_code_H" title="ATC code H">H</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Hypothalamic%E2%80%93pituitary_hormone" title="Hypothalamic–pituitary hormone">Hypothalamic–pituitary hormones</a></li> <li><a href="/wiki/Corticosteroid" title="Corticosteroid">Corticosteroids</a> <ul><li><a href="/wiki/Glucocorticoid" title="Glucocorticoid">Glucocorticoids</a></li> <li><a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">Mineralocorticoids</a></li></ul></li> <li><a href="/wiki/Sex_steroid" class="mw-redirect" title="Sex steroid">Sex hormones</a></li> <li><a href="/wiki/Thyroid_hormone" class="mw-redirect" title="Thyroid hormone">Thyroid hormones</a> / <a href="/wiki/Antithyroid_agent" title="Antithyroid agent">Antithyroid agents</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Infection" title="Infection">infections</a> and <a href="https://en.wiktionary.org/wiki/infestation" class="extiw" title="wikt:infestation">infestations</a> (<a href="/wiki/ATC_code_J" title="ATC code J">J</a>, <a href="/wiki/ATC_code_P" title="ATC code P">P</a>, <a href="/wiki/ATCvet_code_QI" title="ATCvet code QI">QI</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antimicrobial" title="Antimicrobial">Antimicrobials</a>: <a href="/wiki/Antibacterial" class="mw-redirect" title="Antibacterial">Antibacterials</a> (<a href="/wiki/Antimycobacterial" title="Antimycobacterial">Antimycobacterials</a>)</li> <li><a href="/wiki/Antifungal_drug" class="mw-redirect" title="Antifungal drug">Antifungals</a></li> <li><a href="/wiki/Antiviral_drug" title="Antiviral drug">Antivirals</a></li> <li><a href="/wiki/Antiparasitic" title="Antiparasitic">Antiparasitics</a> <ul><li><a href="/wiki/Antiprotozoal_agent" class="mw-redirect" title="Antiprotozoal agent">Antiprotozoals</a></li> <li><a href="/wiki/Anthelmintic" title="Anthelmintic">Anthelmintics</a></li> <li><a href="/wiki/Ectoparasiticide" title="Ectoparasiticide">Ectoparasiticides</a></li></ul></li> <li><a href="/wiki/Intravenous_immunoglobulin" class="mw-redirect" title="Intravenous immunoglobulin">Intravenous immunoglobulin</a></li> <li><a href="/wiki/Vaccine" title="Vaccine">Vaccines</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Malignant" class="mw-redirect" title="Malignant">malignant</a> disease (<a href="/wiki/ATC_code_L" title="ATC code L">L01–L02</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Chemotherapy" title="Chemotherapy">Anticancer agents</a> <ul><li><a href="/wiki/Antimetabolite" title="Antimetabolite">Antimetabolites</a></li> <li><a href="/wiki/Alkylating_antineoplastic_agent" title="Alkylating antineoplastic agent">Alkylating</a></li> <li><a href="/wiki/Spindle_poison" title="Spindle poison">Spindle poisons</a></li> <li><a href="/wiki/Antineoplastic" class="mw-redirect" title="Antineoplastic">Antineoplastic</a></li> <li><a href="/wiki/Topoisomerase_inhibitor" title="Topoisomerase inhibitor">Topoisomerase inhibitors</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Immune_system" title="Immune system">immune</a> disease (<a href="/wiki/ATC_code_L" title="ATC code L">L03–L04</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Immunomodulator" class="mw-redirect" title="Immunomodulator">Immunomodulators</a> <ul><li><a href="/wiki/Immunostimulant" title="Immunostimulant">Immunostimulants</a></li> <li><a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">Immunosuppressants</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Muscle" title="Muscle">muscles</a>, <a href="/wiki/Bone" title="Bone">bones</a>, and <a href="/wiki/Joint" title="Joint">joints</a> (<a href="/wiki/ATC_code_M" title="ATC code M">M</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Anabolic_steroid" title="Anabolic steroid">Anabolic steroids</a></li> <li><a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">Anti-inflammatories</a> <ul><li><a href="/wiki/Non-steroidal_anti-inflammatory_drug" class="mw-redirect" title="Non-steroidal anti-inflammatory drug">Non-steroidal anti-inflammatory drugs</a></li></ul></li> <li><a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">Antirheumatics</a></li> <li><a href="/wiki/Corticosteroid" title="Corticosteroid">Corticosteroids</a></li> <li><a href="/wiki/Muscle_relaxant" title="Muscle relaxant">Muscle relaxants</a></li> <li><a href="/wiki/Bisphosphonate" title="Bisphosphonate">Bisphosphonates</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">brain</a> and <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a> (<a href="/wiki/ATC_code_N" title="ATC code N">N</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Analgesic" title="Analgesic">Analgesics</a></li> <li><a href="/wiki/Anesthetic" title="Anesthetic">Anesthetics</a> <ul><li><a href="/wiki/General_anaesthetic" title="General anaesthetic">General</a></li> <li><a href="/wiki/Local_anesthetic" title="Local anesthetic">Local</a></li></ul></li> <li><a href="/wiki/Anorectic" title="Anorectic">Anorectics</a></li> <li><a href="/wiki/Antihyperkinetic" class="mw-redirect" title="Antihyperkinetic">Anti-ADHD agents</a></li> <li><a href="/wiki/Addiction_medicine" title="Addiction medicine">Antiaddictives</a></li> <li><a href="/wiki/Anticonvulsant" title="Anticonvulsant">Anticonvulsants</a></li> <li><a href="/wiki/Antidementia_drug" class="mw-redirect" title="Antidementia drug">Antidementia agents</a></li> <li><a href="/wiki/Antidepressant" title="Antidepressant">Antidepressants</a></li> <li><a href="/wiki/Antimigraine_drug" title="Antimigraine drug">Antimigraine agents</a></li> <li><a href="/wiki/Management_of_Parkinson%27s_disease#Medication" title="Management of Parkinson's disease">Antiparkinson agents</a></li> <li><a href="/wiki/Antipsychotic" title="Antipsychotic">Antipsychotics</a></li> <li><a href="/wiki/Anxiolytic" title="Anxiolytic">Anxiolytics</a></li> <li><a href="/wiki/Aphrodisiac" title="Aphrodisiac">Aphrodisiacs</a></li> <li><a href="/wiki/Depressant" title="Depressant">Depressants</a></li> <li><a href="/wiki/Entactogen" class="mw-redirect" title="Entactogen">Entactogens</a></li> <li><a href="/wiki/Entheogen" title="Entheogen">Entheogens</a></li> <li><a href="/wiki/Euphoria" title="Euphoria">Euphoriants</a></li> <li><a href="/wiki/Psychedelics,_dissociatives_and_deliriants" class="mw-redirect" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a> <ul><li><a href="/wiki/Psychedelic_drug" title="Psychedelic drug">Psychedelics</a></li> <li><a href="/wiki/Dissociative" title="Dissociative">Dissociatives</a></li> <li><a href="/wiki/Deliriant" title="Deliriant">Deliriants</a></li></ul></li> <li><a href="/wiki/Hypnotic" title="Hypnotic">Hypnotics</a> / <a href="/wiki/Sedative" title="Sedative">Sedatives</a></li> <li><a href="/wiki/Mood_stabilizer" title="Mood stabilizer">Mood stabilizers</a></li> <li><a href="/wiki/Motivation-enhancing_drug" title="Motivation-enhancing drug">Motivation-enhancing drug</a></li> <li><a href="/wiki/Neuroprotective" class="mw-redirect" title="Neuroprotective">Neuroprotectives</a></li> <li><a href="/wiki/Nootropic" title="Nootropic">Nootropics</a></li> <li><a href="/wiki/Neurotoxin" title="Neurotoxin">Neurotoxins</a></li> <li><a href="/wiki/Orexigenic" class="mw-redirect" title="Orexigenic">Orexigenics</a></li> <li><a href="/wiki/Serenic" title="Serenic">Serenics</a></li> <li><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a></li> <li><a href="/wiki/Wakefulness-promoting_agent" title="Wakefulness-promoting agent">Wakefulness-promoting agents</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Respiratory_system" title="Respiratory system">respiratory system</a> (<a href="/wiki/ATC_code_R" title="ATC code R">R</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Decongestant" title="Decongestant">Decongestants</a></li> <li><a href="/wiki/Bronchodilator" title="Bronchodilator">Bronchodilators</a></li> <li><a href="/wiki/Cough_medicine" class="mw-redirect" title="Cough medicine">Cough medicines</a></li> <li><a href="/wiki/H1_antagonist" title="H1 antagonist">H1 antagonists</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sense" title="Sense">sensory organs</a> (<a href="/wiki/ATC_code_S" title="ATC code S">S</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Ophthalmology" title="Ophthalmology">Ophthalmologicals</a></li> <li><a href="/wiki/Otology" title="Otology">Otologicals</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">other <a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC</a> (<a href="/wiki/ATC_code_V" title="ATC code V">V</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antidote" title="Antidote">Antidotes</a></li> <li><a href="/wiki/Contrast_medium" class="mw-redirect" title="Contrast medium">Contrast media</a></li> <li><a href="/wiki/Radiopharmacology" title="Radiopharmacology">Radiopharmaceuticals</a></li> <li><a href="/wiki/Dressing_(medicine)" title="Dressing (medicine)">Dressings</a></li> <li><a href="/wiki/Senotherapeutics" class="mw-redirect" title="Senotherapeutics">Senotherapeutics</a></li></ul> </div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <ul><li><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png" decoding="async" width="16" height="16" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/23px-Symbol_category_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/31px-Symbol_category_class.svg.png 2x" data-file-width="180" data-file-height="185" /> <a href="/wiki/Category:Drugs" title="Category:Drugs">Drugs</a></li> <li><a href="/wiki/Category:Pharmacological_classification_systems" title="Category:Pharmacological classification systems">Pharmacological classification systems</a></li> <li><a href="/wiki/Category:ATC_codes" title="Category:ATC codes">ATC codes</a></li> <li><a href="/wiki/File:Symbol_portal_class.svg" class="mw-file-description" title="Portal"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/16px-Symbol_portal_class.svg.png" decoding="async" width="16" height="16" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/23px-Symbol_portal_class.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e2/Symbol_portal_class.svg/31px-Symbol_portal_class.svg.png 2x" data-file-width="180" data-file-height="185" /></a> <a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine portal</a></li></ul> </div></td></tr></tbody></table></div>    </div><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Anticoagulant&oldid=1253673333">https://en.wikipedia.org/w/index.php?title=Anticoagulant&oldid=1253673333</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Anticoagulants" title="Category:Anticoagulants">Anticoagulants</a></li><li><a href="/wiki/Category:Blood_tests" title="Category:Blood tests">Blood tests</a></li><li><a href="/wiki/Category:Medical_signs" title="Category:Medical signs">Medical signs</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2021" title="Category:Articles with unsourced statements from November 2021">Articles with unsourced statements from November 2021</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2022" title="Category:Articles with unsourced statements from August 2022">Articles with unsourced statements from August 2022</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_November_2021" title="Category:Articles containing potentially dated statements from November 2021">Articles containing potentially dated statements from November 2021</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 27 October 2024, at 07:51 (UTC).</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Anticoagulant&mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://wikimediafoundation.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/static/images/footer/wikimedia-button.svg" width="84" height="29" alt="Wikimedia Foundation" loading="lazy"></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/w/resources/assets/poweredby_mediawiki.svg" alt="Powered by MediaWiki" width="88" height="31" loading="lazy"></a></li> </ul> </footer> </div> </div> </div> <div class="vector-settings" id="p-dock-bottom"> <ul></ul> </div><script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-f69cdc8f6-72jvb","wgBackendResponseTime":198,"wgPageParseReport":{"limitreport":{"cputime":"1.563","walltime":"1.725","ppvisitednodes":{"value":8630,"limit":1000000},"postexpandincludesize":{"value":412152,"limit":2097152},"templateargumentsize":{"value":2756,"limit":2097152},"expansiondepth":{"value":23,"limit":100},"expensivefunctioncount":{"value":7,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":547014,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00% 1462.345 1 -total"," 67.31% 984.265 1 Template:Reflist"," 43.57% 637.073 106 Template:Cite_journal"," 13.07% 191.061 19 Template:Cite_web"," 8.96% 130.968 5 Template:Navbox"," 7.42% 108.488 1 Template:Antithrombotics"," 5.54% 80.969 1 Template:Short_description"," 3.93% 57.427 1 Template:Infobox_drug_class"," 3.74% 54.714 1 Template:Infobox"," 3.73% 54.476 2 Template:Citation_needed"]},"scribunto":{"limitreport-timeusage":{"value":"0.962","limit":"10.000"},"limitreport-memusage":{"value":6692422,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-f69cdc8f6-g5pcr","timestamp":"20241122140504","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Anticoagulant","url":"https:\/\/en.wikipedia.org\/wiki\/Anticoagulant","sameAs":"http:\/\/www.wikidata.org\/entity\/Q215118","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q215118","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-02-02T16:45:43Z","dateModified":"2024-10-27T07:51:14Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/f\/f4\/Coagulation_Cascade_and_Major_Classes_of_Anticoagulants.png","headline":"chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time"}</script> </body> </html>